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Abstract
The aim of this study was to obtain a better understanding in the healing of 
LASlK-like flaps using an in vitro organ culture method in bovine corneas.
At early stages of the PhD, during protocol optimisation, a 5mm trephine was 
used to injure bovine corneas. At later stages a custom-made eye holder was used to 
induce LASIK-like incisions in corneas. Immunohistochemistry for a-smooth muscle 
actin (aSMA) and cytokeratin was used to monitor myofibroblast and epithelial cell 
expression, respectively, during the wound healing process. Additionally, the effect of 
certain cytokines (i.e. TNFa, Fas ligand, TGF-Pi and IL-la) was tested in terms of
corneal transparency, myofibroblast expression and tissue mechanical strength during the 
healing process. The later series of experiments was an attempt to manipulate and 
improve wound healing after LASIK. Healing in this in vitro system closely followed the 
effects that are already known from the literature. In addition, preliminary evidence on 
the cytokine corneas proved that there is a correlation between cytokine type and 
concentration with the effect in tissue transparency, extend of wound healing response 
and tissue mechanical strength.
X-ray diffraction also provided important information about collagen 
ultrastructural changes in the corneas during the healing process. Parameters such as 
fibrillar diameter, spacing, distribution and orientation were studied. Collagen fibrillar 
diameter and spacing remained constant for control corneas during the organ culture 
time-span, indicating that this in vitro system does not induce any swelling effects on the 
tissue. However, injured corneas became significantly swollen (p<0.05) during culture. 
Swelling effects were more severe in trephined corneas than in LASIK-like injured ones. 
However, collagen fibrillar diameter remained normal in the periphery of injured corneas, 
but it increased significantly in areas within and around the wound in trephined samples 
and in the flap incision site for LASIK-like ones. In both types of wounding, collagen 
orientation changes were observed and were associated with the process of creating the 
injury. However, in the case of trephine wounded corneas, tissue swelling and changes in 
collagen orientation reflected the processes of tissue repair. These differences will 
determine corneal stability and strength follow trauma and, possibly, refractive surgery.
The transparency of the cornea depends on both the collagen and the interstitial 
proteoglycans. In order to obtain a better insight in ultrastructural changes during the 
wound healing process molecular modelling techniques were used in order to construct a 
theoretical model for the core protein of biglycan. This molecule is a dermatan sulphate 
proteoglycan and its numbers increase up to seven times during wound healing. It is 
considerably larger than the rest of proteoglycans and molecular modelling also revealed 
numerous potential collagen interaction sites.
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1. Introduction
1.1 The Cornea
The cornea is a dome shaped transparent layer that is situated at the front of 
the eye globe. Its anterior part is covered by the tear film and its posterior side is in 
direct contact with the aqueous humor. Both the cornea and the tear film protect the 
eye from physical injury and from the invasion of pathogenic micro-organisms. The 
major function of the cornea is to refract and transmit light to the retina in order for 
visual function to occur.
The cornea consists mainly of epithelial cells, collagen, proteoglycans, 
keratocytes, water molecules and endothelial cells (Table 1.1). The organisation of 
collagen fibrils within the cornea and the lack of any vascular system make the cornea 
transparent. Corneal transparency is essential for normal visual function. Since there 
is no blood supply to the cornea, its oxygen is provided by the tear film and the 
metabolic requirements are provided by the aqueous humour.
Substance %
Water 78
Collagen 15
Other Proteins 5
Keratocytes 5
Keratan Sulphate 0.7
Chondroitin Sulphate 0.3
Salts 1
Table 1.1: The composition of the cornea.
(Table after Hogan 1971)
The cornea consists of five well-differentiated layers, i.e. the epithelium, 
Bowman’s layer, the stroma, Descemet’s membrane and the endothelium (Fig. 1.1).
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Figure 1.1: Anatomy of the cornea 
(Picture after www.northemvision.com 2003)
1.1.1 Tear film
The tear film is the superficial layer of the eye. Its anterior part is in direct 
contact with the air, whereas its posterior part is adjacent to the epithelial layer of the 
cornea. Initially it was proposed that the tear film consists of three layers: the lipid, 
the aqueous and the mucous layer (Wolf 1946). However, this was later challenged by 
(Dilly 1994) who proposed that the mucous and the aqueous layers are not discrete 
and they form a single layer. The same review also describes the tear film as a 
hydrated mucin gel with variable viscosity.
The lipid layer lies at the anterior side of the tear film and it prevents 
evaporation of the tear film and hence the cornea from the air. This layer is produced 
by the meibomian glands and the glands of Zeis and Mol. The aqueous portion is the 
major component of the tear film and it is produced by the main lacrimal glands and 
the accessory lacrimal glands such as the Krause and Wolffing glands. The mucous 
portion of the tear film is secreted by conjuctival goblet cells and it is a hydrophilic 
layer that covers and hydrates the anterior part of the cornea. The tears contain 
antimicrobial agents (i.e. lysozyme, lactoferrin and IgA) and hence the colonisation of 
potential pathogens is prevented (Azar 1997, Johnson and Murphy 2004).
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1.1.2 Epithelium
The comeal epithelium is a stratified, squamous, non-keratinised epithelium. 
In human, it is 5-6 cells thick (70pm) and it is subdivided into three different layers: 
the squamous, the wing and the basal cells.
The squamous cells are located at the anterior part of the epithelium. They are 
flat, polygonal cells that provide the cornea with a smooth surface (Saude 1993). 
What is more, these cells are joined with desmosomes and tight junctions. The tight 
junctions between the squamous cells make this layer a semipermeable membrane 
that controls the para-intracellular movement of substances and excess fluid from the 
tear film. Desmosomes between the cells provide the layer with even more adhesion. 
The existence of tight junctions and desmosomes make the epithelium difficult to 
penetrate and this feature of the squamous cells’ arrangement provides the cornea 
with protection against physical damage. Finally, the squamous cells have microvilli 
which attach to the tear film. These tiny projections keep the tear film in place.
The wing cells are flattened, polyhedral and they exist at the middle of the 
epithelium. In human cornea they are three layers thick and the cells are attached to 
each other with desmosomes and gap junctions. Wing cells are attached to the 
squamous cells and basal cells with desmosomes (Remington 1998).
The basal cells are one layer thick, located at the posterior surface of the 
epithelium and they are attached to each other via desmosomes and gap junctions. The 
basal cell layer is where mitosis of the epithelial cells takes place. After each mitotic 
division some of the basal cells differentiate to become middle and superficial cells 
(Azar 1997). Stem cells at the limbus are responsible for cell replacement and tissue 
regeneration. Basal cells have a completely different morphology from the cells of the 
squamous and wing layers since they have cubical or cylindrical forms with varying 
heights and rounded heads. The basal cells secrete the basement membrane that links 
the epithelium with the adjacent Bowman’s layer below by hemidesmosomes (Young 
et al 1994). Anchoring fibrils pass from these junctions through the Bowman’s layer 
to plaques of the extracellular matrix of the stroma. Finally, interdigitations and 
desmosomes link the basal cells with the wing cells above (Saude 1993). Corneal 
epithelial stem cells are located in the basal epithelial layer of the limbus. These cells 
are highly proliferative and are responsible for corneal epithelial cell proliferation and 
differentiation (Stepp and Zieske 2005).
3
1.13 Bowman’s layer
Bowman’s layer is one of the acellular parts of the cornea and it is 8-14 pm 
thick. It originates from the mesenchymal cell processes of the superficial stroma 
during embryogenesis (Azar 1997). It consists mainly of randomly arranged collagen 
fibrils. Due to its acellular nature it is incapable of regenerating itself after injury. 
However, its existence seems not to be crucial for proper vision function since some 
mammalian species do not posses any Bowman’s layer at all. Probably its existence in 
the cornea is correlated with providing the tissue with an extra layer and hence 
providing it with resistance to mechanical strength.
1.1.4 Stroma
The stroma (or substantia propria) is located at the middle of the cornea and it 
is the thickest layer (500 pm-90% of overall corneal thickness in human). It consists 
mainly of collagen lamellae, keratocytes and proteoglycans. The stroma is difficult to 
regenerate after injury and hence it is likely to develop opacities after disturbance. 
Types I, III, V, VI, XII and XIV are the main collagens in the corneal stroma (Meek 
and Fullwood 2001). All collagen fibrils have a uniform diameter and regular spacing. 
This feature is essential for the maintenance of corneal transparency (section 1.2). 
Collagen fibrils in any one lamella run in a parallel direction whereas lamellae are at a 
certain angle to each other and parallel to the corneal surface. With the anterior 
stroma being an exemption, each lamella runs across the entire cornea, i.e. from 
limbus to limbus (Remington 1998).
Keratocytes are differentiated mesenchymal fibroblasts and they actively 
produce and secrete substances for the production, maintenance and repair of 
proteoglycans, collagen and keratocytes (Azar 1997, Green 2003). They are flattened 
cells. The morphology and the anatomy of keratocytes differ throughout the stroma 
and according to Poole et al (2003) the keratocytes of the corneal stroma in humans 
form three distinctive layers (Fig. 1.2). The anterior layer is adjacent to the epithelium 
and Bowman’s layer and it has a higher cell density than the bulk of the rest of the 
stroma. Keratocyte density tends to be the highest in the anterior 10% of the stroma 
(Patel et al. 2001). Additionally, although keratocytes in this layer have a poor 
lamellar organisation they form an extensive network of branching and 
interconnecting cell bodies. The central layer has the least keratocyte density and the 
cells have variable orientation. Finally, keratocytes in the posterior layer have
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distinctive morphology and they are denser than the cells at the central layer. 
Keratocyte cell bodies are larger and are connected by small cell processes (Poole 
2003).
Figure 1.2: Anterior (A), Middle (B) and Posterior (C) stromal keratocytes of a 10- 
year old individual (Scale bar = 50 pm).
(Picture after Poole 2003)
The ground substance of the stroma is made up of proteoglycans (Fig. 1.3). 
These are macromolecules composed of a protein core and a carbohydrate 
glycosaminoglycan (GAG) side chain. GAG’s are hydrophilic, negative charged 
molecules located at specific sites around each collagen fibril (Remington 1998). 
According to Zieske (2001) the corneal stroma contains two major classes of 
proteoglycans containing either keratan sulphate side chains or dermatan/chondroitin 
side chains. Lumican, keratocan and mimecan are the major keratan sulphate PG’s, 
whereas decorin is the major dermatan/chondroitin PG (Fig. 1.3). Another heparan 
sulphate PG is heparin which exists in the basement membrane (Zieske 2001).
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Figure 1.3: Proteoglycans present at the cornea 
(Picture adapted from Zmuda-Trzebiatowska 1997)
1.1.5 Descemet’s Membrane
Descemet’s membrane is an acellular membrane that lies between the stroma 
and the endothelium. It is 8- 10pm thick and consists of three layers. It is composed of 
type IV collagea glycine and hydroxyproline (Azar 1997). Descemet’s membrane is 
secreted by the endothelium, it is capable of regenerating itself after a disturbance, it 
has good antigenic properties and its thickness increases with age (Saude 1993).
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1.1.6 Endothelium
The endothelium comprises a single layer of cells. These cells are flattened, 
hexagonal in shape with oval nuclei. Tight junctions join the cells, whereas 
intercellular communication is maintained by gap junctions. The main function of the 
endothelium is the maintenance of corneal hydration and it also allows the passage of 
ions, glucose, amino acids and water from the aqueous humour to the cornea. Glucose 
and amino acids diffuse into the cornea through a leaky barrier that is formed by the 
endothelial adhesions. Water and ions are actively transported by the endothelial 
pump. The Na+/K+-ATP pump system is the most important for water/ion exchange. 
Endothelial cells rarely divide and they decrease in number with age (Remington 
1998). Cell loss is compensated by an increase in endothelial cell size (Azar 1997). In 
cases where the cell density falls below a critical minimum, corneal hydration 
increases causing loss of transparency and visual impairment.
1.2 Corneal transparency
Corneal transparency is an essential requirement for visual function to occur. 
It is mainly due to the collagen and proteoglycan organisation of the stroma. In order 
for corneal transparency to be established, stromal collagen fibrils need to have 
uniform spacing. Collagen spacing is mainly controlled by proteoglycans that fill the 
space between the fibrils. Therefore, the physical and chemical properties of 
proteoglycans play an important role in establishing and maintaining corneal 
transparency. In order for an object to be transparent it must fulfil two basic 
requirements (Meek 2002). Firstly, it must not absorb light. Although glycoproteins in 
the stromal ECM absorb light in the electromagnetic spectrum below 310nm vision is 
not affected. In fact the ultraviolet radiation is harmful for the tissues. In contrast, 
none of the components of the cornea absorbs light in the visible region of the 
spectrum. Secondly, a transparent object must not scatter light. According to 
(Freegard 1997) it is essential that as little light as possible should be scattered in the 
forward direction relative to that transmitted in order for a clear image to be formed. 
Several models have already been proposed in order to explain light scattering and 
corneal transparency. The simplest model introduced the theory of the uniform 
refractive index of all corneal components. It is assumed that spacing between 
particles is very much less than the wavelength of light and hence light cannot 
distinguish between the fibrils and the material between them. Therefore light passes
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through the tissue without any scattering. In this case, the medium is considered to 
have a uniform refractive index different from unity. This has the effect of slowing 
down the light, but there is no scattering of light away in the forward direction. 
However, this is not the case since it has been shown that there is a small amount of 
scattering per particle (Maurice 1957). Other models introduced theories such as the 
perfect crystal or perturbed lattice arrangement of fibrils. The most realistic model 
was introduced by Hart and Farrell (1969) and proposes that only a short-range order 
in the packing of the collagen fibrils is required for the appropriate destructive 
interference of scattered photons to occur. There is disorder in the packing of 
collagen, but all fibrils are within a small range of distances from each other (Meek 
2003).
Figure 1.4: Collagen fibrils are within a small range of distances from each other
(Picture after Maurice 1957).
1.2.1 Collagen structure and organisation within the cornea
The overall mechanical strength of a connective tissue depends on the 
interfibrillar interactions of collagen molecules and the interactions of collagen with 
proteoglycans and water (Cameron 2002). Collagen has a special amino acid 
composition. Its major feature is that one in every three amino acids is a glycine and it 
adopts a Gly-X-Y pattern, where usually X is a proline and Y a hydroxyproline. 
Consequently, collagen does not appear to have a typical a-helical or (3-sheet 
conformation. The collagen helix has a left hand twist instead of the right handed one 
that is adopted by typical a-helical structures. This is due to the existence of 
hydroxyproline within the protein structure. This amino acid has a tendency of
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inducing a left handed twist and because it appears in high frequency within the 
collagen structure it causes the whole helix to obtain a left handed twist. A collagen 
fibril consists of three parallel helices joined together with hydrogen bonds in a left 
handed twist (Fig. 1.5). According to Rainey and Goh (2002) collagen is either a 
homotripeptide or heterotripeptide with a repeating primary sequence of (Gly-X-Z)n, 
displaying characteristic peptide backbone dihedral angles. Furthermore, glycine has 
the smallest side chain of all amino acids and this causes the three chains to pack 
together very tightly (Woodhead-Galloway 1980).
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Figure 1.5: The structure of collagen at different levels. Three subunits of the a- 
helical protein (a) coil together to form a collagen fibre (b and c). In a collagen fibril 
(d) many fibres are stuck together and separated by 67nm from one another 
lengthwise. This feature produces the black and white patches in electron micrographs 
representing collagen fibres (e). Collagen fibrils form lamellae in tissues (f).
(Picture after http://wwwfac.mcdaniel.edii/Chemistrv/CH3321JPGs/Proteins/CoHagen.iDg 2003)
Collagen organisation within the stroma is essential for corneal transparency. 
Out of the 19 known collagen types, at least 10 of them are expressed in the adult 
mammalian cornea (i.e. Types I, III, IV, V, VI, VII, VIII, XII, XIII and XVII). Most 
collagen types are fibrillar, however types IV, VI and VII are nor fibril forming 
collagen types (Zieske 2001). Predominantly, types I (85%), III (10%) and V (5%) 
collagen are present in the human corneal stroma (Marshall 1991). All collagen types 
are classified into three superfamilies. Class 1 or banded fibrillar collagens and have 
the typical D-period fibril appearance. Types I, III and V which are predominantly
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present at the cornea are Class 1 collagens. Class 2 are fibril associated collagens with 
interrupted triple helices (FACIT). Such collagen types do not form fibrils by them 
selves but interact with fibrillar collagens. Types XII and XIV are Class 2 collagens. 
Class 3 collagens have fibrillar structures, but they are not the same as Class 1 
collagens. Type VI is a Class3 collagen (Meek and Fullwood 2001).
Collagen fibrils within the bovine cornea have a diameter of 36 nm 
approximately and are parallel to one another forming the lamellae. Each lamella is 1- 
2 pm thick. Central regions in the human corneal stroma consist of about 200 stacked 
lamellae that run parallel to the corneal surface (Boote et al. 2006). Collagen fibrils 
within the cornea are packed in a short-range order. The axial periodicity corneal 
collagen is 65nm, slightly lower than in other collagenous tissues (e.g. tendon, 67nm) 
(Meek and Boote 2004). The average fibril diameter of corneal collagen in humans 
remains constant across the cornea; its value is in the region of 31nm and it can 
increase up to 34nm with age (Daxer et al. 1998, Meek and Boote 2004). Corneal 
proteoglycans lie in between the collagen fibrils assisting in the maintenance of 
normal interfibrillar spacing and therefore preserving transparency at the tissue. 
Under normal conditions in a transparent cornea the intermolecular spacing between 
the consituent molecules of a fibril is about 1.8nm (Malik et al. 1992, Meek and 
Boote 2004). In the peripheral cornea, collagen fibrils have a wider spacing than in 
central parts (Boote 2006). This is mainly due to the existence of chondroitin 
sulphate, a large PG, at the periphery. The corneal stroma has a tendency to swell 
easily since hydrophilic PGs attract water molecules (Freegard 1997). If the collagen 
arrangement within the corneal stroma is disrupted, light scattering might occur and 
therefore the cornea will not be transparent any more.
1.2.2 Proteoglycan structure, localisation and its role in corneal transparency
It is widely accepted that the properties of the extracellular matrix are highly 
correlated with its structural characteristics (Berthiaume et al. 1996, Fitton et al. 1998, 
Ranucci et al. 2000, Wu et al. 2003). The Extracellular Matrix (ECM) plays a key 
role in the maintenance and function of connective tissue and consists predominantly 
of collagen, proteoglycans, glycosaminoglycans and other minor proteins (Hocking 
1998).
Proteoglycans are macromolecules composed of a protein core and a 
carbohydrate glycosaminoglycan (GAG) side chain. GAG’s are highly hydrophilic,
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negatively charged molecules located at specific sites around each collagen fibril 
(Scott 1988) (Fig. 1.3). The core protein of a proteoglycan seems to be the most active 
part of the molecule and structurally it is a leucine zipper kind of protein that obtains a 
horse-shoe spatial arrangement. It interacts with the collagen fibrils and the 
extracellular matrix at specific sites. Consequently, they play an important role in 
corneal hydration. According to (Cintron 1989) the precise arrangement of PGs 
presumably reflects specific intermolecular interactions with collagens. Therefore, 
loss of PGs might cause alterations to the collagen organisation and hence to corneal 
transparency. For example, lumican, which is a keratan sulphate-containing 
proteoglycan, seems to play a key role in corneal transparency, since it is a key 
molecule in the neonatal development of the stromal matrix (Beecher et al. 2006) and 
it was also observed that mice homozygous for a null mutation in this molecule had 
opaque corneas ( Chakravarti et al. 1998, Quantock et al. 2001).
1.2.3 Hydration of the cornea
It should be taken into consideration that abnormal hydration of the cornea 
might cause serious disturbances in visual function. Corneal hydration is defined as 
the weight of water in the cornea divided by the dry weight of the tissue. Under 
normal conditions corneal hydration is around 3.2 and the tissue remains transparent 
(Hodson et al. 1991).
Wet _  weight -  Dry _  weight 
Dry weight
Figure 1.6: Equation for cornea hydration. Wet weight is the initial corneal weight. 
Dry weight is the weight of the tissue after the whole water content is being removed.
The mechanism by which the cornea maintains its level of hydration is called 
deturgescence. This is very important for comeal transparency and in healthy corneas 
there should be a constant proportion between solids and water (i.e. 22% solids to 
78% water) (Saude 1993). In cases where the endothelium is disturbed comeal 
hydration from the aqueous humour also becomes abnormal. Oedema or comeal 
swelling might appear, causing rearrangement of collagen fibrils in the stroma. The 
cornea becomes opaque and this might have severe implications in normal visual
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function. The force which the tissue swells is called swelling pressure and it is 
inversibly related to the hydration of the tissue (Hedbys and Dohlman 1963).
1.3 Corneal shape defects
Refractive errors in the eye are usually corrected by the use of the appropriate 
visual aids (e.g. spectacles or contact lenses). However, there are cases where the use 
of visual aids is inadequate and the refractive surgery approach is then preferred. The 
use of refractive surgery is considered in cases where the refractive error is minimized 
and hence the patient is able to use no spectacles or much smaller ones for their 
convenience. Additionally, refractive surgery might also be applied to patients who 
wish to eliminate completely their refractive error for their careers or jobs 
requirements or even for vanity.
The refractive power of the eye is predominantly determined by three 
variables: the refractive power of the cornea, the power of the lens and the length of 
the eye globe. Myopia or “near sightedness” is the most common refractive error 
(25% for Caucasians and 13% for African Americans) (Azar 1997). This condition 
occurs when the cornea is too steeply curved or the eye globe is too long. In this case, 
the light that enters the eye is focused in front of the retina (Fig. 1.6A). Patients 
suffering from myopia are unable to see clearly objects that are at a long distance.
Hyperopia or “far sightedness” affects almost 40% of the adult population, but 
is much less visually significant than myopia. Patients suffering from hyperopia are 
incapable of seeing clearly objects that are at a near distance. The great majority of 
young hyperopes regard themselves to be optically “normal”, but they may develop 
presbyopia and manifest hyperopia in their mid to late 30s (Azar 1997). In hyperopia 
light rays focus behind the retina (Fig. 1.6B) and the diffusion circles, which are 
formed result in a blurred and indistinctive image (Bores 2001). Hyperopia is a 
consequence of a too small eye globe or a too flattened cornea.
Almost 95% of the human population have some clinically detectable 
astigmatism. However, only a 3% - 15% has astigmatism greater than 2 diopters 
(Azar 1997). In this case, the radius of the curvature is not constant and the refractive 
powers varies across the cornea. People suffering from astigmatism have a blurred 
vision for objects situated in both near and long distance (Fig. 1.6C).
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Figure 1.7: In myopia light rays focus in front of the retina (A). In hyperopia light 
rays focus behind the retina (B). In astigmatism light rays do not focus at any one 
point, rather an area, resulting in a blurred distorted image (C).
(Picture after www.northemvision.com 2003)
1.4 Refractive surgery
Refractive surgery has been widely used for the correction of corneal shape 
defects. Refractive surgery originally involved incisions from a blade (i.e. radial 
keratotomy) but with technological developments excimer lasers are now widely used 
in order to reshape the cornea and correct various degrees of myopia and astigmatism. 
The excimer laser is an argon-fluoride gas combination, which is capable of creating a 
high-power ultraviolet light beam. Laser pulses are usually 193nm and they break 
organic molecular bonds. They also remove the tissue in the area of application, 
causing very little thermal damage to the rest of the adjacent tissues (Singerman and 
Coscas 1992). A number of different laser refractive procedures have been developed; 
most common of which are radial keratotomy (RK), photorefractive keratectomy 
(PRK), laser in situ keratomileusis (LASIK) and laser epithelial keratomileusis 
(LASER).
1.4.1 Radial keratotomy (RK)
In radial keratotomy, microscopic radial incisions are created in the cornea 
with the aid of an ultra-thin diamond scalpel. RK incisions weaken the outer cornea,
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so that it bulges forward slightly as a result there is flattening of the central cornea and 
a decrease of its refractive power. Experimental studies confirm that the deeper the 
incisions the more the cornea is centrally flattened postoperatively (Grimmett and 
Holland 1996). RK is recommended for 1.50 up to 5.00 diopters of myopia. Its 
advantages include minimal postoperative recovery time, not considerable pain, 
relatively low cost and it does not involve damage to the central cornea. 
Disadvantages include permanent weakening of the cornea, endothelial damage, 
possible infection, high rate of reoperation (up to 30%), regression, hyperopic shift 
and, for some patients, occasional fluctuation of vision and sensitivity to glare 
(Chaudhry 1999).
1.4.2 Photorefractive keratectomy (PRK)
In PRK the excimer laser (193nm) sculpts the cornea into a flatter shape to 
correct vision in myopia. Each pulse of laser energy disrupts the molecular bonds of 
the cornea and removes 0.2-0.3 pm of tissue. Most of the heat is dissipated into the air, 
and there is minimal thermal or radiation damage to the underlying tissue which 
remains structurally normal. The laser is programmed to remove more tissue centrally 
than peripherally for the correction of myopia. As a result, the central cornea is 
flattened and normal focus ability is obtained. Elliptical ablations are created for the 
correction of astigmatism. The laser beam quality and the frequency of the pulses 
administered are controlled by an algorithm (Fagerholm 2000).
PRK proved to be a more precise and a better technique than RK. PRK does 
not involve deep cuts into the cornea and therefore does not weaken the cornea 
(Chaudhry 1999).
PRK causes damage in the central cornea, includes considerable postoperative 
pain and longer recovery, due to the establishment of epithelial debridement after 
surgery (Shah 2001). Immediately after PRK the anterior part of the stroma is covered 
by a pseudomembrane (20-100nm thick). It is degraded by plasmin and MMPs within 
a few hours postoperatively (Corbett and Marshall 1996). In addition, disturbance of 
the comeal epithelium and Bowman's membrane may lead to an increase of the 
incidence of comeal haze and scarring. Another drawback is the risk of a decentred 
ablation, which can result in irregular astigmatism (Singerman and Coscas 1999).
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1.4.3 Laser in situ keratomileusis (LASIK)
In LASIK an automated microkeratome creates a thin layer of corneal tissue 
(flap) that covers the area to be sculpted by the laser. This flap allows for rapid 
recovery of vision and reduces discomfort after surgery. The flap is left hinged at one 
side, is lifted and placed aside. Then a computer-controlled excimer laser sculpts the 
underlying cornea, correcting the refractive error. The flap is repositioned without 
sutures and is secure after a few minutes so that a patch is not required. Visual 
recovery is typically rapid, and there is little or no postoperative pain (Azar and Farah 
1998). Additionally, LASIK is considered to be superior in efficacy and safety when 
compared to other popular refractive surgery procedures (Shortt et al. 2006).
The most important drawback of LASIK is that wound healing response is 
very poor and occurs only at the edge of the flap. A small increase in the expression 
of specific cytokines such as HGF and HGF-a is noted shortly after surgery at the flap 
edge. Proliferative cells of the epithelium release IL-lp, TGF-a and PDGF-BB, 
trigger keratocyte apoptosis in the stroma near the flap margins (Philipp 2003). ECM 
proteins such as fibrinogen and tenascin do not seem to appear after LASIK and hence 
the wound healing process depends only on the epithelial-stromal interaction. The 
strict localisation of fibrosis marginally at the flap edge, contrary to the minimal 
fibrosis below the entire flap, suggests that the LASIK interface never heals (Ivarsen 
2003). Also there is a decrease in keratocyte numbers and this loss of cell numbers is 
reported to continue up to 3yrs after surgery (Erie et al. 2006). Additionally, epithelial 
ingrowth results in haze and focal stromal loss at the flap margin (Perez-Santonja 
1998). After LASIK the cornea might be weakened, resulting in loss of its 
biomechanical stability. This causes postoperative keratoectasia and may have severe 
implications in visual function (Pallikaris et al. 2001). The incidence of ectasia after 
LASIK is not known precisely, but according to American Society of Cataract and 
Refractive Surgery (ASCRS 2003) has been estimated to be between 0.2-0.66% 
(Pallikaris et al. 2001). Ectasia can be defined as progressive non-inflammatory 
corneal thinning after surgery resulting in irregular topographic steepening and 
resultant irregular astigmatism (Chan and Boxer-Walcher 2006). However, it has been 
recently proposed that insights into the biomechanics and genetics of the cornea 
may help to further reduce the occurrence of corneal ectasia after LASIK 
(Rabinowitz 2006). In addition, recent studies suggest different approaches to
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enhance the healing response of LASIK flaps and therefore increase the 
mechanical stability of the tissue. Kymionis et al. (2006) proposes that “Intacs” 
implantation can be an effective approach in preventing post-LASIK ectasia and 
Abdelkader et al (2006) suggests that the addition of sutures in the corneal flap 
after LASIK appears to stimulate a stronger wound-healing response at the edge of 
the flap and therefore to improve the long-term stability of LASIK surgery in 
borderline thin corneas.
Late traumatic flap dislocations are rare but they have been reported in several 
cases (Melki 2000, Iskander 2001, Heickell 2004, Landau 2006). The limited 
peripheral wound healing response after LASIK is not usually enough to secure the 
flap and make it patent under mechanical or pressure stress (Crawford 2003). This is 
the reason why people who have had LASIK are disqualified from becoming pilots in 
combat aircraft jets in certain countries (Levy 2003). LASIK surgery may also induce 
epithelial defects to the cornea. Epithelial defects or erosion is seen in 1-3% of 
patients undergoing LASIK. This condition is mainly caused by the tangential 
shearing effect of friction caused by the movement of the microkeratome over the 
cornea. It should be taken into consideration that the epithelium in the superior cornea 
is hypoxic and hence more vulnerable. In rare cases the whole epithelium may slide as 
a sheet, denuding the whole flap. Patients who develop epithelial defects after LASIK 
are more susceptible to develop eye infections (Wilson 1998).
1.4.4 Laser epithelial keratomileusis (LASEK)
In this particular approach a thinner flap is created as the comeal epithelium is 
peeled off. In contrast with LASIK, a microkeratome is not used and the flap is 
created by chemical agents (i.e. alcohol). There are two basic types of LASEK flap: 
one with a superior hinge and the other nasal and temporal hinges. The epithelial 
basement membrane is delaminated using ethanol (18%) placed in an alcohol well for 
30 seconds and then washed off with balanced salt solutions (Shah and Kumar 2003). 
The hinged flap is lifted back and an excimer laser corrects the defect. LASEK is used 
for the correction of myopia, astigmatism and hyperopia. It is a relative new technique 
and it is considered as an alternative to PRK because it causes less haze and 
postoperative pain and as an alternative to LASIK because there are no interface 
problems and there is less tissue to recover after surgery. However, according to
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Litwak et al. (2002) LASEK did not result in faster visual rehabilitation than PRK in 
patients with low to moderate myopia. Indeed, LASIK proved to have a faster 
recovery time than LASEK.
1.5 Wound healing
Wound healing in general occurs in several different phases: acute 
inflammation, proliferative stage, angiogenesis and remodelling phase 
(epithelialisation) (Bale 2000). Blood loss (haemorrhage) after injury is eliminated 
through vasoconstriction and the coagulation cascades. The coagulation pathway 
results in the formation of a fibrin clot that seals the damaged blood vessels (Clark 
1993). Platelets degranulate and release cytokines (i.e. PDGF, PGF, TGF-p, EGF and 
IGF) that stimulate various leucocytes. Blood supply increases at the wound site 
(inflammation). Polymorphonuclear cells and monocytes attack pathogens at the 
wound site. During the proliferative stage, fibroblast number increases and 
myofibroblasts appear. Growth factors such as TGF-P, PDGF and EGF regulate the 
stimulation or the inhibition of the fibroblasts. The action of myofibroblasts is 
regulated by an autocrine pathway (Bale 2000). Subsequently, epithelial cells migrate 
over the surface of the wound and restore the epithelial barrier. New vessel formation 
and subsequent vascular restoration also occur during this phase. Finally, during the 
remodelling phase cell numbers return to normal levels. Granulation tissue replaces 
the fibrin clot within the wound. Mature granulation tissue produces a scar, but at the 
end it is covered by a viable epidermal surface (Iocono 1998).
1.5.1 Corneal Wound Healing
Wound healing in all body parts follows a similar pattern with local variations. 
In the cornea because of the lack of a vascular system, the inflammatory stage of 
wound repair and granulation are usually minimal or non-existent. In general, upon 
injury corneal epithelial cells and activated stromal fibroblasts secrete growth factors 
and cytokines that have paracrine and autocrine functions (Lim et al. 2003). Corneal 
repair might last up to several weeks after injury and the wound healing response in 
the cornea can differ for the various refractive surgery approaches discussed in 
Section 1.4.
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1.5.2 Epithelial Wound Healing
Comeal epithelia wound healing occurs in three stages: a) the latent phase, b) 
cell migration and adhesion and c) cell proliferation. The first phase occurs within 4 
to 6 hours after wounding. PMNs are derived from the tear fluid and they remove the 
necrotic tissue. After epithelial debridement basal cells start flattening and separating 
(Lu et al 2001). Hemidesmosomal attachments between the basal membrane and the 
basal cells disappear to approximately 70pm outward from the wound margin. The 
epithelium immediately adjacent to the wound exhibits lamellipodial and filopodial 
extensions. During cell migration and adhesion the extension of filopodia and 
lamellopodia is completed. Cell bodies become larger and they move forward. 
Finally, once the wound defect is completely covered hemidesmosomes are reformed 
(Steele 1999). During homeostasis and following injury to the comeal epithelium, the 
limbal stem cells divide to produce transient amplifying cells (TACs) that proliferate, 
migrate and differentiate into post mitotic cells (PMCs) and subsequently terminally 
differentiated cells (TDCs). The later ones replace lost cells in the wound area 
(Daniels and Khaw 2000).
Cytokines are also considered to have important roles in epithelial wound 
healing. The levels of IL-1 and IL-6 rise immediately after wounding and they initiate 
the cascade of epithelial wound healing events. IL-1 induces keratocyte growth Factor 
(KGF) and HGF expression in comeal fibroblasts, causing epithelial cell proliferation. 
KGF is a paracrine effector of comeal epithelial cells accelerating comeal epithelial 
cell growth (Wilson 1999). Cytokines such as the epidermal growth factor (EGF), 
KGF and HGF induce mitogenic activity and subsequent cell proliferation in comeal 
epithelial cells (Bansal and Veenashree 2001). In contrast, TGF-pl and TGF-p2 
inhibit and have no effect on epithelial cell proliferation, respectively (Carrington et 
al 2006). The relationships between EGF, KGF, HGF and TGF-p are thought to be 
responsible for comeal epithelial wound healing (Baldwin and Marshall 2002). HGF 
was found to have a delaying and KGF an accelerating effect on epithelial cell 
proliferation. It was also proposed that HGF causes the formation of an abnormal 
epithelium but also causes extensive differentiation of keratocytes into myofibroblasts 
(Carrington and Boulton 2005).
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1.5.3 Stromal wound healing
Shortly after wounding keratocytes undergo programmed death (i.e. 
apoptosis), phenotypic change and finally proliferation and migration (Helena 1998). 
These processes are stimulated by the presence of certain cytokines. Immediately after 
wounding keratocyte apoptosis occurs in areas below the epithelial wound. Apoptosis 
in the comeal stroma is triggered by IL-1 a, the Fas-Fas ligand and bone morphogenic 
protein 2 and 4 (Wilson and Kim 1998, Lim et al. 2003). However, a week after 
surgery keratocyte number is elevated rapidly. These remaining keratocytes start to 
undergo fibroblastic transformation into myofibroblasts with resulting expansion of 
the fibroblast population by mitosis after approximately 48 to 72 hours, which reaches 
its peak between three to six days, whilst new connective tissue is synthesised (Mohan 
2003). The new keratocytes are created by mitotic division of cells peripheral to the 
epithelial defect and they migrate into the wound. The activated fibroblasts under the 
influence of the TGF-p/CTGF system synthesise new extracellular matrix 
components (i.e. collagens, glycoproteins, proteoglycans) which form the scar tissue 
(Lim et al. 2003).
During wound healing chondroitin/dermatan sulphate levels increase 
significantly. Consequently, the newly synthesised collagen fibrils are larger in 
diameter than normal ones. This variation in collagen fibril diameter may cause 
disruption of comeal transparency and scarring. Initially, the extracellular matrix, 
which normally contains high levels of type IV collagen, laminin and proteoglycans 
(i.e. keratan sulphate, dermatan sulphate and heparan sulphate) is also disorganised 
(Ishizaki et al 1994, Saika 1998). Stromal remodelling is thought to be controlled, in 
part at least, by various MMPs, e.g. collagenase, stromelysin and gelatinase. Removal 
of damaged collagen fibres is performed by polymorphonuclear leukocytes. After 
almost two years, the lamellar collagen pattern is almost back to normal dimensions 
but with shorter and narrower lamellae. The strength of comeal scars never reaches 
that of uninjured comeal tissue (Steele 1999).
1.5.4 Synopsis of corneal wound healing
Shortly upon epithelial/stromal injury epithelial cells are believed to release 
IL-1 p towards the stroma. Stromal cells then release KGF that causes the stem cells in 
the limbal region to proliferate and differentiate into terminally differentiated
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epithelial cells. Myofibroblasts at the wound site in the stroma release HGF that acts 
as a chemoattractant for the newly formed epithelial cells. This causes the epithelial 
cell migration towards the wound site in order for the defect to be covered. Shortly 
after the epithelial cell migration is completed, apoptosis of stromal cells occurs in the 
stroma. Finally the remaining quiescent keratocytes transform into myofibroblasts and 
the stromal wound repair process is initiated (Fig. 1.7).
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Figure 1.8: Overview of the corneal wound healing process.
1.5.5 Proteoglycan and matrix metalloproteinase alterations during the wound 
healing process
Several weeks after laser surgery regions of the ECM at the wounded area 
contain large amounts of unusually large sized proteoglycan molecules (i.e. 
chondroitin/ dermatan sulphate). Additionally, keratan sulphate appears to be 
transiently undersulphated, whereas chondroitin/ dermatan sulphate oversulphated. In 
case of LASIK these alterations in the proteoglycan molecules occur in response to 
the insult that occurred in the stroma (Quantock et a l 2003).
Dermatan sulphate proteoglycans are small leucine rich proteins (SLRPs) with 
an ‘'arc’’ shaped spatial conformation and tend to form dimers. The amino-acid 
sequence of these proteins is characterised by long arrays of leucine-rich repeat motifs 
of about 24 amino acids in length (Jolles 1994). A feature that is of great interest 
about SLRPs is that they contain an amphipathic consensus sequence, with leucine as 
the predominant hydrophobic residue placed in conserved positions (Hocking 1998).
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Right after LASIK there is a dramatic reduction of a3 -  a6 type IV collagen 
chains in the epithelial basement membrane at the transected flap. This finding 
suggests that the LASIK flap acquires an early developmental character during 
remodelling, since this type of collagen is almost absent during human embryonic 
development. There are also great amounts of al -  a3 type IV collagen present. These 
alterations in type IV collagen may be caused by the selective activity of selected 
MMPs. Fibrosed areas of the anterior stroma appear to have increased levels of MMP- 
1 and MMP-2. These MMPs cause loss of the a3 -  a6 type IV collagen in the 
epithelial basement membrane. Extensive action of these certain MMPs and 
subsequent collagen IV loss might result on flap ectasia after LASIK (Maguen 2002).
1.6 Introduction and theoretical background of laboratory techniques to be 
used in this study
1.6.1 Organ culture
There are several models for studying corneal wound healing. However, the organ 
culture model that was introduced by Foreman et al. (1996) is one of the most 
representative. This is a simple air interface model in which full thickness re- 
epithelialisation of wounds occurs and it is possible to assess the role of growth 
factors in corneal wound healing (Fig. 1.8).
Excisional
trephine
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Figure 1.9: Diagram of the organ culture model. 
(Picture after Foreman 1996)
This method has various advantages over other methods that have been used 
for studying wound healing. Firstly, it is less expensive than in vivo studies and also it
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reduces using animal experiments. Secondly, it is more accurate and reliable than cell 
culture techniques since the whole organ is cultured and therefore various cell 
processes (i.e. wound healing) are mimicked more accurately. Finally, in submerged 
organ cultures, corneas appeared to have epithelial and stromal oedema and 
keratocyte deterioration (Foreman et al 1996).
Many studies have used successfully corneal organ culture techniques to study 
the wound healing process (Foreman et al 1996, Carrington and Boulton 2005, 
Carrington et a l 2006, Zhao et al 2006). However, it must be taken into 
consideration that an in vitro system lacks certain factors essential for the wound 
healing process. Such parameters are the absence of any tear cytokines, nerve 
responses and intraocular pressure fluctuations in response to injury. However, the 
lack of these parameters has not been an issue in previous in vitro corneal wound 
healing studies.
1.6.2 Light microscopy
In light microscopy visible light and lenses are used to magnify the specimens. 
Light microscopes can magnify up to 1500 times and have a resolution limit of about
0.2pm. There are six different types of light microscopy: dark field illumination, 
fluorescence microscopy, phase contrast, nomarski or differential interference 
contrast, polarised light microscopy and confocal (Reed 1998). Preparation of the 
tissue involves fixation, processing, sectioning and staining. Histological Staining 
(e.g. using Haematoxylin and Eosin stains) or immunostaining (using various 
antibodies) might be preferable for phase contrast microscopy.
1.6.3 Electron microscopy
In electron microscopy radiation at short wavelength in the form of an electron 
beam is used. The electrons are produced by a tungsten filament and are focused by 
electromagnets. In transmission electron microscopy (TEM) a very short wavelength 
beam of electrons is accelerated by an electric field. Finally the electron beam passes 
through the specimen. Then the image is formed on a fluorescent screen. A 
transmission electron microscope magnifies up to 200 000 times and has a resolution 
limit of lnm for biological specimens. It principally uses a fine electron beam, which 
is subsequently reflected from a metal-coated specimen surface. The secondary 
electrons that are generated from the specimen-surface impact are collected by a
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scintillation crystal that converts each electron impact into a flash of light. Each flash 
of light generated inside the crystal is then amplified by a photomultiplier and used to 
build up an image on a fluorescent screen. In histology, chemical agents called 
histological stains are applied to specimens in order to increase contrast and hence the 
resolution. Heavy metals are used for specimens for electron microscopy. In TEM 
contrast is enhanced by incorporating heavy metal salts into the specimens. In this 
case electron absorption is increased. Immunogold staining is preferred because gold 
is an electron dense element and more particularly, the use of antibodies allows 
specific molecules to be stained (Wilson and Walker 1997).
In TEM the tissue undergoes a fixation and embedding procedure. The tissue 
is initially submerged in a fixative solution (e.g. paraformaldehyde or glutaraldehyde). 
These solutions cross-link different protein groups within the tissue and preserve the 
structures. The second step of this procedure involves the staining of the tissue with 
certain heavy metals, in order for further electron contrast to be achieved. Cuprolinic 
Blue is extensively used for proteoglycan localisation experiments. This chemical 
complexes with negatively charged GAGs and it is later enhanced by the addition of 
tungstate groups (Scott and Stockwell 1967). Then the dehydration and infiltration 
step follows. In this case, the embedding medium replaces the water content of the 
tissue. Embedding media are water insoluble solutions. Epoxy resin is an embedding 
medium and provides support to the tissue when it finally stabilises (polymerises). 
Once the tissue has been embedded then ultrathin sections (less than 600A or 70-100 
nm) are obtained by using an ultramicrotome. Finally, the section undergoes further 
staining with a heavy metal salt solution (e.g. OSO4). This step is carried out in order 
to enhance contrast under the EM (Meek 1981).
1.6.4 X-ray diffraction
X-rays are electromagnetic radiation with typical photon energies in the range 
of 100 eV-100 keV. For diffraction experiments short wavelength x-rays (i.e. 1-120 
keV) are produced by either x-ray tubes or synchroton radiation.
In the current project synchroton x-ray radiation was used in order to map 
corneal collagens. Synchroton radiation is emitted by electrons or positrons travelling 
at close to the speed of light in a circular storage ring. The electron beam hits the 
tissue and the scattering pattern is related to the structural properties of the tissue. 
However, precise information about the structural properties of macromolecules
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cannot be obtained directly from x-rays, as there are no lenses to bend and focus the 
scattered x-rays. X-ray images have to further be reconstructed using computer 
analysis in order to obtain structural information of the scanned tissue (Hendrickson 
1986).
X-rays scatter through differing angles when they interact with biological 
tissues (Fig.: 1.10). Different levels of interference occur as a result and they are 
dependent on the degree of order in the structure. Perfect or near perfect order will 
produce true diffraction maxima. Less ordered structures would produce more diffuse 
interference maxima (i.e. x-ray reflections), which are being produced by the 
existence of many fibres. The series of reflections arising from a given periodic 
structure is numbered consequently from the centre of the pattern outward (Meek and 
Quantock 2001).
Figure 1.10: Visual representation of the x-ray diffraction technique. A 
bundle of vertically arranged collagen fibrils produce meridional x-ray reflections, 
which are parallel to the fibril axes and equatorial reflections and are perpendicular to 
the fibril axes (Meek and Quantock 2001)
X-ray scattering has been established as a very powerful experimental research 
tool for examining corneal ultrastucture (Meek and Quantock 2001, Boote et al. 
2005). The X-ray diffraction technique for generally measuring the interfibrillar 
spacing and diameter is proven to be more accurate than known TEM techniques. 
TEM is a time consuming, complex procedure and the whole processing and sample 
preparation compromises the physical state of the tissue. Consequently, electron
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micrographs underestimate the centre-to-centre distance of collagen fibrils (Fullwood 
and Meek 1993, Meek and Boote 2004). On the other hand x-ray diffraction 
techniques are less invasive to the tissue and with the improvement of technology is 
an effective technique that helps in the physical preservation of the tissue during data 
collection.
1.6.5 Molecular modelling
Molecular modelling is the computer aided prediction of the structure of 
behaviour of molecules. It is a fast growing and powerful technique that is used in 
the fields of computational chemistry (i.e. chemoinformatics), biology (i.e. 
bioinformatics) and materials science for the study of a range of small molecular 
structures to larger macromolecules and material assemblies. The use of 
computers and knowledge of programming is essential for molecular modeling 
methods. The benefit of molecular modelling is that it predicts the behaviour of 
molecular systems before trying experiments in the lab, saving time, money and 
effort in research.
Homology modeling or comparative modelling is the prediction of the 
structure of an unknown protein, based on information of its sequence and the 
structure of other known proteins that share similar sequence and functional 
aspects with the unknown protein. Comparative modelling exploits the structural 
similarities between proteins by constructing a three-dimensional structures of one 
or more related proteins (Leach 2001). Homology modelling is based on the 
simple principle that proteins with similar sequence tend to have similar three- 
dimensional structures (Chothia and Lesk 1986).
1.7 Aims and objectives
This project was based on the simple hypothesis that wound healing in the 
cornea is incomplete after LASIK surgery. The main aim was then set to identify why 
corneal wound healing is incomplete after LASIK. The objectives that were set in 
order to achieve this aim, were to develop an in vitro model for studying wound 
healing after LASIK, identify and test factors that affect wound healing, assess wound 
healing using histological analysis, mechanical strength testing and transparency
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assessment. Finally, ultrastructural analysis was carried out by means of x-ray 
diffraction, transmission electron microscopy and molecular modelling.
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2. Method development for microscopy laboratory techniques
2.1 Organ Culture
Bovine eye globes were obtained from the Ciderford abattoir and transported 
to the laboratory on ice. Healthy eyes with clear/transparent corneas were processed 
for organ culture as previously described by Foreman et al (1996) within the same 
day of slaughter. Initially excess tissue was removed from the exterior of the eyes. 
The cleared eye globes were submerged in 25% (v/v with PBS) Betadine solution for 
3-5min to decontaminate the exterior of the eye globes and then washed with sterile 
PBS solution. The eyes were then dissected using a surgical blade and their corneas 
were isolated. Two different groups of corneas were cultured. Half of them were 
wounded (either trephined or in a LASIK-like manner) and half of them were 
unwounded and acted as controls. For trephine wounded corneas, a 5mm trephine was 
used. The wound extended half-way through the stroma and upon wounding the 5mm 
disc was excised. Trephine wounding was used in this project as a methodological 
development as well as a correlation to LASIK-like flaps. For LASIK-like incisions a 
custom made devise that was developed locally was used to create a stromal flap 
ranging 180-250nm in thickness. After the induction of the wounds the eyes were 
dissected, the corneas removed and the rest of the eye globe discarded. The posterior 
endothelial cavity of each cornea was filled with an agar-gelatin support gel (appendix 
III). As soon as the gel had set at RT the corneas were inverted and placed in a 60mm 
tissue culture dish (Fig. 2.1). Serum-free Trowells T8 medium containing antibiotics 
and fungizone (see appendix III) was placed into the dishes up to the limbal area to 
preserve the corneas during the culture period. The medium was replaced every four 
days during the culture period. 200pl of medium was dripped at certain times on the 
comeal surface twice every 24hrs throughout the duration of the experiment, in order 
to prevent the comeal surface from drying out.
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Figure 2.1: Diagram of the organ culture model. 
(Picture after Foreman et al. 1996)
2.2 Light Microscopy
2.2.1 Preparation of Frozen Sections
Corneas (n=16) were removed from the culture at different time-points (0, 1, 
3, 7, 14, 21 and 28 days) and they were bisected. Each half was placed in a foil 
mould, which was filled with Tissue-Tek OCT compound. The foil container was 
placed in pre-cooled iso-pentane solution and then placed in liquid nitrogen until the 
whole block had frozen. Frozen blocks were kept at -20°C.
Frozen blocks were trimmed and 7pm-thick sections were obtained using a 
cryostat (Fig.2.2). The sections were then transferred to SuperFrost Plus microscope 
slides and allowed to air-dry for l-4hrs at RT. The slides were submerged in ice-cold 
methanol for 5min and then left on the bench to air-dry for lOmin. Finally the slides 
were wrapped in aluminium foil and kept at -20°C until further processing.
Figure 2.2: The Cryostat (Leica, UK)
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2.2.2 Preparation of wax sections and method development
Corneas (n=16) were removed from the culture at different time-points (0, 1, 
3, 7, 14, 21 and 28 days) and they were fixed in 10% Neutral Buffered Formalin 
(NBF).
Approach No 1:
Fixed corneas were dehydrated by treating the samples with a series of 
increasing alcohol dilutions (50%, 70%, 90%, 100%, 100% - v/v with ddFbO) at 
60min intervals. Dehydrated samples were washed once with 50% chloroform (v/v 
with IMS) for 60min and twice with 100% chloroform. Finally, the corneas were 
embedded in paraffin wax.
Final protocol:
Steps were repeated as described above but changing two parameters:
1. The tissue was fixed in 10% NBF and processed within 48hrs.
2. Incubation times were eliminated to 30min instead of 60min.
Wax blocks were trimmed and 7pm-thick sections were obtained by using a 
microtome (Fig. 2.3). The sections were then placed in a water bath (almost 45 °C) 
and they were allowed to flatten. Finally, the sections were collected from the water 
bath by floating on to Histobond slides. The slides were allowed to dry overnight in a 
56°C oven.
Figure 2.3: The Microtome (leica, UK)
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2.2.3 Haematoxylin and Eosin Staining
Wax sections were passed through a series of xylene and alcohol solutions in 
order to dewax and rehydrate the sections. Initially, the slides were submerged twice 
in xylene solutions (5min each). Then the sections were passed through a decreasing 
series of alcohol dilutions (100%, 90%, 70%, 50% - lmin each). The slides were then 
washed briefly in tap water to remove excess alcohol. The sections were stained with 
filtered Harris’ Haematoxylin for 3min and washed under tap water. Subsequently, 
the sections were counterstained with Eosin for lmin. The slides were then washed 
with water very briefly and then passed through an increasing series of alcohol. 
Finally, the slides were immersed in xylene for lmin and then the sections were 
mounted with coverslips using Xylene-Mounting medium.
Frozen sections were removed from -20°C and they were let to cool down wrapped at 
aluminium foil at RT for 30min. Then they were counterstained with Haematoxylin 
and Eosin. Finally, the sections were mounted by using Hydromount.
2.2.4 Cytokeratin 3 and PAN cytokeratin immunostaining and method 
development
Several approaches were followed in order to optimise the protocol for 
immunohistochemistry. In all cases negative control samples were used. Negative 
controls were not treated with primary antibody.
Approach No 1:
7pm frozen sections were fixed in acetone for lOmin and left on bench to air 
dry for another 5min. Sections were incubated with 0.6% hydrogen peroxide in 
Methanol for 5min. The slides were subsequently treated with 0.1 mg/ml Trypsin 
containing solution for 30min at 37 °C. Then, the slides were treated with 0.1% (v/v) 
Triton xlOO for 30min at 37°C. The slides were incubated with 20% goat serum for 
20min at RT. The serum was tapped off the slides and cytokeratin (ICN Biomedicals) 
primary Ab (1/100) was applied to slides for 60min at RT. The slides were incubated 
with goat mouse-IgG biotinylated secondary Ab (1/50) for lhr at RT and then the 
staining was developed with diaminobenzidine (DAB). Between each step three PBS 
washes were taking place. The sections were dehydrated and mounted using Xylene- 
Mounting medium (DPX) and the slides were kept at RT.
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Approach No 2:
Same as above, but frozen sections were left on bench to air dry for l-4hrs 
before fixing in acetone and two different dilutions of cytokeratin primary Ab was 
used (i.e. 1/100 and 1/200). Additionally, PBS washes were performed on the slides 
and wash time was extended to lOminutes each wash, in order to eliminate hassle to 
the tissue and avoid epithelium detachment from the underlying stroma.
Approach No 3:
Same as above but slides were left on bench to airdry overnight before the 
acetone fixation and PAN cytokeratin (1/25, 1/50, 1/100) as well as cytokeratin 3 
(1/100) were used as a primary Abs.
Approach No 4:
7 pm frozen sections left on bench to air-dry overnight and fixed with acetone 
as described before. Endogenous peroxidase activity was blocked by treating the 
slides with 0.6% hydrogen peroxide for 5min. Sections were washed briefly with 
ddtkO and washed with PBS (DAKO, pH 7) on the slide for lOmin. 20% goat serum 
was applied to the sections for 20min. The serum was subsequently tapped off the 
slides and PAN Cytokeratin primary Ab (1/25, 1/50, 1/100) was applied overnight at 
4°C. The slides were then incubated with AlexaFluor® goat mouse-IgG at 1/1000 
dilution for 2hrs in the dark at RT. The sections were mounted using Hydromount. 
The slides were then wrapped in aluminium foil, left at 4°C O/N or at -20°C for a 
longer period. Between each step three PBS washes were taking place.
Approach No 5:
Same as above, but slides were incubated with 10 mg/ml Proteinase K buffer 
for 20min at 37°C.
Approach No 6-Final optimised protocol:
7pm wax sections were wax cleared and rehydrated. Sections were incubated 
with 3% hydrogen peroxide in ddH20 for 5min in order to block endogenous 
peroxidase activity within the tissue. The slides were subsequently treated with 
0.1 mg/ml Trypsin containing solution for 30min at 37°C. Then, the slides were treated 
with 0.1% (v/v) Triton xlOO for 30min at 37°C in order to achieve further antigen 
retrieval. The slides were incubated with 20% goat serum for 20min at RT. The serum 
was tapped off the slides and cytokeratin (ICN Biomedicals) primary Ab (1/100) was 
applied to slides for 60min at RT. The slides were incubated with goat mouse-IgG
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biotinylated secondary Ab (1/50) for lhr at RT and then the staining was developed 
with diaminobenzidine (DAB). Between each step three PBS washes were taking 
place. The sections were dehydrated and mounted using Xylene-Mounting medium 
(DPX) and the slides were kept at RT.
2.2.5 a-smooth muscle actin immunostaining and method development 
Approach No 1:
Monoclonal a-smooth muscle actin antibody was purchased from Sigma (A 
2547). Initially 7pm frozen sections were used. Sections were left on bench overnight 
in order to achieve better adhesion of the tissue onto the SuperFrost slides. All slides 
were then fixed in cold acetone for lOmin and subsequently were left on bench to air 
dry for another lOmin. Half of the slides that would be stained with peroxidase were 
treated with 0.6% Hydrogen Peroxide in methanol for 5min in order to avoid 
background staining caused by any peroxidase activity within the tissue. Meanwhile, 
the rest of the slides that would be treated with AlexaFluor secondary were kept in 
PBS. Although 1/400 dilution (i.e. 5pg/ml) of the primary Ab was suggested as 
optimum by sigma 1/200 was used as well. All slides were incubated with the primary 
Ab at 4°C overnight. Negative control slides were treated with 25% goat serum. For 
the peroxidase staining the slides were incubated with goat mouse-IgG biotinylated at 
1/50 dilution for lhr at RT and then the staining was developed with 
diaminobenzidine (DAB). The sections were mounted using Xylene-Mounting 
medium (DPX) and the slides were kept at RT. For the fluorescent staining the slides 
were incubated with AlexaFluor® 488 goat mouse-IgG at 1/1000 dilution for 2hrs in 
the dark at RT. The sections were mounted using Hydromount. The slides were then 
wrapped in aluminium foil, left at 4°C O/N or at -20°C for a longer period. Between 
each step three PBS washes were taking place.
Approach No 2:
7pm wax sections were wax cleared and dehydrated as previously described. 
Slides were divided in two groups and subsequently in four subgroups (Table 2.1). 
Half of the slides were treated with 0.1 mg/ml Trypsin containing solution for 35min 
at 37°C and the remaining half of the slides were treated with 20pg/ml Proteinase K 
containing solution for 35min at 37°C.
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Subgroup Approach
A Block with 20% Goat serum in PBS for 20 min
B 0.2% BSA in PBS used for Ab dilutions
C 0.05% Tween 20 in PBS for Ab dilutions & washes
D Plain PBS
Table 2.1: Solutions that used for the four different subgroups of slides.
The slides were then treated with primary Ab (1/200) at 4°C overnight. 
Negative control slides were treated with 25% goat serum in plain PBS. The 
following day were incubated with AlexaFluor® 488 goat mouse-IgG at 1/1000 
dilution for 2hrs in the dark at RT. The sections were mounted using Hydromount. 
The slides were then wrapped in aluminium foil, left at 4°C O/N or at -20°C for a 
longer period. Between each step three PBS washes were taking place.
Approach No 3:
7pm wax sections were wax cleared and dehydrated as previously described. 
The slides were treated with 20pg/ml Proteinase K containing solution for 20min at 
37°C and washed with PBS. All sections were incubated with 20% goat serum for 
20min at RT. Goat serum was tapped off the slides and primary Ab dilutions were 
applied. Half of the slides were treated with primary Ab (1/200 or 1/400) diluted in 
0.05% Tween 20, 0.2% BSA, PBS. The other half of the slides were treated with 
primary Ab (1/200 or 1/400) diluted in 0.05% Tween 20, PBS. Primary Ab incubation 
was left overnight at 4°C. Negative control slides were treated with 25% goat serum 
in plain PBS. The following day sections were incubated with AlexaFluor® 488 goat 
mouse-IgG (1/1000) diluted in either 0.05% Tween 20, 0.2% BSA, PBS or 0.05% 
Tween 20, PBS for 2hrs in the dark at RT. The sections were mounted using 
Hydromount. The slides were then wrapped in aluminium foil, left at 4°C O/N or at - 
20°C for a longer period. Between each step three 0.05% Tween 20, 0.2% BSA, PBS 
or 0.05% Tween 20, PBS washes were taking place.
Approach No 4-Final optimised protocol:
7 pm wax sections were wax cleared and dehydrated. Sections were incubated 
with 20%goat serum for 20min at RT. Goat serum was tapped off the slides and 
primary Ab dilutions were applied. The slides were treated with primary Ab (1/400 or
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1/800) diluted in 0.05% Tween 20, 0.2% BSA, PBS at 4°C overnight. The following 
day sections were incubated with AlexaFluor® 488 goat mouse-IgG (1/1000) diluted 
in 0.05% Tween 20, 0.2% BSA for 2hrs in the dark at RT. The sections were mounted 
using Hydromount. The slides were then wrapped in aluminium foil, left at 4°C O/N 
or at -20°C for a longer period. Between each step three 0.05% Tween 20, 0.2% BSA, 
PBS washes were taking place.
2.3 Transmission Electron Microscopy (TEM)
2.3.1 Cuprolinic Blue fixation in a critical electrolyte condition 
Approach No 1:
Sixteen corneas from the organ culture were fixed with 4% PFA and they 
stored at 4°C. The tissue was cut into 25mm2 cubes and the samples washed with PBS 
and treated with 0.05% Cuprolinic Blue buffer overnight at RT. The tissue was then 
washed with three changes of 2.5 % glutaraldehyde solution for 15min. Subsequently, 
the samples were incubated with three changes of both 0.5% sodium tunsgate buffer 
for 15min and with 0.5% sodium tunsgate in 50% ethanol for 15min. The tissue then 
was dehydrated by passing it through of a series of increasing alcohol concentrations 
(50%, 70%, 90%, 100%, 100%, 100% v/v with ddH20 -  15min each). The samples 
were incubated with 1:1, 2:1, 3:1 Resin:Ethanol solutions for lhr with each resin 
dilution. Then, the samples were incubated with 100% resin for 8hrs for three times. 
Finally, the tissue was placed in small container and incubated with 100% resin in a 
70 °C oven for 8hr.
Approach No 2- Final optimised protocol:
Sixteen corneas from the organ culture were fixed with 4% PFA and they 
stored at 4°C. The tissue was cut into 25mm2 cubes and the samples washed with PBS 
and treated with 0.05% Cuprolinic Blue buffer for almost 24hrs at RT. The tissue 
blocks then were washed with three 15min washes of 2.5 % glutaraldehyde. 
Subsequently, the samples were incubated with three changes of both 0.5% sodium 
tunsgate buffer for 15min and with 0.5% sodium tunsgate in 50% ethanol for 15 min. 
The tissue then was dehydrated by passing it through a series of a series of increasing 
alcohol concentrations (50%, 70%, 90%, 100%, 100%, 100% v/v with ddH20- 15min 
each). The tissue was then incubated with propylene oxide for 15min twice. The 
samples were subsequently incubated with 1:1 medium Epon Resin: Propylene Oxide 
solution for lhr. Tissue blocks were then incubated with pure medium Epon Resin for
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lhr, twice. At this point, the lids of the vials were removed in order to allow any 
remaining propylene oxide to evaporate from within the tissue. The tissue was 
incubated with fresh 100% medium Epon Resin overnight at RT. The next day the 
tissue was incubated in 100% medium Epon Resin for 6hrs. The resin was renewed 
twice during the 6hr period. At the end of the six-hour resin incubation the tissue was 
placed in small container and incubated with 100% medium epon resin in a 60°C oven 
for 48 hrs.
2.3.2 Sectioning
Sections of 80nm thickness were obtained by using a Reichert-jung Ultracut E 
Ultramicrotome. The sections were placed on a 3mm copper grid and allowed to air 
dry.
2.3.3 Staining of ultrathin sections
2.3.3.1 Uranyl Acetate (UA) / Lead Citrate Staining
The grids were placed face down on a drop of 2% Uranyl Acetate (UA) for 
15min. Then, each grid was passed over 5 drops ddthO in order for the sections to be 
washed. They were blotted on filter paper in order to remove excess water. The grid 
was then placed on 2% lead citrate for lOmin. Finally, the sections were washed five 
times with distilled H2O.
2.33.2 Uranyl Acetate (UA) / PTA Staining
UA and PTA containing vials were centrifuged at 14,000 for 5min at RT. 
Meanwhile, two sheets of filter paper were placed on the bench and soaked with 
ddFhO. Parafilm pieces were placed on the filter papers. Copper grids were placed on 
top of 1% PTA solution drops and left to stand at RT for lOmin. Sections were 
washed with five 3min washes of filtered ddFbO. Sufficient amount of ddFhO was 
applied in a Petri dish until the surface of the dish was covered. A piece of paraffin 
was placed into the Petri dish and the grids were placed on drops of UA. The Petri 
dish was transferred in a 45°C oven and the tissue was incubated with the UA for lhr. 
Finally, the sections were washed five times with distilled H2O as described before.
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2.3.4 Observing the samples under a TEM
The samples were observed under a JEOL 1010 transmission electron 
microscope (TEM) at 80kV. The images of the corneal stroma were taken at various 
magnifications. Electron micrographs were obtained using a Kodak Megaplus 3.0 
digital camera, which was attached to the electron microscope.
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3. Morphological and cellular assessment of LASIK-like injured corneas
3.1 Introduction
Trephine injured corneas were used as a preliminary to the study of the wound 
healing response in LASIK-like injured corneas. The extent and the severity of the 
wound healing response in the cornea depend on the cause of injury. A surgical 
trephine causes a circular wound that can either extend half way or all the way 
through the cornea. Once the trephined corneal disc is removed a severe injury is 
induced in the cornea and an intense wound healing response is caused. However, 
LASIK-like injuries are not so severe and therefore wound healing response events 
tend to be milder.
In order to understand the cellular behaviour in trephined and LASIK-like 
injured corneas the expression of various intracellular proteins within the tissue was 
monitored. Such proteins include the cytokeratins (CKs) and a-smooth muscle actin 
(aSMA). Both types of proteins are part of the cytoskeleton, serving different 
functions to the cells that express them.
Cytokeratins are intermediate filaments. The principal function of the 
intermediate filaments is to reinforce cells by distributing tensile powers. Cytokeratin 
(CK) nos. 3, 5 and 12 are the most abundant ones in the adult cornea and they are 
expressed uniformly all over the tissue. CK 12 forms a heterodimer with CK3 in the 
cornea, whereas CK5 forms homodimers. CKs 4, 14, 15 and 19 are also present in 
minor amounts. Additionally, CK 4 is expressed only in the upper corneal epithelial 
cells from about the third layer upwards and CK 19 expression is restricted to the 
peripheral regions of the corneal epithelium (Kasper et al. 1988).
Actin filaments are 8nm wide and they are thinner and more flexible that other 
cytoskeleton components and therefore this type of filaments is a characteristic of 
highly motile cells (Alberts 1994). In the cornea myofibroblasts occur after the 
transformation of corneal keratocytes (Mohan 2003) after wounding and they express 
a-smooth muscle actin (aSMA). The main role of myofibroblasts in the wound 
healing process is to modify the composition of the extracellular matrix, by producing 
new components and subsequent scaring and wound contraction (Wilson 1998).
In the current study the cellular expression in both the corneal epithelium and 
stroma was monitored. Epithelial cell response is immediate after injury (Wilson 
1999) whereas the stromal wound healing process is slower and occurs when the 
epithelial one is upon completion (Mohan 2003). In the current study a major part of
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the immunohistochemical analysis focused on the LASIK-like injured corneas only 
because similar experiments have already been performed extensively in the past in 
trephine wounded bovine corneas (Carrington and Boulton 2005, Carrington et al. 
2006). Stromal wound healing response is impaired in LASIK (Pallikaris et al. 2001, 
Ivarsen and Moller-Pedersen 2003, Phillip et al. 2003) and therefore a significant part 
of this study was focused on the expression and cell population variation of stromal 
cells. The aim of this study was to gain a better understanding of both the epithelial 
and stromal wound healing response in the cornea after LASIK-like incisions.
3.2 Experimental design
3.2.1 Organ Culture
Bovine corneas were organ cultured as detailed in section 2.3.1.
Trephine wounded corneas
B
Figure 3.1: Control (A) and Wounded (B) bovine corneal samples in organ culture
for 24hrs (20x)
Two different groups of corneas (n=32) were cultured. Sixteen were centrally 
wounded with a 5mm biopsy punch and sixteen were unwounded and acted as 
controls (Fig. 3.1 and 3.2). The depth of the trephine wound was extending half way 
through the corneal stroma. The trephined disc was excised using a surgical blade and 
the corneas were cultured for 0, 1,3, and 7 days. At the end of each culture period 
control and wounded corneas were cut in half and processed into wax. During the 
organ culture the eyes were observed under a microscope in order to monitor the 
progress and the quality of the culture. The progress of the wound healing was 
monitored under the microscope, as was the occasional presence of contaminating 
micro-organisms.
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Excisional 
trephine 
wound
Comeal epithelium
Conjunctiva 
Culture medium
Sclera
Agar/collagen
Figure 3.2: Diagram representing a trephine wounded cornea in organ culture 
(Picture taken from Foreman et al. 1996)
LASIK-like injured corneas
Two different groups of corneas (n=48) were cultured. Twenty four were 
wounded in a LASIK-like fashion using the custom made eye holder (section 2.2.2). 
Twenty four corneas were unwounded and acted as controls (Fig. 3.3). The corneas 
were cultured for 0, 1 and 3 days, 1, 2, 3, 4 weeks. At the end of each culture period 
three control and three wounded corneas were fixed in 10% neutral buffered formalin 
and wax embedded. Control corneas were cut into halves before fixation, whereas 
LASIK-like corneas were trimmed close to the flap area before fixation.
( om ral epithelium
Conjunctiva 
Culture medium
Sclera
Agpi collagen
Figure 3.3: The organ culture set up representing a control/uninjured cornea 
(Picture adapted from Foreman et al. 1996)
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3.2.2 Wax embedding and tissue sectioning
Each trephine wounded cornea was cut into half exactly at the middle of the 
wound before fixation in 10% Neutral Buffered Formalin. LASIK-like and trephine 
injured corneas were embedded in paraffin wax perpendicular to the surface of the 
wax pot. Tissue blocks were left in 4°C overnight before attempting to cut sections. 
Each wax block containing a trephine wounded cornea was clamped on the 
microtome in such a way that a cross section of the cornea extending from limbus to 
limbus, including the wound would be obtained. Each block was trimmed and a series 
of 10pm thick sections was obtained. Each block containing a LASIK-like injured 
cornea was then clamped on the microtome in such a way that a cross section would 
be obtained, cutting from the flap hinge towards the flap edge. The wax block was 
then trimmed until the tread in the middle of the flap was obvious. Finally, a series of 
10pm thick corneal cross sections were cut from the middle of the flap. Series of 
10pm thick corneal cross sections from central regions of control/uninjured corneas 
were also obtained. The sections were floated as described in section 2.3.2.3 and 
collected using SuperFrost slides for better tissue adhesion. Slides were then 
incubated overnight in a 56°C oven.
3.2.3 Haematoxylin and Eosin staining
Haematoxylin and Eosin staining was performed in trephined, LASIK-like 
injured and control corneas as described in section 2.3.2.5.
3.2.4 Immunohistochemistry
Immunohistochemistry using anti aSMA (Sigma) and PAN-Cytokeratin 
(DAKO) was performed in LASIK-like injured and control corneas as described in 
section 2.3.2.7. Anti aSMA immunostaining was not performed in trephine wounded 
corneas, because it has been done before by Carrington et al (2006).
3.2.5 Cell counts
3.2.5.1 Total cell counts and statistics
LASIK-like (n=24) and control (n=24) corneal cross sections were dewaxed 
and dehydrated as described in sect.2.3.2.4. Samples had been in culture for 0, 1 and 3
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days, 1, 2, 3, 4 weeks. The sections were then mounted with hydromount mountant 
containing lpg/ml of bisbenzimide solution. Slides were then placed on the viewing 
stage of a fluorescent microscope (Olympus, UK). Colour photographs were taken at 
lOx magnification using the SPOT software package and a digital camera (Leica), 
which was attached to the microscope. A scale bar was also included in the image. A 
scale bar was then transferred to the CorelDrawl 1® software package and transparent 
rectangular boxes of 100x200pm were constructed. Six images were taken from each 
corneal sample; above and below the incision site, above and below the incision at the 
equidistance and above and below the incision at the flap edge (Fig. 3.4). Cell counts 
of total cells were made by opening the light micrographs in the ImagePro Plus 
software package and pasting the 100x200pm box on the picture. For each time-point 
three control sections and three LASIK-like injured samples were photographed, in 
order for the subsequent statistical analysis to be viable.
Incision site Equidistance Flap edge Bovine
cornea
LASIK-like
incision 100x200pm  box
Figure 3.4: Corneal diagram with rectangular boxes (100x200pm) in six positions 
denoting the location of the area assessed for quantitative total cell counts
The statistical analysis was carried out in SPSS 11. The data was checked for 
normality and one-way ANOVA and paired t-test were performed in order to check 
the differences in numbers between the different time-points and various locations.
3.2.5.2 Myofibroblast cell counts and statistics
LASIK-like (n=12) and control (n=12) corneal cross sections were dewaxed 
and dehydrated as previously described (sect. 2.3.2.4). Corneal samples that had been 
in culture for 0, 1, 2, 3, 4 weeks were stained with anti aSMA as previously described 
(section 2.3.2.7). Slides were then placed on the viewing stage of a fluorescent 
microscope (Leica, UK). Colour photographs of a stromal area proximal to the 
epithelial plug and below the incision were taken at 20x magnification using the 
FW400 (Leica) software package (Fig. 3.5). Images were captured using a digital 
camera (Leica), which was attached to the microscope. Blue (i.e. total cells) and green
41
(i.e. positive cells) composite pictures were saved separately. Cell counts of total and 
positive stained cells were done by transferring the light micrographs to the ImagePro 
Plus software package. For each sample the whole of the picture was selected and cell 
counts were performed using the software options. For each time-point three control 
sections and three LASIK-like injured samples were photographed, in order for the 
subsequent statistical analysis to be viable.
Figure 3.5: Diagram representing a LASIK-like injured cornea indicating the area of 
interest for counting total cells and aSMA positive cells.
The statistical analysis was carried out in SPSS 11. Using the positive and the 
total cell numbers the percentage of aSMA positive cells was calculated. The data 
was then checked for normality and Kruskal-Wallis and Mann-Whitney median tests 
were performed in order to check the increase in the percentage of positive aSMA 
cells during the culture period.
Area o f 
interest
Bovine
cornea
LASIK-like
incision
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3.3 Results
3.3.1 Haematoxylin and Eosin staining 
Control/uninjured corneas
Epithelium
Stxoma
Deecemet’s membrane
Endothelium
Figure 3.6: Structure of a cross section in a central region of a normal/uninjured 
bovine cornea. Bovine corneas lack Bowman’s layer. Scale bar 100|im.
A normal bovine cornea at time-point 0 hrs is depicted at Fig. 3.6. There are 
only four distinctive layers present since the bovine species do not possess any 
Bowman’s layer.
43
Trephine wounded corneas
Figure 3.7: Wound healing progress in trephined bovine corneas at different time 
points. Light micrograph for 72hrs is a focused image in the right side of the wound 
that shows the formation of a thin layer of epithelium covering the site of injury. This 
layer becomes thicker at the 7th day after injury (Black arrows indicate the incision 
site).Scale bars: Ohrs and 7 days=25pm, 24hrs=100 pm, 72hrs=50 pm.
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Haematoxylin and Eosin counterstaining was applied to wax sections in order 
to observe the morphological changes that occur in bovine corneas during the wound 
healing process (Fig. 3.7). At 0 hrs it can be seen that there are some stromal gaps at 
the wound edge. These gaps are filled within the first 24 hrs of the culture. However, 
it is expected to observe a stromal wound healing response at these sites although the 
overlaying epithelium is not injured. At the same time point (i.e. 24 hrs) the 
epithelium at the edge of the wound starts to build up. At the third day of the culture 
the epithelium still migrates from the edges of the wound towards the centre of the 
wounded area. Finally, by the seventh day complete re-epithelialisation is observed. 
The epithelium at the wounded area is thicker than the rest of the cornea and it fills 
the stromal gap that was created initially.
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LASIK-like injured corneas
0 hours
24 hours
Figure 3.8: LASIK-like injured bovine corneas in culture for up to one month. 
LASIK-like flap immediately after wounding at Ohrs. Epithelial plug formation within 
24hrs post-wounding. Incision still intact within the stroma at 1 and 4 weeks after
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injury, respectively. Scale bars: 0 hrs= 100pm, 24 hrs= 100pm and 30pm, 1 
week= 100pm and 30pm, 4 weeks=25pm.
Using a surgical blade a LASIK-like flap was induced in bovine corneas 
cutting initially the epithelial interface, proceeding into the stroma parallel to the 
cross-sectional plane of the cornea (Figure 3.8 Ohrs). The induction of the flap 
disrupted severely the epithelium at the incision site and stromal gaps were created as 
the scar was extending within the mid stroma. The depth of the flap was around 180- 
250pm. Immediately after wounding epithelial cells migrated towards the site of 
injury. An epithelial plug was created at the incision site. The epithelium in this area 
was obviously thicker than the epithelium across the rest of the cornea (Figure 3.8 
24hrs). By 24hrs complete re-epithelialisation had occurred and epithelial cells 
covered the stromal gap that was created initially at the incision site. By 1 to 4 weeks 
the epithelium still migrated towards the stromal gaps (Figure 3.8 1 and 4 weeks). 
The incision was still obvious within the stroma even at areas proximal to the 
epithelial plug, suggesting minimal or non existent stromal wound healing response.
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3.3.2 Epithelial cells
Control/uninjured corneas
Figure 3.9: Epithelial cell expression in central region of control/uninjured corneas 
(A and B). Limbal region of control/uninjured cornea (C). Negative control/ central 
corneal region (D). Yellow arrow indicates site of positive staining for cytokeratin in 
epithelial cell cytoplasm (Green-> Cytokeratin, Blue-> Biz-benzimide).
In order to assess epithelial cell expression during the wound healing process a 
two step indirect immunostaining method was performed using a PAN Cytokeratin 
primary antibody (DAKO). The PAN Cytokeratin antibody is a cocktail of two 
primary monoclonal antibodies (i.e. AE1 and AE3 clones) and stains cytokeratin 
isoforms 1-8, 10, 13-16 and 19. Cytokeratins are a diverse family of intermediate 
filaments that are expressed in epithelial cell cytoplasms. Cytokeratin is only being 
expressed in terminally differentiated epithelial cells and therefore it is considered as 
a marker for differentiation. In Fig. 3.9 positive staining within the cytoplasm of 
corneal epithelial cells is obvious. In central regions of normal corneas it is also 
apparent that cell population at the upper layers of the epithelium is less dense than 
that in the suprabasal epithelium. Additionally, there is no positive staining for
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cytokeratin at the basal epithelium in the limbal area (Fig. 3.9C). This was expected, 
as it is believed that the stem cell population of the cornea is based in this area.
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LASIK-like injured corneas
Figure 3.10: Epithelial cell expression LASIK-like injured corneas up to four weeks 
after injury. Epithelial cells at the site of incision at Ohrs time-point (A). The epithelial 
pug that was formed within 24hours after injury consisted of terminally differentiated 
epithelial cells. The epithelium also started to migrate towards the stroma covering 
gaps (B). The profile of the epithelial cellular behaviour remained the same after 
lweek (C) and 4 weeks (D) after wounding.
The epithelial plug that was created at the incision site consisted of terminally 
differentiated epithelial cells at all time-points, as there was positive staining for 
cytokeratin. The epithelium at the incision site consisted of differentiated epithelial 
cells soon after injury (Figure 3.1 OB). Epithelial cells migrated towards the stroma in 
order to fill gaps that were created after injury. They kept migrating until the end of 
the culture period as the epithelial plug at the 4weeks time point is considerably 
bigger compared to the epithelial plug of earlier time-points.
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3.3.3 Stromal cells numbers in LASIK-like injured corneas
Days in 
culture
Incision site 
No of cells No of cells 
above ± SD below ± SD
Corneal periphery control 
(No of cells ±SD)
0 10 ±3.1 14 ±5.7 15 ±2.2
1 22 ±8.5 23 ±10.9 16 ±6.2
3 14 ±6.0 14 ±2.5 19 ±2.9
7 12 ±3.3 15 ±3.7 14 ±3.3
14 16 ±4.5 15 ±3.1 15 ±1.7
21 12 ±1.2 11 ±2.5 16 ±6.2
28 13 ±1.6 25 ±2.5 19 ±2.9
Days in 
culture
Equidistance 
No of cells No of cells Equidistance control (No of cells ± SD)above ± SD below ± SD
0 12 ±4.1 10 ±2.6 19 ±2.8
1 23 ±2.5 21 ±6.2 15 ±2.1
3 11 ±2.1 14 ±1.2 15 ±1.2
7 10 ±1.7 12 ±0.9 10 ±3.1
14 11 ±3.7 11 ±2.2 19 ±2.8
21 11 ±0.8 11 ±0.5 15 ±2.1
28 7 ±0.8 8 ±0.5 15 ±1.2
Days in 
culture
Flap edge 
No of cells No of cells 
above ± SD below ± SD
Mid Cornea control 
(No of cells ±SD)
0 12 ±3.3 16 ±2.3 19 ±2.9
1 20 ±5.4 16 ±7.1 17 ±1.4
3 15 ±5.4 17 ±2.9 18 ±1.7
7 12 ±3.4 14 ±3.3 10 ±1.4
14 13 ±2.4 12 ±4.2 19 ±2.9
21 9 ±0.8 10 ±0.5 17 ±1.4
28 7 ±0.8 8 ±1.2 18 ±1.7
Table 3.1: Total cell counts for stromal cells from different areas along the LASIK- 
like flap. For each time-point 3 corneas were used (For cell numbers/mm2 and also
raw data please refer to Appendix 4).
Significant differences in cell numbers above and bellow the incision counts at 
the incision site at lwk (0.035) and 4wks (p=0.05) were observed. In specific, cell 
numbers were higher below the scar at the incision site.
Comparison of cell counts in wounded corneas against controls revealed the 
following observations.
1. Ohrs significant decrease in equidistance below (p=0.027)
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2. lwk significant decrease in equidistance above (p=0.025)
3. 2wks significant decrease in equidistance below (p=0.034)
4. 3wks significant decrease in “edge” region (p=0.005)
5. 4wks significant decrease in “equidistance” and “edge” regions
(p=0.003 and p=0.001, respectively)
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3.3.4 Myofibroblast expression and cell numbers in LASIK-like injured 
corneas
Figure 3.11: Myofibroblast cell expression in LASIK-like corneas. Positive stained 
cells were first observed at the 1 week time-point (A) and they were present for the 
rest of the organ culture time span (B-D depict 2-4 weeks, respectively). aSMA 
staining was also positive in the limbal vessels of all corneas (E). Negative control (F) 
(Green-> aSMA, Blue-> Biz-benzimide).
aSMA positive staining in LASIK-like injured corneas confirmed the presence 
of myofibroblasts in scar tissue. Staining was negative at 0, 1 and 3 days after injury. 
aSMA positive staining became evident at the 1 week time-point and it remained 
obvious at later time-points of the organ culture. During all the time-points that 
positive aSMA was observed, myofibroblast expression was only present in a stromal 
area proximal to the epithelial plug. There was no staining at all in stromal areas close 
to the middle or the edge of the flap.
Positive staining was also observed in the limbal vessels of all corneas, both 
injured and uninjured ones (Fig. 3.1 IE). This was expected as actin filaments are 
known to surround blood vessels and therefore staining in the limbus for aSMA was 
considered as a positive control for this series of experiments.
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Figure 3.12: Graph representing the increase in % myofibroblast population over a 
four weeks period after injury in LASIK-like injured corneas. Error bars represent the
standard error of mean (B).
According to the statistical analysis, the myofibroblast population was 
increasing from the first week after injury. Specifically, the Kruskal-Wallis test 
revealed that there were significant increases in the percentage of positive stained 
cells between 0 and lweek, 1 and 2 weeks and 2 and 3 weeks (p=0.011). There was 
not a significant change between the 3rd and 4th week percentages suggesting that the 
myofibroblast population gradually increases during the first three weeks after injury 
and then it tends to stabilise. The data was further analysed by performing Mann- 
Whitney median tests that provided with a p value of 0.001. This outcome confirms 
that the observed response in myofibroblast population increases as the independent 
variable (i.e. time) increases.
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3.4 Discussion and conclusions
The organ culture model that was used for this study has been described 
before by Foreman et al (1996). Several models can be used in order to assess wound 
healing (i.e. cell culture, in vivo studies or submerged organ cultures). However, this 
simple air-interface organ culture model is preferable for monitoring wound healing 
in this study. It is relatively accurate since the whole cornea is cultured including the 
limbal area and therefore architecture, cellular interaction and wound healing are 
mimicked more accurately than simple cell culture. The bovine species was chosen 
for this study, since bovine corneas are readily available and commercially cheap to 
obtain. Additionally, the tissue has the appropriate size and makes handling in the 
laboratory more efficient. Moreover, in terms of ethical considerations, the use of 
bovine tissue does not raise any ethical issues that human tissue would do. However, 
the bovine species is not as ideal as it can be difficult to find appropriate antibodies 
for immunohistochemistry and the bovine genome is not fully elucidated.
In this study the wound healing process was monitored for several weeks and 
in agreement with Foreman et al (1996) complete re-epithelialisation in trephine 
wounded cultured bovine corneas occurred within the first 72 hrs post wounding. 
While re-epithelialisation could be visualized, it was sometimes more difficult to 
interpret following sectioning. In some micrographs, even at 7 days, the epithelium 
had detached from the wound surface and in some cases it had fallen off. This artefact 
represents weak adhesion between the new epithelium and the underlying stromal 
surface and a requirement of further optimization of the wax embedding and 
sectioning technique. Furthermore, it should be taken into consideration that the 
bovine cornea does not possess a Bowman’s layer and therefore the connection 
between the epithelium and stroma might be weaker, compared to other species which 
posses a Bowman’s layer. The wax embedding procedure had to be optimized for the 
bovine cornea, since extensive treatment of the corneas with the neutral buffered 
formalin buffer, chloroform and paraffin wax had made them rigid and it was 
impossible to produce full length sections of the cornea without the sections tending 
to break or fold up.
Total cell numbers tend to be significantly decreased at later stages of the 
organ culture time span. In the current study, total stromal cell numbers remain 
decreased until the end of the organ culture period. This leads to the conclusion that
55
cell numbers decrease possibly because of the occurrence of apoptosis as a natural 
response to injury. However, the fact that cell numbers do not increase indicates that 
there is no cellular proliferation, supporting the existence of a poor wound healing 
response in LASIK-like incisions.
Total cell counts in stromal cells revealed that there was a significant increase 
in the cell density at the incision site, below the incision, at 1 and 4 weeks. Later 
experiments confirmed the existence of myofibroblasts in this area. Additionally, at 
Ohrs there was a significant decrease in cell numbers at the equidistance region below 
the incision. This observation might be due to the fact that the blade mechanically 
removed cells during the induction of the injury in the stroma. Between the 1 and 4 
weeks time-points there is a variation in cell numbers along the flap, as there is a 
significant decrease in cell density when injured corneas are compared to control 
ones. According to Wilson and Kim (1998) keratocytes in a wounded area undergo 
cell shrinkage and subsequent apoptosis. Additionally, according to previous studies 
the stromal response to refractive surgery is characterised by a reduction in size and 
density of keratocyte cell bodies, and by migration of the remaining keratocytes to 
repopulate the areas in which cell density has decreased (Rajan et al 2005). What 
causes keratocyte loss around the wound area right after wounding is still unclear. 
This might be a homeostatic internal response from living organisms. Besides, it has 
been proposed by Wilson et al (1997) that this might be a defence mechanism in order 
to prevent the passage of viral material into the eye when a wound occurs. According 
to Zieske et al (2001) cell proliferation and the appearance of myofibroblasts in a 
wounded cornea occurs 24-48hrs post wounding. The same report also supports that 
myofibroblast transformation might take up to one month to become apparent, 
whereas they do not regress even one year after wounding. The fact that the remaining 
keratocytes tend to repopulate low cell density areas instead of transforming into 
myofibroblasts, explains the fact that the stromal wound healing response is impaired 
in the stroma after LASIK.
In PRK, the wound healing response in the stroma takes place at the stroma- 
epithelium interface as a result of interaction of a number of cytokines that are 
released by the injured epithelium (Marshall et al 1988, Wilson et al 1999, Rajan et 
al 2005). In the case of LASIK, the epithelium is only injured at the incision site and 
therefore the stromal wound healing response takes place in areas proximal to the 
incision site, leaving central areas of the flap intact. Keratocyte apoptosis only takes
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place in a zone approximately 50pm anterior and 50pm posterior to the incision in 
stromal areas close to the epithelial plug (Helena et al. 1998, Wilson et al. 2001, 
Mohan et al. 2003, Dawson et al. 2005).
Attempts to optimize immunostaining for CK 3 were unsuccessful despite the 
fact that CK3 is prominent in the comeal epithelium. This may reflect a problem with 
the antibody of species difference. It was therefore decided to use a PAN Anti- 
Cytokeratin Ab which reacted with a wide range of cytokeratin isoforms. Cytokeratin 
(CK) nos. 3, 5 and 12 are the most abundant ones in the adult cornea and they are 
expressed uniformly all over the tissue. The PAN Cytokeratin Ab that was used for 
this study does not stain for CK 12. However, CK 12 forms a heterodimer with CK3 
in the cornea and therefore after staining CK3, CK12 is also co-localized. CKs nos 4, 
14, 15 and 19 are also present in minor amounts. In light micrographs for cytokeratin 
it is obvious that the staining is denser at the upper part of the epithelium. It should be 
taken into consideration that CK 4 is expressed only in the upper comeal epithelial 
cells from about the third layer upwards. Additionally, CK 19 expression is restricted 
to the peripheral regions of the comeal epithelium (Kasper et al 1988). Therefore, the 
existence of additional CK isoforms in the upper levels of the comeal epithelium 
makes CK immunostaining denser along the periphery.
The histological evaluation of LASIK-like injured corneas revealed a rapid 
epithelial wound healing response and a rather delayed stromal repair. A plug was 
created at the site of injury and covered the stromal gaps at the incision site. This plug 
was later confirmed to consist of terminally differentiated epithelial cells indicating a 
rapid epithelial wound healing response. Although the epithelial plug was created 
very quickly after injury, epithelial cells carried on migrating towards the stroma even 
at later stages of the organ culture time span, as the epithelial wound healing response 
is known to reach completion at approximately 1 month after injury.
It appears that the epithelium possibly has an evolutionary mechanism for 
smoothing the anterior surface of the cornea in cases where it is disrupted by various 
external factors, such as injury. According to Dawson et al. (2005b) mild focal or 
moderate, diffuse stromal loss can be compensated with hypotropic or hypertropic 
epithelial cell adjustments. This response takes place only at the basal epithelial cells, 
but the reason is yet unknown. In the case of the LASIK-like injuries studied in the 
present work, the epithelium was obviously thicker than normal at the incision site.
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Myofibroblast expression was only observed in an area underneath the 
epithelial plug in LASIK-like injured corneas. Cell density was increasing during the 
first three weeks after injury, but it seemed to stabilise after this period. These 
findings confirmed a minor stromal wound healing response that was only observed in 
an area close to the stromal-epithelial interface. During the 4week organ culture time 
span there was not any evident stromal wound healing response either in the middle of 
the flap or at the hinge area. Additionally, histology also confirmed that the incision 
within the stroma was still intact by the end of the organ culture period. aSMA 
staining was negative in these areas confirming the absence of any active 
myofibroblasts. A likely explanation for this could be the absence of certain cytokines 
that are being released by the epithelium in response to injury and transform quiescent 
keratocytes into myofibroblasts. The epithelium that lies above the middle of the flap 
or the hinge is not injured and cytokines that are released by the epithelium at the 
incision site might not be able physically to reach areas deeper in the stroma towards 
central flap areas.
In conclusion, this in vitro model closely mimics the cellular events observed 
in previous studies in vivo. Within 24hrs after inducing a LASIK-like injury a normal 
epithelial repair was observed and confirmed. In contrast, impaired stromal wound 
healing was observed, as myofibroblast expression was only present in the stromal 
area at the incision site. The myofibroblast phenotype was totally absent in stromal 
areas towards the middle or the edge of the LASIK-like flap. The histological 
evaluation of LASIK-like corneas also confirmed that the scar was still intact within 
the stroma even 4 weeks after injury. These observations are very important in real 
time LASIK as impaired wound healing makes the flap unstable and prone to 
decentration or detachment, raising serious concerns regarding the safety and long 
term stability of LASIK.
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4. Association of myofibroblast induction with LASIK-flap adhesion and
corneal transparency
4.1 Introduction
Cytokines are known to play a key role in cellular proliferation and 
differentiation in biological tissues (Wilson et al 2003). On many occasions growth 
factors are being used for medical purposes in order to heal or improve certain 
conditions. For example, NGF has been successfully used for the treatment of 
neurotrophic and autoimmune corneal ulcers (Lambiase et al 2000).
Considering refractive surgery, one of the major drawbacks of LASIK is that 
the flap is being reported not to heal completely even after several years 
postoperatively (Ivarsen 2003). ECM proteins such as fibrinogen and tenascin do not 
seem to appear after LASIK and hence the wound healing process depends only on 
the epithelial-stromal interaction. The strict localisation of fibrosis marginally at the 
flap edge, contrary to the minimal fibrosis below the entire flap, suggests that the 
LASIK interface never heals (Ivarsen 2003). The limited peripheral wound healing 
response after LASIK is not usually enough to secure the flap and make it resistant to 
dislocation under mechanical stress (Crawford 2003). Myofibroblast expression was 
only observed in stromal areas proximal to the epithelial plug (Chapter 3). The fact 
that there was no myofibroblast phenotype expressed at the bed of the flap leads to the 
assumption that cytokines that are released from the epithelium do not physically 
reach areas at the bed of the flap. Therefore, a series of experiments was designed in 
order to supply the flap with certain cytokines in various dilutions and monitor the 
wound healing response in culture for up to four weeks.
The effectiveness of the cytokines that were applied to the corneas was 
assessed at initial stages by judging the mechanical strength and transparency of the 
samples. Considering the fact that the cornea is the major refractive part of the eye, 
any biological or mechanical alteration in the tissue will influence optical 
performance. Maintenance of transparency in any attempt to improve wound healing 
in LASIK flaps is a very important issue, as the further objective is the maintenance 
of a normal visual function. In addition, enhancing the wound healing response in 
LASIK flaps aims to increase the mechanical strength of the corneas and therefore 
avoid any keratectasia.
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Four cytokines were selected and applied at the flap interface (i.e. TNF-a, IL- 
la, Fas-ligand and TGF-Pi). It has already been proposed that cultured corneal 
keratocytes exposed to TNF-a have increased cellular proliferation in the stroma 
(Mohan et al. 2000). Hong et al. (2001) suggested that human IL -la induced 
apoptosis in human corneal keratocytes. Fas-ligand (Wilson et al. 1996) and TGF-pi 
induce apoptosis to comeal keratocytes. However, to date there has not been any 
experimental evidence to support the amount of these factors required in order for 
apoptosis to be triggered in keratocytes. A series of various dilutions of these proteins 
was applied to the tissue to investigate the effect of these cytokines on tissue wound 
healing, increase in mechanical strength and the maintenance of comeal transparency.
4.2 Experimental design
4.2.1 Organ Culture
Bovine corneas were organ cultured as detailed in section 2.3.1. Three 
different groups of corneas (n=304) were cultured (Table 4.1). Two hundred and 
eighty eight (288) were wounded in a LASIK-like fashion using the custom made eye 
holder (section 2.2.2). Thirty two (32) samples were treated with carrier solution 
(PBS/BSA or HC1/BSA). Two hundred and fifty six (256) corneas were treated with 
cytokine solution (i.e. TNF-a, IL-la, FasL and TGF-pi/R&D Systems) in various 
dilutions (i.e. 0.1, 10, 50 and lOOng/ml). The corneas were cultured for 1, 2, 3 and 4 
weeks. Four corneas were put in culture for each cytokine dilution for each time point. 
Sixteen corneas were not wounded and acted as controls (Fig. 4.1). At the end of each 
culture all samples were fixed in 10% neutral buffered formalin and processed into 
wax. Control corneas were cut into halves before fixation, whereas LASIK-like 
corneas were trimmed close to the flap area before fixation.
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No of corneas in culture
Control PBS/BSA HC1/BSA TNF-a IL-la Fas-ligand TGF-p,
.S g
5  s
1 4 4 4 16 16 16 16
2 4 4 4 16 16 16 16
o —« 3
£  W
3 4 4 4 16 16 16 16
4 4 4 4 16 16 16 16
Total 16 16 16 64 64 64 64
Table 4.1: Number of corneal samples put in culture for each cytokine dilution for
each time-point
C om p.il e p ith e liu m
Conjunctiva 
Culture medium
Sclera
AgnrcoUapm
Figure 4.1: The organ culture set up.
(Picture adapted from Foreman et al. 1996)
4.2.2 Evaluation of transparency
Organ culture Petri dishes were placed on a grid (Fig. 4.2). Corneal 
transparency was assessed by three independent observers each time.
Figure 4.2: Sample of the grids that were used to assess the transparency of control
and cytokine treated corneas.
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Comeal samples were characterized for their transparency based on a scale of 
0 (the control sample that remained clear at all times) to 100% (when the cornea is 
opaque) (Fig. 4.3).
0%
Clear M oderately Cloudy M oderate O paque
Cloudy O paque
Figure 4.3: Scale for assessing comeal transparency
4.2.3 Assessment of mechanical strength/adhesion of the flap
A Lloyd instruments tensiometer (Lloyd Instruments Ltd, Hampshire, UK) 
was used in order to assess the extent of adhesion of the flap. The “pull to break” test 
was performed. In this method, the cornea was clamped on the machine by gluing 
equal size of cardboard paper in exactly opposite sites and the anterior (middle of 
flap) and posterior cornea. It was then pulled in opposite vertical directions until the 
flap was lifted and detached (Fig. 4.4B). The upper arm of the machine was clamped 
on the middle of the flap on the anterior of the cornea whereas the lower arm was 
clamped on the exact opposite position on the posterior part of the cornea. This test 
measured the force that was required to break the flap. The data was recorded using a 
Nexygen 4.1 software package and it was stored in an MS Windows operated 
workstation (Fig. 4.4A).
Once a complete set of data was recorded, a non-parametric statistical analysis 
(i.e. Kruskal-Walis) was performed in SPSS. Three samples were used for each 
sample dilution at each time-point in order for the statistical analysis to be viable.
100%
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Figure 4.4: Lloyd tensiometer set up (A) Each cornea was clamped on the two metal 
arms (yellow arrows-upper arm 1, lower arm 2) of the tensiometer and was pulled 
apart in opposite vertical directions (red arrows) (B).
4.2.4 Wax embedding and tissue sectioning
LASIK-like injured corneas were embedded in paraffin wax perpendicular to 
the surface of the wax pot. Before processing a thread was placed at the hinged part in 
the middle of the flap. Tissue blocks were left in 4°C overnight before attempting to 
cut sections. Each block containing a LASIK-like injured cornea was then clamped on 
the microtome in such a way that a cross section would be obtained, cutting from the 
flap hinge towards the flap edge. The wax block was then trimmed until the thread in 
the middle of the flap was obvious. Finally, a series of 10pm thick corneal cross 
sections were cut from the middle of the flap. Series of 10pm thick corneal cross 
sections from central regions of control/uninjured corneas were also obtained. The
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sections were floated as described in section 2.3.2.3 and collected using SuperFrost 
slides for better tissue adhesion. Slides were then incubated overnight in a 56°C oven.
4.2.5 Immunohistochemistry
Immunohistochemistry using anti aSMA was performed in LASIK-like 
injured and control corneas as described in section 2.3.2.7.
4.2.6 Myofibroblast cell counts and statistics
LASIK-like (n=12) and control (n=12) corneal cross sections were dewaxed 
and dehydrated as previously described (section 2.3.2.4). Corneal samples that had 
been in culture for 0, 1, 2, 3, 4 weeks were stained with anti aSMA as previously 
described (section 2.3.2.7) and counterstained with biz-benzimide to identify nuclei. 
Slides were then placed on the viewing stage of a fluorescent microscope (Leica, 
UK). Colour photographs of a stromal area proximal to the epithelial plug and below 
the incision were taken at 20x magnification using the FW400 (Leica) software 
package (Fig. 4.2.5.1). Images were captured using a digital camera (Leica), which 
was attached to the microscope. Blue (i.e. total cells) and green (i.e. aSMA positive 
cells) composite pictures were saved separately. Cell counts of total and positive 
stained cells were made by transferring the light micrographs to the ImagePro Plus 
software package. For each sample, the whole of the picture was selected and cell 
counts were performed using the software options. For each time-point, three control 
sections and three LASIK-like injured samples were photographed, in order for the 
subsequent statistical analysis to be viable.
Area o f  Bovine
interest cornea
LASIK-like
incision
Figure 4.5: Diagram representing a LASIK-like injured cornea indicating the area of 
interest, in the flap bed, for counting total cells and aSMA positive cells.
The statistical analysis was carried out in SPSS 11. Using the aSMA positive 
and the total cell numbers, the percentage of aSMA positive cells was calculated. The
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data was then checked for normality and Kruskal-Wallis and Mann-Whitney tests 
were performed in order to check the increase in the percentage of positive aSMA 
cells during the culture period.
4.3 Results
4.3.1 Evaluation of transparency, corneal mechanical strength/flap adherence 
and myofibroblast cellular expression and density in response to exogenous 
factors
4.3.1.1 Control/untreated corneas
At preliminary stages of the experiment, corneas were left in culture over a 
period of four weeks. The samples were injured in a LASIK-like fashion and left 
untreated without any cytokine solution. The wound healing response was monitored 
during this time.
Time in culture (weeks)
Mean force required 
for flap detachment 
(Newton)
0 hours 0.04500
1 week 0.03733
2 weeks 0.04433
3 weeks 0.05100
4 weeks 0.05500
Table 4.2: Mean force required to detach control non-cytokine treated corneas over a
period of 4 weeks in culture.
I *■-<u u
00 1.00 2 00 3.00 4 00
Time in culture (weeks)
Figure 4.6: Graph showing the flap adherence of non-cytokine treated corneas
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The mean force that was required to detach the flap in non-cytokine treated 
corneas increases gradually over the four week culture time span (Fig. 4.6). However, 
statistics proved that there are not significant differences in mean force values 
between 0 and 4 weeks (p>0.05). Therefore it can be concluded that flap adherence is 
still poor 4 weeks after injury, an observation that is in accordance with mid-stromal 
or LASIK like injuries.
PBS/
BSA
0 hours Clear
1 week Clear
2 weeks Clear
3 weeks Clear
4 weeks Clear
Table 4.3: Visual transparency assessment of control non-cytokine treated corneas
over a 4 week period in culture.
LASIK like injured, non-cytokine treated corneas acted as controls when 
compared to cytokine treated corneas. However, control corneas maintained their 
transparency at all times during the organ culture period confirming the integrity and 
reliability of the culture technique.
4.3.1.2 Tumour Necrosis Factor alpha (TNF-a) treated corneas
TNF-a caused an effect on the treated corneas as various concentrations of the 
cytokine increased adherence and cloudiness to the tissue (Tables 4.4 and 4.5)
Mean force required to pull the flap 
apart (N)
TNF-a
Concentration
(ng/ml)
0.1 10 50 100
0 hours 0.04867 0.04867 0.04867 0.04867
1 week 0.06900 0.08767 0.09433 0.08067
2 weeks 0.07567 0.09433 0.09667 0.08467
3 weeks 0.08367 0.09667 0.09800 0.09467
4 weeks 0.07200 0.10000 0.11133 0.10067
Table 4.4: Mean force required to detach TNF-a treated corneas over a period of
4weeks in culture.
66
% 
of 
m
yo
fib
ro
bl
as
t 
po
pu
lat
ion
 
Me
an
 
for
ce 
req
uir
ed
 
for
 f
lap 0.1 ng/ml 50 ng/ml10 ng/ml 100 ng/ml
On
O  »
oo 100 300 4.00 100 200 3.00 400 100 200 300 400 100 200 3.X
Time in culture (Weeks)
Figure 4.7: Graphs showing the effect of various concentrations of TNF-a on the flap
adhesion
The mean force required for flap detachment increased rapidly during the first 
week in culture and then it kept increasing gradually (Fig. 4.7). The same pattern is 
observed in all four dilutions with little differences between each one of them. Flap 
adherence kept increasing with a slower rate (i.e. significant increase every two weeks 
for most of the samples; p>0.05).
0.1 ng/ml 10 ng/ml 50 ng/ml 100 ng/ml
1 1 ) 1  I I  S 3  S 3
00 1 00 2 00 3.00 4 00 1 00 2 00 3 00 4 00 1 00 2.00 3 00 4 00 1 00 2.00 3 00 4 00
Time in culture (Weeks)
Figure 4.8: Graphs showing the effect of various concentrations of TNF-a on 
myofibroblast proliferation on the flap bed.
Both 0.1 and 10 ng/ml of TNF-a caused an immediate increase in 
myofibroblast population on the flap bed, but cell numbers do not increase 
significantly (p>0.05) for the rest of the organ culture time span. However, 50ng/ml 
and lOOng/ml caused a gradual, significant increase (p<0.05) in myofibroblast 
population (Fig. 4.8).
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0.1 ng/ml lOng/ml 50ng/ml lOOng/ml
1 week ModerateCloudy Cloudy Cloudy
Moderate
Cloudy
a■fa
2
weeks
Moderate
Cloudy Cloudy Cloudy
Moderate
Cloudy
z
H 3weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
4
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
Table 4.5: Visual transparency assessment of TNF- a treated corneas over a 4 week
period in culture.
Mid range concentrations of TNF-a (i.e. lOng/ml and 50ng/ml) caused severe 
cloudiness in the corneas during the early stages of the organ culture (Table 4.5). 
Lower concentration of the cytokine caused a moderate effect on comeal 
transparency. However, lOOng/ml triggered a mild effect on the corneas, which 
became more severe at later stages of the organ culture period.
43 .13  Interleukin 1 alpha (IL-la) treated corneas
IL-la caused a relatively mild effect on the treated corneas. However, in some 
cases the cytokine caused a significant effect on the flap adhesion in the treated 
corneas.
Mean force required to pull the 
flap apart (N)
IL-la
Concentration
(ng/ml)
0.1 10 50 100
0 hours 0.04867 0.04867 0.04867 0.04867
1 week 0.06733 0.07333 0.08500 0.08200
2 weeks 0.07200 0.07400 0.09067 0.10100
3 weeks 0.07833 0.08667 0.09200 0.10733
4 weeks 0.08733 0.09033 0.10667 0.10500
Table 4.6: Mean force required to detach IL-la treated corneas over a period of 4
weeks in culture.
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Figure 4.9: Graphs showing the effect of various concentrations of Il-la on the flap
adhesion
In lower IL-la concentrations (i.e. 0.1 ng/ml and 10 ng/ml), flap detachment 
was not significantly increased when compared to control during the first week in 
culture after injury. IL-la had a relatively mild effect in treated corneas and, for the 
0.1 ng/ml dilution, there was no significant increase in the mean force required for flap 
detachment (p>0.05). Additionally, at lOng/ml there was also no significant increase 
during the first two weeks in culture. However, there is a significant increase in the 
mean force that was required for flap detachment between the second and the third 
week after injury. The value of the mean force seems to stabilise after the third week 
after injury.
0.1 ng/ml 10 ng/ml 50 ng/ml 100 ng/ml
00 100 200 300 400 100 200 300 400 100 200 300 400 1 00 200 3.00 400
Time in culture (Weeks)
Figure 4.10: Graphs showing the effect of various concentrations of IL-la on 
myofibroblast proliferation on the flap bed.
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All concentrations had a gradual effect on the increase of myofibroblast 
population and all of them caused a significant increase at certain time points of the 
organ culture time span (Fig. 4.10).
O.lng/ml lOng/ml 50ng/ml lOOng/ml
1 week ModerateCloudy
Moderate
Cloudy Cloudy Cloudy
a
2
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
3
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
4
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
Table 4.7: Visual transparency assessment of IL-la treated corneas over a 4 week
period in culture.
Only high concentrations of IL -la  caused severe opacities in the corneas. 
Lower concentrations caused a moderate effect on the clarity of the treated corneas 
(Table 4.7).
4.3.1.4 Fas Ligand (FasL) treated corneas
Fas-ligand had the mildest effect among the four cytokines that were applied 
to the LASIK like injured corneas.
Mean force required to pull the flap 
apart (N)
FasL
Concentration
(ng/ml)
0.1 10 50 100
0 hours 0.04867 0.04867 0.04867 0.04867
1 week 0.06900 0.07133 0.07300 0.08400
2 weeks 0.07567 0.07133 0.06867 0.09800
3 weeks 0.08367 0.07050 0.07050 0.10200
4 weeks 0.07200 0.07800 0.07300 0.10200
Table 4.8: Mean force required to detach FasL treated corneas over a period of 4
weeks in culture.
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Figure 4.11: Graphs showing the effect of various concentrations of FasL on the flap
adhesion
Low concentrations of the cytokine (i.e. 0.1 and 10 ng/ml) caused a significant 
increase in the mean force that it is required for flap detachment when compared to 
control untreated samples as shown in the graphs (Fig. 4.11). However, for these 
concentrations mean force values do not increase significant for the treated samples 
from 0 to 4 weeks after injury, as p value was too low (p>0.05). This a common 
statistical and in this case it will be considered that low concentrations of FasL do not 
increase significantly the mean force that it is required for flap detachment and 
therefore this concentration of the cytokine does not contribute to the improvement of 
flap adherence in LASIK-like corneal injuries. Higher concentrations of the cytokine, 
50ng/ml and lOOng/ml, caused a statistically significant increase in the mean force 
that it is required for flap detachment during the second and the third week after 
injury respectively (p<0.05, Fig. 4.11). However, it was observed that there was not 
any further increase in mean force values thereafter. For example, in 50ng/ml samples 
there is a rapid increase in flap adherence during the first two weeks after injury. It 
then tends to stabilise towards the end of the organ culture time span (Fig. 4.11). For 
the 1 OOng/ml samples flap adherence increases during the first week, tends to stabilise 
and then it increases again during the third week after injury.
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Figure 4.12: Graphs showing the effect of various concentrations of FasL on 
myofibroblast proliferation on the flap bed.
0.1 ng/ml of FasL did not cause any significant increase in myofibroblast 
population during the four week culture time span (p>0.05, Fig. 4.12). lOng/ml 
caused a significant increase in myofibroblast cell numbers between the second and 
the third week after injury (p<0.05). 50 and 100 ng/ml samples had a more significant 
effect in the increase of cell numbers towards early and late stages of the organ 
culture, respectively (p<0.05).
0.1 ng/ml lOng/ml 50ng/ml lOOng/ml
1 week ModerateCloudy
Moderate
Cloudy Cloudy
Moderate
Cloudy
•oc 2 Moderate Moderate Cloudy Moderate50£ weeks Cloudy Cloudy Cloudy
J
«u.
3
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
4
weeks
Moderate
Cloudy
Moderate
Cloudy Cloudy Cloudy
Table 4.9: Visual transparency assessment of FasL treated corneas over a 4 week
period in culture.
FasL caused moderate opacities when it was applied at low dilutions in injured 
corneas (Table 4.9). 50ng/ml had the most severe effect in the clarity of the treated 
corneas, as it caused cloudiness in the corneas during the whole of the organ culture 
time span. Finally, lOOng/ml had a milder effect than the previous concentration as 
significant cloudiness was observed in the corneas after the third week in culture.
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4.3.1.5 Transforming Growth Factor beta 1 (TGF-Pi) treated corneas
TGF-Pi caused the most severe effect on the treated corneas. Treated corneas 
appeared to be severely cloudy and although they seemed to be rather fragile when 
handling, a great amount of force was needed to be applied in order for the flap to be 
detached. Samples that processed for immunohistochemistry did not produced any 
significant results, as there were only random cellular nuclei present and signs of 
deterioration to the issue.
Mean force required to pull the 
flap apart (N)
TGF-pi
Concentration
(ng/ml)
0.1 10 50 100
0 hours 0.04867 0.04867 0.04867 N/A
1 week 0.07100 0.07467 0.13800 N/A
2 weeks 0.06733 0.09000 0.13967 N/A
3 weeks 0.07733 0.12200 N/A N/A
4 weeks 0.08400 0.13800 N/A N/A
Table 4.10: Mean force required to detach TGF-pi treated corneas over a period of 4
weeks in culture.
0.1 ng/ml 10 ng/ml 50 ng/ml
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Figure 4.13: Graphs showing the effect of various concentrations of TGF-Pi on the
flap adhesion.
0.1 ng/ml and 50ng/ml of the cytokine caused a gradual increase in the flap 
adherence. The effect of the cytokine was more rapid in the 1 Ong/ml treated samples 
as flap adherence kept increasing significantly every single week.
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0.1 ng/ml lOng/ml 50ng/ml lOOng/ml
col1
to
O
H
1 week ModerateCloudy
Moderate
Cloudy
Moderate
Opaque Opaque
2
weeks
Moderate
Cloudy
Moderate
Cloudy
Moderate
Opaque Opaque
3
weeks
Moderate
Cloudy
Moderate
Opaque Opaque Opaque
4
weeks
Moderate
Cloudy
Moderate
Opaque Opaque Opaque
Table 4.11: Visual transparency assessment of TGF-Pi treated corneas over a 4 week
period in culture.
TGF-lp had the strongest effect on the corneas, as higher concentrations of the 
cytokine caused severe opacities and signs of deterioration to the tissue.
4.4 Discussion and conclusions
The main aim of this experimental set up was to enhance the appearance of 
myofibroblats in the stroma of injured corneas. This was achieved by treating injured 
corneas with growth factors that are known to cause either apoptosis (i.e. TNF-a, IL- 
la, FasL) or myofibroblast transformation (TGF-pi) to quiescent keratocytes in the 
comeal stroma.
Several studies have so far investigated the effect of growth factors in 
keratocytes within the comeal stroma, confirming that several cytokines can trigger 
cytokine-mediated apoptosis in fibroblasts (Wilson et al. 1996 (a and b), Fini 1999, 
Mohan et al. 2000, Jester and Ho-Chang 2003). Additionally, it is also known that 
subsequent to apoptosis, keratocytes transform into myofibroblasts (Wilson et al 
1996). In the current study TNF-a, IL-la and FasL caused significant increases in the 
myofibroblast population. In Chapter 3 the myofibroblast population in plain LASIK- 
like injured corneas reached a maximum of approximately 63%. However, in cytokine 
treated corneas, myofibroblast population clearly became denser and reached up to 
80% for some of the dilutions of FasL and IL-la. TNF-a also caused an increase in 
myofibroblast cell numbers (max~70%) but it was not as intense as the effect that IL- 
la  and FasL had. There is no myofibroblast data for TGF-pi as stained samples had 
signs of deterioration of the tissue. Physically the tissue itself had visual signs of 
deterioration as it was extremely cloudy and fragile at the periphery. The preparation 
of the tissue was repeated several times and it always seemed to have the same
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appearance. These observations lead to the conclusion that applying TGF-P directly 
onto the corneal stroma in such concentrations (i.e. 0.1, 10, 50 and 100 ng/ml) can be 
rather toxic for the tissue itself. The main role of TGF-p i is to induce the 
transformation of keratocytes to myofibroblasts (Wilson et al 1996). Given that the 
quantity and the concentration of the applied cytokine were high, it triggered a very 
intense response in cell transformation. This disrupted the balance within the tissue 
that had fatal effects for the treated corneas.
All four cytokines applied to LASIK-like corneas in the current study increased 
significantly the flap adherence. However, flap adherence did not increase 
significantly for non-cytokine treated samples over the 4 week organ culture time 
span. This confirms that 4 weeks after injury flap recovery is poor and the cornea very 
unstable. However, previous studies have revealed that LASIK flap adhesion 
increases significantly 3 months after surgery (Kim et al. 2006). All concentrations of 
TNF-a, IL-la and TGF-Pi caused significant increase in flap adherence. FasL had the 
mildest effect as lower concentrations of the cytokine did not cause any significant 
increase in flap adherence. However, TGF-Pi caused the maximum flap adherence 
among the four cytokines that were used. TGF-P i had the most severe effect in the 
corneas in all the assessments that were made, mainly because this cytokine has an 
immediate effect in myofibroblast transformation (Carrington et al 2005). In fact, it 
has already been proposed that dilutions as low as 15 ng/ml of TGF-pi are known to 
cause maximal expression of aSMA in treated keratocytes (Micera et al 2006). 
Additionally, according to Saika (2004) wound healing problems in the cornea can be 
treated by manipulating TGF-p signals. The findings of the current study and the 
suggestions in the literature imply that the application of TGF-P i can be ideal for 
increasing flap adherence and therefore corneal stability in LASIK-like injured 
corneas. However, a smaller quantity of the cytokine in a lower dilution is clearly 
required.
Samples that were characterised with the same visual assessment in terms of 
transparency (i.e. clear, moderately cloudy, etc) seem to have similar values of flap 
pulling forces as well as myofibroblast increases. This observation implies that there 
might be a possible correlation between the degree of transparency, hence 
myofibroblast expression and the extent of flap adherence. Therefore, the application 
of certain cytokines for the improvement of flap adherence might be useful in further 
medical practice It is obvious that different, lower dilutions need to be applied in
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order to avoid compromising the clarity of the corneas, a vital feature for the function 
of the tissue. Therefore, it is possible to improve flap adherence using these cytokines, 
but this is achieved at the expense of comeal clarity. Maintaining comeal 
transparency is essential for a normal visual function to occur. Therefore, it is 
important to determine an optimal correlation between cytokine type/dilution and 
improved flap adherence.
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5. Investigation of collagen ultrastructure in normal, LASIK-like and trephine 
wounded corneas
5.1 Introduction
X-ray diffraction experiments have been widely used to gain important information 
about the ultrastructure of connective tissue. In the current study synchrotron radiation 
was used (Daresbury Laboratories, UK- Fig. 5.1) to obtain information about the 
structure of collagen within the cornea following trephine and LASIK-like wounding and 
healing in the culture system.
Accelerating an electron beam within a magnetic field to the speed of light 
produces synchrotron radiation. A series of magnets is used in order to bend the electron 
beam and accelerate it into a circular shape. As they pass these “bending” magnets, the 
path of the electrons is deflected and they emit an intense beam of light, known as 
synchrotron radiation. The beam has the shape of a cone in front of the electron. The 
spectrum of synchrotron radiation covers the part of the electromagnetic spectrum from 
infra-red through to gamma-rays (Margaritondo 1988, Meek and Quantock 2001).
Figure 5.1: Aerial photo of the Synchrotron Radiation Source (SRS) in Daresbury, UK 
(Picture taken from http://es 1 .ph.man.ac.uk/research/svnc/daresburvr.jpg)
Synchrotron radiation is much more intense than common laboratory radiation 
sources and therefore it enables scientists to run experiments in a relatively short time and 
hence obtain readings from multiple samples. This is also very important as the tissue is 
not exposed for a long time and therefore there are minimal degradation effects on the
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samples.
For convenience, x-rays are passed through the entire thickness of the cornea, 
parallel to the optical axis. The x-ray beam has a finite cross-section so x-ray diffraction 
yields the average values of ultrastructural parameters by averaging the whole depth of 
the area of the cornea that is examined. By scanning across the tissue, patterns from each 
position allow spatial variations in these structural parameters to be mapped and to be 
compared between wounded and unwounded tissues.
5.2 Methods 
5.2.1 Sample preparation
Bovine corneas were wounded (either trephined or in a LASIK-like fashion) and 
organ cultured as previously described (section 2.1). Unwounded clear corneas were also 
organ cultured and were used as controls. Corneal samples were removed from the organ 
culture at various time points (i.e. 0, 1, 2, 3 and 4 weeks), wrapped in Clingfilm and 
immediately frozen in liquid N2 . Samples were then kept at -80°C until they were 
transferred to Synchrotron Radiation Source (Daresbury, UK); freezing does not affect 
the structural parameters being measured (Fullwood and Meek 1994). While transferring 
to the SRS stations samples were kept in an isothermic box containing dry ice and placed 
in a -80°C freezer upon arrival. The samples were finally thawed before exposed to the x- 
ray beam.
5.2.2 X-ray diffraction
LASIK-like and trephine wounded and unwounded control corneas were scanned 
at stations 2.1 and 14.1 in Daresbury SRS (Fig: 5.1). Station 2.1 (small angle), has a long 
camera and this allows us to measure parameters such as the centre to centre collagen 
inter fibrillar spacing (IFS) and fibrillar diameter. The set up in station 14.1 (wide angle), 
is suitable for measuring molecular parameters of collagen such as direction and 
distribution.
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Figure 5.2: 18mm corneal circular area including the LASIK-like incision. For the wide 
angle x-ray diffraction experiments the whole area was scanned. For small angle 
experiments a cross section of the cornea (blue dashed line) was scanned (A). 18mm 
corneal circular area with a 5mm trephine wound in the middle. A cross section of the 
cornea was scanned (blue, dashed line) in order to observe interfibrillar spacing (IFS) and 
fibrillar diameter variation outside the wound, whereas the whole corneal button was 
scanned for wide-angle experiments (B).
During data collection all samples were wrapped in cling film and placed in an 
airtight Perspex/Mylar chamber in order to prevent dehydration of the tissue. X-rays were 
passed through the anterior corneal face, parallel to the optical axis, and the small and 
wide angle diffraction patterns recorded on a detector situated behind the specimen. 
Before data collection the x-ray beam had to be located. This was achieved by exposing a 
piece of green x-ray sensitive paper that was mounted on graph paper and placed in the 
sample holder for 10 sec. A red dot was created by the x-ray beam on the green paper and 
with the use of the attached graph paper the exact position of the x-ray beam was located.
Small angle x-ray scattering (SAXS) was performed in station 2.1 at the UK 
Synchrotron Radiation Source (Daresbury laboratories) using an evacuated camera of 
length 8.25m and a focused monochromatic beam x-ray beam (k=0.154nm). These series 
of experiments were performed in order to measure fibrillar diameter and spacing as 
previously described by Meek and Quantock (2001). The x-ray patterns were recorded at 
different positions across the cornea as shown in Fig. 5.2. For trephine wounded samples 
point 0,0 was placed right in the middle of the wound and 9mm scans were performed 
towards the periphery on either sides. The LASIK-like samples were scanned in a similar
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manner, by positioning point 0,0 in the flap incision and extending 11mm towards the 
nasal and 6mm towards the temporal regions of the corneal button. The size of the beam 
was 1mm2, the step size was 1mm and the exposure time was 90sec.
Wide angle x-ray scattering (WAXS) was performed in station 14.1. at the UK 
Synchrotron Radiation Source (Daresbury laboratories). This method was used to map 
the collagen distribution and orientation across the cornea as described by 
Aghamohammadzadeh et al. (2004). The whole of the 18mm corneal button was scanned 
using a 1mm2 beam, at 1mm steps, with exposure time of 30sec. A lead backstop was 
positioned between the detector and the sample in order to stop any undeviated rays. The 
ion chamber was placed in between the incident x-ray beam and the specimen.
5.2.3 Data analysis for SAXS
Data analysis for SAXS experiments was performed using a Unix based graphics 
program (Fit2D, produced by Dr Hamersley, ESRF, Grenoble, France) and Windows 
based programs (StatSoft Statistica and Microsoft Excel).
Initially, each data file was normalised against the appropriate ion chamber 
reading in order to compensate for any beam current decay during data collection. Then, 
the detector response pattern was removed from each normalised image to obviate 
systematic error caused by the detector’s non-uniform response. An intensity profile of 
the x-ray pattern was then created by taking a vertical centrally located transect of the 
pattern. The intensity pattern was then folded in the middle of the pattern, as it is 
symmetrical, to increase the signal/noise ratio. The scatter intensity (I) was then 
multiplied by the radial position (R); because only a small sample of the pattern was 
used, the integrated intensity distribution profile and therefore the use of a linear scan 
across the x-ray pattern, had to be corrected.
Bragg’s law states:
nX = 2Msin0
where n is the order of diffraction, X is the wavelength of the radiation, M is the Bragg 
spacing and 20 is the scattering angle. The size of the structure that causes the scattering 
is therefore inversely related to the scattering angle. At this stage of the analysis, the 
intensity distribution is described as a function of radial distance (R ) from the centre of
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the pattern in pixels. The first step, therefore, was to calibrate the system and this was 
done using the 67nm meridional reflection from wet rat-tail tendon. Because the patterns 
were obtained at very low angles, the small angle approximation could be used, whereby 
sin 0 » tan 0 » 0. With this approximation, one can obtain the Bragg spacing 
corresponding to the interfibrillar spacing using:
M = 67 x Rrtj/ Rc?
where Rc is the position of the interfibrillar peak in the corneal x-ray pattern and RRTt is 
the position of the first order in the meridional pattern from rat tail tendon. Collagen 
fibrils are thought to be arranged with liquid-like packing, so the Bragg spacing is 
multiplied by the factor 1.12 to obtain the interfibrillar spacing (Worthington and Inouye 
1985, Meek and Quantock 2001).
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Figure 5.3: A common intensity profile, first order collagen pointed out by arrow (A) 
and a highly disordered pattern, where first order collagen peak appeared as a small 
shoulder (arrow in B). Both patterns were taken from a LASIK-like injured bovine
cornea.
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Figure 5.3 shows intensity profiles from two adjacent areas in a LASIK-like 
injured cornea; the second graph represents the incision site. X-ray intensity is plotted 
against the reciprocal space co-ordinate Q (=1/M). The first peak arises from the 
interference function and the subsidiary peak from the fibril transform (Meek and 
Quantock 2001). A sharp first peak indicates ordered collagen whereas a diffuse peak or 
shoulder indicates a more disordered packing. Equation 5.1 is the mathematical basis of 
Figure 5.3 showing how the observed intensity I(Q), the fibril transform, and the 
interference function due to the fibril packing E(Q), are related
I(Q)=F2 E(Q)+B
Equation 5.1 Equation for the intensity distribution (I(Q)-> integrated intensity 
distribution, F2-> fibril transform, E(Q)-> the fibril interference function, B-> 
background scatter from other tissue components, Q-> reciprocal space coordinate).
At this stage, the analysis is carried out in a Windows environment using StatSoft 
Statistica 6 and Microsfot Excel. Each data file for each 1mm that was scanned was 
processed separately. The data was opened initially in Statistica and each Statistica file 
was linked to an Excel spreadsheet that contained the Bessel function.
The individual steps involved in obtaining the interfibrillar spacings and fibril 
diameters from the corrected intensity distribution are as follows:
The background scatter, B, was assumed to follow a simple power law. A linear 
background (LOGBK) was therefore generated from the natural log graph of IR against 
Q. The linear background was then anti-logged (ANTILOGB) and subtracted from the 
image profile graph of IR against Q to form a new intensity profile (IR_B). After 
removing this diffuse x-ray scatter, only the peaks associated with the low angle 
reflections of the cornea remained.
Collagen fibrils can be considered as non-ending cylindrical structures. Scattering 
from such cylinders (the fibril transform) takes the mathematical form of a 1st order 
Bessel function. This has a low broad peak as a subsidiary maximum that appears close to 
the 3rd order of the collagen meridional reflection. In order to calculate the fibril diameter,
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a Bessel function graph was plotted superimposed on the IR_B vs Q graph. The program 
allowed the height and position of the Bessel peak to be adjusted to achieve the best fit 
with the IR_B graph. The first maximum in a Bessel function appears at a distance that it 
is inversely related to collagen fibrillar diameter (d). Considering the fact that the 
distance of the Bessel peak is inversely proportional to the Braggs spacing (M) in its 
maximum, there is a simple relationship between M and d and using the following 
equation (Eq. 5.1) it is possible to calculate the fibril diameter of collagen.
, 0 S.14ATa =  2 x -----------
2n
Equation 5.2: Equation for calculating collagen fibrillar diameter (d, fibril diameter; M, 
Bragg spacing of the subsidiary maximum)
5.2.4 Data analysis for WAXS
Data analysis for WAXS experiments was performed using a Unix based graphics 
program (Fit2D, produced by Dr Hamersley, ESRF, Grenoble, France) and Windows 
based programs (Microsoft Excel and Media Cybernetics Optimas 6.5).
In order to correct the beam current decay during data collection an x-ray 
intensity value was calculated by multiplying the average ion reading from each exposure 
by the exposure time in sec (i.e. 30sec). This value was then used to normalise the 
corneal x-ray pattern.
Each of the 200-400 lamellae in the path of the x-ray beam produces an 
equatorial diffraction pattern (Meek and Quantock 2001). Because lamellae occur at all 
angles within the plane of the cornea, this pattern appears as a number of concentric 
circles that span out from the centre of the pattern. The centre of the pattern and the 
intensity of 120 circles for bovine corneas were determined using Optimas 6.5 in the 
current study.
In brief, each circular diffraction pattern was divided into 256 equal sectors and 
the average intensity was calculated for each one of them. Then, the integrated intensity 
was plotted as a function of radial distance from the centre of the pattern for each sector 
producing 256 graphs. Background scatter varies with radial distance from the centre of
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the pattern and it had to be removed. A power law curve was fitted to either side of the 
collagen peak on the plot of scattering intensity versus radial distance for each pattern 
resulting to the subtraction of the fitted curve from the original data and therefore the 
removal of the background scatter (Daxer and Fratzl 1997).
A single intensity value from each point of the circumference of the collagen 
reflection was obtained by integrating radially all the 256 normalised plots. The profile of 
collagen x-ray scatter intensity relative to radial position was then converted to a profile 
of collagen x-ray scatter to angular position around the x-ray diffraction circular pattern. 
The profiling started at 3 o’clock position of the circular pattern and carried on in an 
anticlockwise direction (covering 0-360 degrees). At this stage, the area below the graph 
line represents the total collagen mass, which consists of both collagen lying in all 
directions (isotropic collagen) and fibrillar collagen with a preferred orientation (aligned 
collagen) (Fig. 5.4B). The index of orientation is then the ratio between the scattering of 
preferentially aligned collagen and the total scattering of collagen.
During the last stage of the analysis polar plots were created in order to have a 
visual, more comprehensive representation of the actual orientation of collagen, as well 
as its relative quantity towards a given direction of preferred orientation. The scattering 
from isotropically orientated collagen was removed leaving just the aligned collagen 
scatter relative to angular position (Fig. 5.4C). The data for the aligned collagen was then 
shifted along the x-axis by 90°, as x-rays once they hit the collagen they scatter at right 
angles to the direction of the fibril axis. A new graph was then created showing the 
preferentially aligned scatter intensity versus the angle of molecular orientation. This data 
was also plotted in Microsoft Excel as a propeller-shaped 360° polar plot. A polar plot 
represents the preferred orientation of collagen towards a given direction in a particular 
point of the tissue. The maximum dimension of a polar plot is representative of the 
amount of fibrils in a given direction.
Total scatter from each diffraction pattern was found by integrating the area under 
the scattering intensity versus rotation angle graph (Figure 5.4B). This was done for the 
collagen diffraction maxima from each scattering pattern, resulting in a matrix of 32 * 36 
intensity values. These data were displayed as a contour plot using Microsoft Excel 
software. A contour plot displaying total scatter from only the preferentially aligned
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collagen was produced in the same way, except that only the preferentially aligned scatter 
(unshaded region in Fig. 5.4B) was integrated.
5.2.5 Statistical analysis
All statistical analysis was performed using the statistics software package SPSS. 
Three samples of control and wounded corneas were used for each time-point. Initially all 
data was tested for its normality and then a one-way ANOVA test was performed 
between control and wounded corneas for each different scan (points between -9 to 9 for 
trephined wounded corneas and -6 to 11 for LASIK-like ones). Finally, an independent t- 
test was used in order to compare overall the data between wounded and control corneas 
for each time point.
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Figure 5.4: Part of the analysis for wide angle x-ray scattering. Initially, an x-ray 
scattering pattern that was created by passing a beam of X-rays through the cornea 
parallel to the optical axis (A). Intensity profiles of total and isotropic collagen X-ray 
scatter (B) and preferentially aligned collagen alone (C) as a function of angular position 
around the scatter pattern. Example of a polar plot (D). The size of the polar plot and its 
radial extent in any given direction represents the amount of collagen preferentially 
orientated in that direction (Picture taken from Hayes et al. 2007).
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5.2.6 Transmission electron microscopy (TEM)
TEM was used in this project purely to visualise the ultrastructure of the bovine 
corneal stroma. The procedure was performed as previously described in chapter 2.
5.3 Results
5.3.1 Small angle x-ray scattering (SAXS)
Trephine wounded corneas
Fibrillar diameter and IFS in control corneas
Neither fibrillar diameter nor IFS was affected by the culture system and both 
these variables remain constant during the organ culture time-span (Fig. 5.5). The IFS 
increased slightly during the third week in culture.
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Figure 5.5: Graphs representing Bragg fibril diameter (A) and interfibrillar spacing (B) 
for control corneas over a time of two weeks in culture- Error bars represent standard
error of mean.
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Figure 5.6: Collagen fibril diameter for control and trephine wounded corneas for a two 
weeks organ culture time span (Pale blue area indicates the position of the wound- Error
bars represent standard error of mean)
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Collagen diameter was not affected at the time of injury. However, it increased during the 
first and second week in culture (p<0.05) in a progressive manner (Fig.5.6). The collagen 
diameter was affected in wounded corneas in an area within and around the wound but 
remained within normal values in the periphery of injured corneas (p>0.05).
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Figure 5.7: Collagen interfibrillar spacing for control and trephine wounded corneas for
a two weeks organ culture time span (Pale blue area indicates the position of the wound- 
Error bars represent standard error of mean)
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IFS increased in wounded corneas during the first week after injury and it 
remained high during the second week in culture (p<0.05).
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Figure 5.8: Graphs representing fibril diameter and interfibrillar spacing for control corneas over a time of four weeks in culture-
Error bars represent standard error of mean.
Neither fibril diameter nor IFS was affected by the culture system and both these variables remained constant during the 
organ culture time-span (Fig. 5.8).
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Figure 5.9: Collagen diameter for control and LASIK-like injured corneas for a four 
weeks organ culture time span (incision site for LASIK-like flap at 0,0- Error bars
represent standard error of mean)
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Collagen diameter increased after the first week in culture (p<0.05) in a progressive 
manner (Fig.5.9) in an area in and around the incision site only. Collagen diameter 
remained within normal values in the periphery of injured corneas (p>0.05) and mid flap 
areas.
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Figure 5.10: Interfibrillar spacing for control and LASIK-like injured corneas for a four 
weeks organ culture time span (incision site for LASIK-like flap at 0,0- Error bars
represent standard error of mean)
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Collagen interfibrillar spacing increased in injured corneas during the organ 
culture time span and provided that this was not the case with the corresponding controls, 
it can be concluded that corneas swell during the wound healing process. The 
interfibrillar spacing did not show a consistent change at the incision site, but that was a 
sign of the high disorder of the tissue in this specific area.
5.3.2 Transmission electron microscopy (TEM)
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Figure 5.11: Electron micrographs, obtained using the critical electrolyte method, 
representing area in mid and posterior stroma of trephine wounded corneas within 24hrs 
of injury (A). Control cornea in a posterior site of the stroma (B). Turquoise arrows point 
out the difference in size between proteoglycan molecules in injured and uninjured
corneas.
Shortly after injury abnormally large proteoglycan molecules appear in an area 
proximal to the trephine wound. There is an obvious difference in the size of the 
proteoglycans found in mid stroma of injured corneas and the ones found in control 
corneas (Fig. 5.11 A and B).
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5.3.3 Wide angle X-ray scattering (WAXS)
Control cornea
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Figure 5.12: Polar plot map showing the preferred orientation of fibrils in a control
bovine cornea. Fibrils tend to have a vertical preferred orientation (the map is switched
30 degrees anticlockwise off in vivo orientation). Plots have been scaled down by the
factors shown in the colour key and metric scale is in millimeters-Courtesy of Dr S Hayes
Collagen fibrils in bovine corneas tend to have a vertical preferred orientation in a 
major part of the tissue. However in the periphery of the cornea this pattern obtains a 
circular orientation.
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Figure 5.13: Polar plot map showing the preferred orientation of fibrils in a centrally 
located 6.9><6.9mm area from a trephine wounded cornea over a two week culture time 
span (A-C). The wound was placed in the middle of the scan and the pictures depict 
trephine wounded corneas at Ohrs (A), 1 week (B) and 2 weeks (C). Solid circle
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represents the size and approximate position of the wound. Plots have been scaled down
by the factors shown in the colour key and metric scale is in millimeters.
Fibrils tend to maintain the uniaxial arrangement in a major part of the cornea at 
Ohrs (Fig. 5.13A), although a circular proffered orientation is also formed in the middle 
of the wound area. This circular preferred orientation in the middle of the wound is also 
observed at later time-points (Fig. 5.13B-C). Collagen fibrils form a radial arrangement 
both outside and inside the wound area at 1 and 2 weeks (Fig. 5.13B-C).
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Figure 5.14: Polar plot maps of x-ray scatter (A-D) and contour maps of total collagen 
(E-H) showing the orientation and distribution, respectively, of fibrillar collagen across 
LASIK-like injured corneas at 1, 2, 3 and 4 week after injury. The scan covered an area
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that included the whole of the flap as well as the hinge. Plots have been scaled down by
the factors shown in the colour key and metric scale is in millimeters.
Circular collagen arrangement in the periphery of the corneas was maintained 
throughout the culture time span, but collagen seemed to be fairly disorganized within the 
flap area (Fig. 5.14A-D-> 1-4 weeks, respectively). Total collagen scatter was less in the 
incision area during the whole of the organ culture time (Fig 5.14E-H-M-4 weeks, 
respectively)
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5.4 Discussion and conclusions
The present study revealed important information about the collagen 
ultrastructural changes in bovine corneas shortly after injury. Fibril diameter increased 
during the first week in culture and it kept increasing in a progressive manner for the rest 
of the organ culture time span showing that a stromal repair process had been in progress. 
Fibril diameter in trephined corneas increased in an area within the wound but also in an 
area beyond the wound margin of about 1mm. The interfibrillar spacing increased 
throughout the whole of the corneal buttons within a week after injury and it kept 
increasing during the rest of the organ culture time. However, in trephine wounded 
corneas the interfibrillar spacing was increased compared to the corresponding controls, 
but the spacing was lower in the middle of the tissue, at the wound area, than the 
periphery. According to Connon and Meek (2004) the presence of a disorganized fibril 
arrangement inhibits the normal swelling of the scar tissue, and therefore interfibrillar 
spacing remained reduced in full-penetrating corneal wounds in rabbits. The extent of 
swelling in injured corneas was more severe in trephine-wounded samples than in 
LASIK-like ones. What is more, at the incision site in LASIK-like corneas, the 
interfibrillar spacing was lower than the rest of the cornea. According to Rawe et al 
(1994) the gradual reduction in the spread of interfibrillar spacing is possibly related 
to the progressive decrease in the light scattered from the tissue as the wound heals. 
McCally et a l (2007) suggest that the wound site in fully penetrating wounds in 
rabbit corneas continues to scatter a significant amount of light even 4.5years after 
wounding. The unusual pattern that was observed in the IR_B versus Q graph during 
data analysis in scans from the incision site also indicates a high level of disorder at 
the incision site, a finding that supports even more the fact that collagen fibrils were 
highly disordered at the incision site.
Upon injury, for trephined samples, the whole 5mm was excised and the corneas 
were left to heal in culture. On the contrary, in LASIK-like samples, the comeal stroma 
was sliced and the flap was repositioned back in place. Therefore, the trephine wounding 
is a more severe kind of injury that effectively disrupts the whole homeostasis of the 
tissue, by thinning the cornea and exposing a considerable amount of the stromal surface 
to the air. Provided that a considerable area of the stroma was exposed without having the
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barrier of the epithelium to control water uptake from the environment and also having an 
immediate and intense wound healing response naturally from the tissue itself in order to 
recover the piece that was removed, swelling effects are a lot more severe for trephine 
wounds than other more gentle methods of injury (i.e. LASIK-like ones). Additionally, 
the appearance of high numbers of larger proteoglycan molecules within the extracellular 
matrix during the repair process is already reported in the literature (Funderburgh et al. 
1998), but also large proteoglycan molecules were visually obvious in the present study 
in electron micrographs taken from the wound bed. The existence of these molecules also 
contributes to swelling effects during the wound healing process in the cornea.
Polar plot maps revealed a strong tendency of the collagen fibrils in trephine- 
wounded corneas to form a circular pattern within the wound but, because this happens 
from the moment of injury, it is considered to be an artefact caused by the need to pull 
upwards on the trephined button in order to cut it away from the underlying stroma. 
However, the cornea outside the wound is not affected by artefact, and the 
arrangement that was observed at later stages of the culture period is a result of the 
healing process and a response of the tissue upon wounding.
The polar plots from the trephined wounds were noted to become smaller 
outside the wound area as the wounds healed (Figures 5.13 B and C). This 
phenomenon is due to swelling that occurred in the tissue during wound healing. The 
effect was not observed in LASIK-like wounds because the extent of the wound healing, 
and hence the swelling, was not so pronounced. Figures 5.13 B and C also revealed a 
radical re-alignment of collagen in trephine wounded samples, with collagen fibrils 
bending towards the wound area in the middle of the tissue at later stages of the organ 
culture. It is likely that this specific collagen arrangement is the result of wound 
contraction that occurs during the wound healing process though it could occur as a 
natural response of the tissue to reinforce the central area of the cornea that became 
considerably thinner upon wounding with the trephine. Unlike trephine-wounds, the 
LASIK-like wounds showed no clear evidence of wound contraction, probably 
because the stromal wound-healing response is minimal and is restricted to the flap 
periphery (Perez-Santoja 1998, Ivarsen 2003, Phillipp 2003).
103
In the LASIK-like injured corneas collagen orientation did not adopt such a 
critical pattern as it did in the trephine-wounded ones. After injury, the collagen 
seemed to be highly disorganized and appeared to have a completely different pattern 
within the flap area compared to the control/uninjured sample. This suggests that the 
process of creating then repositioning the flap, at least in the bovine cornea, distorts 
the collagen lamellae. X-ray diffraction provides averaged data throughout the 
comeal thickness, so we cannot say if the distortion is in the flap, the bed, or both. 
However, it is likely to be in the flap, as this is the part that was displaced during the 
induction of the wound.
However, it must be taken into consideration that an in vitro system lacks certain 
factors present in a live organism. Such parameters are the absence of nerve responses 
and intraocular pressure fluctuations in response to injury that potentially can affect the 
mechanical properties of the tissue. However, the lack of these parameters has not been 
an issue in previous in vitro comeal wound healing studies (Carrington and Boulton 
2005, Carrington et al. 2006, Zhao et al. 2006) and, in particular, this has not been related 
to the orientation of collagen.
In conclusion, the extent of the wound healing response in the cornea depends on 
the type of injury. In the present study, the events of the repair process were more 
dramatic in trephine-wounded samples than in LASIK-like ones, because the first type of 
injury is more severe than the latter one. In trephine injured corneas collagen fibrils had a 
preferred orientation pattern to form a ring within and around the wound area. However, 
this might be induced upon wounding with the circular 5mm trephine. In LASIK-like 
ones collagen fibrils tend to form a pattern that follows the incision. This pattern appears 
at the third week after injury and becomes more apparent at the fourth week. It can also 
be concluded that the observations and the conclusions drawn in the present study are not 
artefacts of the in vitro system that was used. The ultrastructure of the tissue was clearly 
not affected in control corneas that remained normal without any swelling effects during 
the 4week organ culture time-span.
104
6. Homology-based molecular modelling of the bovine corneal biglycan core
protein
6.1 Introduction
Collagen/Proteoglycan interactions within the extracellular matrix (ECM) play a 
key role in the maintenance and function of connective tissue. ECM consists 
predominantly of collagen, proteoglycans and other minor proteins (Hockin et al 
1998). For instance, corneal transparency is an essential requirement in order for visual 
function to occur and it is maintained due to the collagen and proteoglycan organisation 
within the corneal stroma. Collagen spacing is mainly controlled by proteoglycans that 
establish ionic interactions with the collagen fibrils within the stroma and fill the space 
between the fibrils. Therefore, the physical and chemical properties of proteoglycans 
play an important role in establishing and maintaining corneal transparency.
The ground substance of the corneal extracellular matrix is made up of 
proteoglycans. Proteoglycans are macromolecules composed of a protein core and a 
carbohydrate glycosaminoglycan (GAG) side chain. GAG’s are highly hydrophilic, 
negatively charged molecules located at specific sites around each collagen fibril (Scott 
and Haigh 1996, Remington 1998). The core protein of a proteoglycan seems to be the 
most active part of the molecule, since it interacts with the collagen fibrils and the 
extracellular matrix at specific sites. According to Cintron et al (1989) the precise 
arrangement of PGs presumably reflects specific intermolecular interactions with 
collagens. Therefore, loss of PGs might cause alterations to the collagen organisation 
and hence to connective tissue stability. According to Cintron et al (1989) the precise 
arrangement of PGs presumably reflects specific intermolecular interactions with 
collagens. Therefore, loss of PGs might cause alterations to the collagen organisation 
and hence to corneal transparency.
The corneal stroma contains two major classes of proteoglycans containing 
either keratan sulphate side chains or dermatan/chondroitin sulphate side chains (Zieske
2001). Lumican, keratocan and mimecan are the major keratan sulphate PG’s, whereas 
decorin and biglycan are dermatan/chondroitin PGs. Keratan sulphate is the major 
glycosaminoglycan in healthy corneal stroma, whereas dermatan/chondroitin sulphate 
molecule levels are lower under normal conditions. However, upon wounding 
dermatan/chondroitin sulphate content increases during tissue remodelling. 
Specifically, decorin levels increase by twofold, whereas biglycan increases seven 
times during the wound healing process (Funderburgh et al 1998).
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Dermatan sulphate proteoglycans are small leucine rich proteins (SLRPs) with 
an “arc” shaped spatial conformation and tend to form dimers. The amino-acid 
sequence of these proteins is characterised by long arrays of leucine-rich repeat motifs 
of about 24 amino acids in length (Jolles 1994). A feature that is of great interest about 
SLRPs is that they contain an amphipathic consensus sequence, with leucine as the 
predominant hydrophobic residue placed in conserved positions (Hocking et al 1998). 
This pattern is highly likely to be involved with protein-protein or protein lipid 
interactions (Krantz et al 1991). With respect to collagen/proteoglycan interactions 
several theories have been proposed to date, with the majority of them suggesting the 
idea that interactions with collagen are being established at the inner site of the 
“horseshoe” shaped molecule (Weber et al 1996, Vesentini et al 2005). Bearing in 
mind that the concave surface is involved in a high-affinity dimer interaction, this 
theory is now being debated (Scott et al 2006, Vesentini et a l  2006). However, it 
should be taken into consideration that there might be a dimer-to-monomer transition of 
proteoglycans in collagen/proteoglycan interactions. For example, dermatan sulphate 
proteoglycans bind collagen as a dimer, conservation analysis across class I SLRPs 
revealed a clustering of partially conserved residues on the sugar-free surface of LRRs 
IV-VI, a region that has been implicated in collagen binding. This theory though has 
yet to be confirmed by further biochemical studies (Scott et al 2004).
Biglycan is a dermatan sulphate proteoglycan and it receives its name because it 
is substituted more often with two glycosaminoglycan chains at the N-terminus (Kresse 
et al 1994, Naito 2005). It is expressed in a variety of epithelial tissues throughout the 
body, such as the lung, spleen, bone, liver, cartilage, tendon, skin, kidney, heart, sclera 
and cornea (Wegrowski et al 1995, Hocking et al 1998, Watson and Young 2004). 
Biglycan interacts with fibrillar collagen and based on immunohistochemical analysis it 
has been proven that the core protein of the proteoglycan interacts directly with the 
collagen fibril (Schonherr et al 1995).
In this study the 3D structure of the core protein of biglycan was determined by 
means of homology based molecular modelling. Descent from a common ancestor, i.e. 
homology, can be hypothesised when similar properties are detected in biological 
objects (Grishin 2001). It is also widely accepted that statistically significant homology 
detected from the sequence alone reflects descent from a common ancestor (Aravid and 
Koonin 1999). Comparative homology-based modelling is based on the observation
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that sequence correlation above a certain proportion implies structural similarity. Thus, 
a protein of a known structure and sequence can be used as a template for the 
construction of a 3D model of another protein with a sequence similar to the template 
(D’Alfonso et al 2001). Additionally, it should be taken into consideration that 
structure is conserved to a much greater extent than sequence and that there is a limited 
number of backbone motifs (Chothia 1992, Baxevanis and Ouellette 2001). A relative 
minimum percentage of homology between two protein sequences that can ensure the 
construction of a reliable model is >40% (MOE 2005). Template and model homology 
sequences identity that greater than 50% normally have 90% or more of the individual 
structures within the common cores and an RMSD (root mean square) value smaller 
than lA, ensuring reliability of the proposed model (Chothia and Lesk 1986). The aim 
of this chapter is to predict the 3-dimensional structure of the core protein of the bovine 
corneal biglycan molecule.
6.2 Materials and methods
6.2.1 Molecular Modelling
All calculations were performed on a dual Pentium 4 workstation running Linux 
and using the Molecular Operating Environment (MOE) 2005.03 software package 
developed by Chemical Computing Group (Montreal, Canada).
6.2.2 Sequence alignment
The amino acid sequence of biglycan was obtained from the protein database 
from NCBI (http://www.ncbi.nlm.nih.gov/protein) (gi|30315664). The PSI-BLAST 
algorithm was used to identify homologous structures for biglycan by searching the 
structural database of protein sequences in the Protein Data Bank (PDB) (Berman HM
2002). The crystal structure of decorin (PDB code 1XKU) (resolution 1.5 A) was 
selected as template structures for homology modelling of the biglycan protein. The 
selection of these structures was based on the highest sequence similarity (56.7% 
similarity). Sequence alignments were created with ClustalW (Thompson 1994).
6.2.3 Homology modelling
The homology model was constructed using MOE version 2005.03. As 
indicated above, the homology model of biglycan was based on the crystal structure of
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1XKU, which shares 56.7% similarity with the sequence of biglycan. The first 
requirement in the construction of a biglycan model structure is a multiple sequence 
alignment against its template. The sequence alignment is based on identifying 
structurally conserved regions (SCRs) common between the model and the template. 
An initial 3D structure of biglycan was obtained by transferring the backbone 
coordinates from the template residues to the corresponding residues of biglycan, 
except for several variable regions (LOOPs). To construct the structural variable 
regions, a loop-searching and generating algorithm over the databank of known crystal 
structures was used from within MOE. Through the procedure mentioned above, an 
initial 3D model was thus completed. The quality of this model was examined by 
WHATCHECK and ProCheck. The three-dimensional model was subjected to 
molecular mechanics energy minimization calculations using the updated MMFF94x 
and Amber algorithms implemented in MOE. The refinement of the homology model 
was carried out through energy minimization: 500 iterations of steepest descent (SD) 
calculation were performed and then the conjugated gradient (CG) calculation was 
carried out until achieving 0.1 kcal/mol A-1 of convergence on the gradient.
6.2.4 Molecular dynamics (MD) simulations
MD simulations were performed using MOE version 2005.03 and its built-in 
Molecular Dynamics module using an NVT ensemble. The protein was solvated in a 
cubic periodic box containing water molecules in order to perform simulations in an 
aqueous environment. Firstly, the model structure was refined by adding all hydrogen 
atoms and subsequent energy minimization with the MMFF94x molecular mechanics 
module of MOE to ensure overall neutrality of the simulated system. The time step was 
2 fs and all simulations were conducted at 300 K.
The model was first equilibrated for 100 ps keeping the whole protein fixed to 
allow the water molecules to relax. A subsequent lOOps of equilibration with the 
protein backbone fixed was carried out. After the equilibration phase, we obtained 1 ns 
MD trajectory for the biglycan model. Additionally, in order to assess the structural 
stability of the protein, 500 pico-second snapshots of the molecular dynamics 
simulation trajectory were taken. This revealed 9 conformations that were 
superimposed together. Each snapshot conformation was coloured with its unique 
colour.
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Finally, a conjugate gradient energy minimization of the full protein was 
performed until the root mean-square (rms) gradient energy was lower than 
0.001 kcal/mol A-1. In this step, the quality of the initial model was improved. After the 
optimization procedure, the structure was checked again by ProCheck.
6.3 Results
6.3.1 Sequence alignment
The sequence that was modelled into a 3D molecule in this study was the 
bovine biglycan core protein. A comparison between the sequences of this protein from 
various mammalian species revealed high homology (Fig. 6.IB).
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Figure 6.1: Sequence alignment between biglycan core proteins of different 
species produced by the ClustalX program (A). Homology scores from sequence 
alignment between the sequences of biglycan core protein from different mammal 
species. Alignment scores were between 94-99% suggesting high homology and 
structural conservation of biglycan core protein throughout mammal species (B).
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Additionally, biglycan protein sequence is the same size in many mammal 
species (Fig. 6.1). Sequence alignment between decorin and biglycan core protein 
sequences revealed a high homology score (i.e. 56.7%) (Fig. 6.2A).
1XKU GPVCPFRCQCHLRWQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTL
Biglycan SAMCPFGCHCHLRWQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYAL
1XKU I LINNKI SKI SPGAFAP LVK LERLY LSKNQ LKE LPEKMPKT LQE LRVHENEITKVRKSVF
Biglycan VLVNNKISKIHEKAFSPLRK LQKLYISKNHLCEIPPNLPSSLVELRIHDNRIRKVPKGVF
1XKU NGLNQMIWELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG
Biglycan SG LRNMNCIEMGGNPLENSGFE PGAFDGL-KLNYLRI SEAKLTGI PKDLPET LNELHLDH
1XKU NKITKVDAAS LKGLNN LAKLGLSFNSI SAVDNGS LANTPH LRELH LNNNK LVKVPGGLAD
Biglycan NKIQAIE LEDLLRYSKLYRLGLGHNQIRMIENGSLSF LPT LRELHLDNNKLSRVPAGLPD
1XKU HKYIQWYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR
Biglycan LK LLQWYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP YWEVQ PATFACVTDR
1XKU AAVQL
Biglycan LAIQF A
1XKU GPVCPFRC LR CSDLGLEKVPKDLPPDTA LQNNKITEIKDGDFKNLKNLH
B i g l y c a n SAMCPFGC LR CS DLGLKAVPKEIS PDT T LQNNDIS RKDDFKGLQHLY
1XKU INNKISKISPGAFAPLVKLE LSKNQLKELPEKMPKTLQ VHENEIT RKSVF
B i g l y c a n VNNKIS HEKAFSPLRKLQ ISKNHLCEIPPNLPSSLV IHDNRIRKVPKGVF
1XKU NGLNQMI LGTNPLKSSGIENGAFQGMKKLS IADTNITTIPQGLPPSLT LDG
B i g l y c a n SGLRNMN MGGNPLENS GFEPGAFDGL- KLN ISEAKLTGIPKDLPETLN LDH
1XKU NKIT DAAS LKGLNN LA L S F N S IS  DN GS LANT PH LR LNNN KLVKVP GGLAD
B i g l y c a n NKIQ ELEDLLRYSKLY LGHNQIR ENGSLSFLPTLR LDNNKLSRVPAGLPD
1XKU HKYIQ LHNNNISAIGSNDFCPPGYNTKKAS YS LFSNPVQYWEIQPSTFRCVYVR
B i g l y c a n  LKLLQ LHTNNITKVGVNDFCPVGFGVKRAYYN LFNNPVP YWEVQ PAT F ACVT DR
1XKU_________________AA L R
B i g l y c a n  LA F ®
Figure 6.2: Sequence alignment between decorin (1XKU) and biglycan produced by 
the ClustalX program. Homology score between the two proteins was 56.7%. (A) 
Secondary structure features prediction. Red: a-helical secondary elements, Black: 13-
sheet pattern (B).
6.3.2 Secondary features and model evaluation
The P-sheet pattern has been completely conserved between the model and the 
template. On the other hand the template’s a-helix distribution was not exactly assigned 
to the model. There are 3 a-helical secondary elements missing from the model, when 
compared to the template (Fig. 6.2B).
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The ProCheck/WHATCHECK evaluation of the model revealed that 95% of its 
residues were found in the core regions and another 5% in the allowed regions of the 
Ramachandran plot (Fig. 6.3).
■hm h  h
Figure 6.3: Ramachandran Plot. In both the template and the model, there are no 
residues in the disallowed regions of the ramachandran plot.
The amino acid sequences of the first 20 amino acids at the N-terminus of 
biglycan and decorin are different. In biglycan, two GAG chains are attached to Ser5 
and Serll at the N-terminus whereas in decorin only one chain is attached to Ser4 
(Scott 2004).
6.3.3 Molecular dynamics
The Molecular Dynamics functions that were used in the present simulations 
solve the equations of motion for a molecular system and store the resulting trajectory 
information to a database. These functions depend on the current state of the system, in 
particular, the force field, the potential setup and the current restraint configuration.
The molecular dynamics simulation serves two purposes in the current study. 
Firstly after 4 ns the protein is completely relaxed and close to its global energetic 
minimum (Fig. 6.4, chart 1). Secondly, the extended molecular dynamics simulation 
does impose a serious structural test to the folding stability of the model. It was proved 
firstly from the energy graph and secondly from the Hamiltonian graph that the energy 
of the system was reduced while its structure was conserved during the MD simulation 
(Fig. 6.4, chart 2). The Hamiltonian is the value of the full (extended system) at time t.
I l l
In a properly functioning simulation, this quantity is conserved at all times (although 
fluctuations will be present). Drift in hamiltonian value (H) is evidence of too large a 
time step.
chart 1. Energy plot vs time
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Figure 6.4: The model quickly reached a plateau, which is considered to be its global 
energy minimum (Chart 1). A constant Hamiltonian value revealed that the molecular 
system was stable throughout the course of the molecular dynamics simulation (Chart
2).
The evaluation for the structural stability of biglycan model showed that the 
inner cliff of the protein, where the parallel P-sheet motif is found, is much more stable 
than the rest of the protein. Visual investigation of the 9 conformations revealed that the 
inner region of the protein (p-sheet motif) is not as colourful as the rest of the protein 
(Data not shown). That proves that the P-sheet motif of the biglycan protein is a very 
stable and conserved motif, whose residues are energetically and conformationally 
more stable than the rest residues of the protein.
6.3.4 Model evaluation
Superimposition of biglycan proposed model to decorin crystal structure 
revealed obvious similarity in the spatial arrangement as well as the structural motives 
of both proteins (Fig. 6.5).
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Figure 6.5: The structure of biglycan superimposed with its template. Reasonably high 
homology identity guaranteed the retention of the major secondary elements and shape.
The above structure has been obtained after a 2 nanosecond molecular dynamics
simulation.
Also, the proposed model for biglycan appears to obtain an “arc” shape spatial 
arrangement, which is in consistency with the rest of the RSLPs (Fig. 6.6). The inner 
cliff of the protein consists of parallel p-sheets made mainly of hydrophobic amino 
acids.
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Figure 6.6: Proposed homology model for the structure of the biglycan core protein.
6.3.5 Comparison of theoretical model to its crystal structure
The crystal structure of biglycan has recently been released (Scott 2006) and a 
comparison of the homology model with the x-ray structure was performed. The 
secondary elements of the structure (i.e. a-helices and p-sheets) were found to be highly 
similar. The main differences between the model and the x-ray data lie in two extra a- 
helical loops the homology model has on its outer surface between residues 206-207 
and 248-250, respectively (Fig. 6.7A). The areas of interest, such as the inner cliff of 
the protein and N- and C- terminal regions were the same between the two molecules. 
Superimposition of the two models revealed an RMSD of 1.32A (Figure 6.7B).
BFigure 6.7: The structure of the homology model was very similar to the crystal 
structure. Superimposition of the two structures revealed the existence of two loops at 
the surface of the molecule (indicated by turquoise arrows). Key: Green and aqua-> a- 
helix and P-sheet, respectively, for the homology model; Red and yellow-> a-helix and 
P-sheet, respectively, for the crystal structure (A). The homology model of biglycan 
superimposed with the crystal structure of the same protein. Key: Yellow-> X-ray 
structure, Red-> homology model (B).
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6.4 Discussion and conclusions
The sequence of biglycan is highly conserved among higher mammalian 
species, a common characteristic of SLRPs. In addition to high homology scores (Fig. 
IB) biglycan sequences from different mammalian species have the same size (Fig. 1). 
This observation suggests that biglycan structure and hence function is very similar in 
epithelial tissues of various mammals. Therefore, biglycan serves the same function to 
the different species. Additionally, biglycan and decorin share a high homology 
between their sequences. These proteins belong to the same family of proteoglycans, 
type I dermatan sulphate. Although their function differs structurally they share 
structural similarities. In previous studies it has been observed that decorin is involved 
with collagen fibrilogenesis, whereas biglycan is not. Additionally, decorin is released 
by keratocytes, whereas biglycan is the result of myofibroblast activity in epithelial 
tissues (Funderburgh 2001, Funderburgh 2003 )
It was also observed that the inner cavity of the “arc” shaped molecule consists 
mainly of hydrophobic amino acids, whereas the outer surface of the molecule 
consisted of hydrophilic amino acids. This explains the arc shape of the molecule, as an 
adaptive response to “hide” these amino acids in aqueous biological environments. 
Additionally, parallel p-sheets are known to have a tighter spatial arrangement than 
antiparallel p-sheets (Zubai 1998). This shape obtained for biglycan is consistent with 
the rest of the known SLRPs.
Findings confirm that a possible interaction site for the collagen fibrils is the 
inner cavity of the arc-shaped molecule. This is supported by three different arguments. 
Firstly, by structurally evaluating the model of biglycan, it appears that it has the 
correct dimensions to accommodate a collagen fibril (Scott 1996). Secondly, the 
presence of hydrophobic residues implies they must be covered by a second molecule 
to avoid exposure to the aqueous phase. Thirdly, the inner cavity of the biglycan model 
is a beta-sheet motif, which is highly conserved among other collagen interacting 
proteins of the same families. That is shown in the alignment between the template and 
the model too.
A preliminary data investigation of the relevant literature, combined with the 
findings of this study, poses important questions such as: how does biglycan interact 
with collagen fibrils? The proposed patterns of interaction can be investigated in a 
future protein-protein docking / interaction in silico investigation. Biglycan and 
collagen can be imported to the MOE docking algorithm and after the final interaction
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conformations are obtained and the stability and biological viability of the system can 
be verified by means of Molecular Dynamics. A separate MD simulation will be 
performed for each viable docking conformation and the various energies will be 
compared. Finally, a mode of association and interaction will be suggested. However, 
the means of technology that are currently available are not powerful enough to 
simulate a whole collagen fibril.
Previous studies suggest a collagen binding domain both in the C- and N- 
terminal regions of the core protein of decorin ( Scott et al. 2004, McEwan 2006). Data 
suggest a collagen binding site at the N-terminal half of the decorin core protein. The 
importance of amino acids 125-158 of the mature core protein is further supported by 
the finding that these amino acids are likely to be on the surface of the molecule 
according to computer modelling and antibody-binding studies (Scott, 2004).
In conclusion, the comparison between the proposed theoretical model for 
biglycan and the recently released x-ray structure for the same protein revealed high 
similarities between the two proteins. The low RMSD value confirms the accuracy of 
the theoretical model as well as the reliability of the homology methods and algorithms 
that were used for the current study.
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7. General discussion
Wound healing is a complex process that, especially in the ocular surface, 
demands to be performed in such a way that the clarity of the tissue is not being 
compromised in the long term. The extent and severity of the wound healing response in 
the cornea clearly depend on the type of injury. In the present study the repair process in 
bovine corneas after trephine wounding and LASIK-like incisions was closely 
investigated. The cellular expression of the tissue during wound healing was investigated 
by monitoring epithelial cell and myofibroblast expression. However, in normal comeal 
tissue there are other cell types expressed such as the quiescent keratocytes, limbal stem 
cells of the epithelium, bone marrow derived cells in the stroma and the endothelial cells. 
Keratocytes are the main cell type in the stroma. Limbal stem cells are located at the 
basal layer of the comeal epithelium in the limbus and they differentiate and proliferate in 
epithelial cells in order to recover the comeal surface upon injury (Wilson 1999). The 
existence of bone marrow derived keratocytes that give rise to either bone marrow 
haemopoetic stem cells or major histo-compatibility complex (MHC) class II 
macrophages has also been confirmed (Sosnova et al. 2005). Lastly, the endothelial cells 
form a layer over the posterior part of the tissue providing regulation of fluid uptake in 
the cornea.
In vitro models have become increasingly popular in studying the short term 
effects of comeal wound healing (Richard et al. 1991, May et al. 2004, Zhao et al. 2006). 
In the current study, a simple air interface organ culture method was used (Foreman et al. 
1996) as this culture system achieves excellent re-epithelialisation (Foreman et al. 1996, 
Zhao et al. 2006). Additionally, it doesn’t appear to induce any swelling effects to the 
tissue, as comeal thickness remains stable during the maximum term of culture (i.e. 4 
weeks) (Carrington, personal communication 2004). In the current study, swelling effects 
in the cultured corneas were monitored by measuring the interfibrillar spacing of 
control/uninjured bovine corneas (Chapter 5). During the four weeks in culture 
interfibrillar spacing increased only slightly indicating that there were no swelling effects 
induced in the tissue by the culture system. This observation confirmed the reliability of 
this organ culture method for the in vitro study of wound healing in comeal tissue, as it 
keeps the endothelial barrier intact and fully functional.
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The external surface of the human body (i.e. skin, ocular surface) consists of 
stratified squamus epithelium that protects and provides a physical barrier from the 
external environment. Part of the immunohistochemical investigation in this study 
focused in the expression of epithelial cells in the cornea after injury (Chapter 3). In 
LASIK-like incisions the epithelium reacted rapidly at the incision, forming an epithelial 
plug that covered stromal gaps in the stroma. At later stages of the organ culture this plug 
had a tendency to increase in size and also epithelial cells migrated towards inner parts of 
the stroma. Positive cytokeratin staining confirmed the cell type of these cells as 
cytokeratins 3, 5 and 12 are known cells markers for corneal epithelial cells (Kasper et al. 
1988). This is a common observation in LASIK, known as epithelial ingrowth that is 
often associated with haze and diffuse lamellar keratitis (Vesaluoma et al. 2000).
In this study it was observed that stromal wound healing response events were more 
severe for trephine injured corneas than LASIK-like ones. Cellular expression for 
myofibroblasts and tissue swelling were more obvious in trephine-wounded corneas than 
in LASIK-like samples (Chapters 3 and 5). Stromal swelling is a part of the wound 
healing process and it was estimated by determining the interfibrillar spacing of collagen 
fibrils. Comeal hydration and therefore swelling is monitored by the epithelium/ 
endothelium barriers and also the extracellular matrix components of the stroma (i.e. 
proteoglycans, cells). It was noted to be extensive in trephine wounded corneas within a 
short period of time after injury. Swelling occurred in LASIK-like corneas as well but it 
was not so extensive. During wound healing there is a series of events that take place in 
both the comeal stroma and the epithelium and cause swelling to the tissue as part of a 
normal repair process. Initially, cytokines released by the epithelium (i.e. IL-lp) cause 
stromal cell transformation into myofibroblasts and subsequent proliferation (Wilson 
2002). Secondly, during the wound healing process elevated numbers of abnormally large 
proteoglycans appear in the extracellular matrix (Fundeburgh et al. 1998). This was also 
confirmed by transmission electron microscopy (Chapter 5) and the molecular modelling 
study (Chapter 6).
The three dimensional structure of biglycan was constructed in silico. Proteoglycan 
molecules play a key role in comeal hydration, hence swelling, and their levels are 
affected in pathologic situations (Funderburgh 1998, Funderburgh 2001). In particular,
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biglycan, a dermatan sulphate proteoglycan, levels increase seven fold during the healing 
process (Funderburgh 1998). The present study revealed that the core protein of biglycan 
appears to be highly reactive with numerous potential interaction sites throughout the 
molecule, for the formation of dimers and also with collagen. This, physically increases 
the water uptake in the cornea and considering the dramatic increase in protein levels 
during wound healing, as proteoglycans are highly hydrophilic water uptake in the tissue 
increases also. Biglycan molecules exist in between the collagen fibrils and when they are 
hyper-hydrated they increase the collagen interfibrillar spacing inducing swelling effects. 
However, in the current study fibrillar spacing was increased not only at areas proximal 
to the wound but throughout the whole cornea, implying a disruption of the function of 
the endothelial barrier. Nevertheless, it needs to be considered that water uptake in the 
cornea is also increased during the wound healing process, as the energy requirements of 
the tissue increase.
All the above events take place in the injured cornea regardless of the type of injury. 
However, it has been reported that the function of the endothelium is compromised after 
severe injury (Edelhauser 2000). Kim et al. (1997) proposed that during ablation it is 
crucial to leave a residual stromal thickness of 200pm above the corneal endothelium that 
should not be ablated to protect the corneal endothelial structure and barrier function. 
According to Edelhauser (2000) LASIK doesn’t affect the endothelial architecture as the 
flap is normally 160pm thick and the flap bed is thicker than 200pm. In the same study 
laser ablation was also performed in corneas that caused a deeper, more severe type of 
injury that left less than 200pm of residual stroma above the endothelium. In this case it 
was observed a loss of the hexagonal morphology in cells and the endothelial barrier 
function was also compromised. Therefore, in the present study, swelling was not as 
extensive in LASIK-like incisions, as the function of the endothelium was not seriously 
affected by the injury. In trephine wounds swelling was extensive, indicating that the 
severity of the injury had impaired the function of the endothelial barrier.
In scar tissue, fibrils in newly deposited collagen are thicker than normal (Connon 
2004) and that is the reason that fibrillar diameters were found to increase in the wound 
area or the incision site in the injured corneas in the present work. In trephine wounded 
corneas, fibril diameter was also affected in an area of about 1mm around the wound
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(Chapter 5). This could be explained by the results in Chapter 3, where histology revealed 
that the stromal area under normal epithelium proximal to the trephine wound was also 
affected by the cut. In addition, cytokines by the injured epithelium affect a stromal area 
under non-affected epithelium, close to the wounded area. In LASIK-like corneas, 
fibrillar diameter increased only around and at the incision site, finding that it is 
consistent with the findings from immunohistochemistry. Additionally, histology/cell 
counts revealed a decrease in the flap bed in LASIK-like injured corneas, an observation 
that it is consistent to previous studies (Ivarsen 2004). a-smooth muscle actin was 
positive in a stromal area close to the incision site only, indicating the existence of active 
myofibroblasts in this area only. There were no signs of myofibroblast expression 
anywhere in the flap bed. Therefore, it was concluded that cytokines released by the 
epithelium play a crucial role in the initiation of the stromal wound healing response. 
Subsequently, it was assumed that in the case of LASIK-like incisions the cytokines 
released by the epithelium could only reach a stromal area at the incision site, where the 
adjacent epithelium was being injured.
In the current study an attempt was made to improve the wound healing response in 
the cornea (Chapter 4). In the past the effects of UV radiation has been applied to cause 
collagen cross linking in the corneal stroma and therefore improve the wound healing 
response (Nagy et al. 1997). However, in this project it was already obvious that 
epithelial cytokines could not physically reach stromal areas further inside the flap. 
Therefore, a series of different cytokines (i.e. TNF-a, IL-la, FasL and TGF-pl) were 
tested in LASIK-like injured corneas and their effect on transparency, myofibroblast 
proliferation and tissue mechanical strength was monitored for up to four weeks in 
culture. It was observed that there might be a possible correlation between the extent of 
transparency, hence myofibroblast expression, and the extent of flap adherence. 
However, it was obvious that the stronger the effect of the cytokine in flap adherence the 
more the clarity of the corneas was compromised. This is mainly to the fact that the more 
severe the wound healing response becomes under the effects of cytokines, the more 
swelling occurs to the tissue. In addition, myofibroblast cell numbers were also noted to 
increase in all cytokine treated corneas. Corneal crystallins are expressed in lower levels 
in myofibroblasts during wound repair, and this is reported to be associated with a loss of
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cell transparency (Stramer and Fini 2004, Jester et al. 1999). These findings imply that 
further investigation is needed in order to find an optimum relationship between using the 
appropriate quantity and type of cytokine to secure the flap, but still maintain the clarity 
of the cornea.
7.1 Future work
The x-ray diffraction technique in general averages out the parameters it is 
measuring throughout the depth of the area that it is scanned. Considering that the 
changes in the interfibrillar spacing were very weak for the LASIK-like corneas it would 
be worth, in the future, to take slices of injured corneas from certain depths of the tissue 
and scan them separately. Additionally, it would be very interesting to scan separately the 
upper flap and the flap bed in order to see in which part fibrillar diameter and 
interfibrillar spacing changes more severely.
In the current study wide angle x-ray diffraction experiments revealed remarkable 
collagen orientation patterns in wounded corneas. This is an observation made for the 
first time and it is important in providing us with information about the structure and the 
stability of the tissue during wound healing. However, the factors that cause the change in 
collagen orientation are still unknown. Multi-photon confocal microscopy utilising 
second harmonic imaging is a new technique that allows individual collagen fibrils or 
bundles of fibrils to be visualised. It would be useful to use this method to see the 
direction of fibrils in specific points in the tissue and therefore discover the factors that 
affect collagen orientation during wound healing.
The series of experiments that tested the effect of various growth factors in the 
cornea proved that there is a correlation between the type/quantity of growth factors and 
their influence on the effectiveness of the wound healing response and the maintenance 
of the transparency of the tissue. So far it was shown that growth factors improve the 
healing of the tissue, but in all cases the transparency was compromised. Therefore, a 
series of weaker growth factor solutions should be used in order to see if the clarity of the 
cornea can be retained.
Corneal transparency is compromised during wound healing. One of the basics of 
corneal transparency is collagen-proteoglycan interactions. Therefore, in order to gain a
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better understanding of corneal wound healing, it is needed to gain a better insight in 
tissue ultrastructure and specifically collagen-proteoglycan interactions. Theoretical 
techniques and specifically molecular modelling can be a valuable tool in the prediction 
of interactions between molecules of the extracellular matrix. However, to date, 
processing power is insufficient to be able to simulate a whole collagen fibril. In the 
future, with the development of technology, this might be an achievable task that could 
save scientists a lot of time and effort in performing long laboratory based experiments.
123
APPENDICES
Appendix 1 - Nomenclature
Symbol used for abbreviation
ctSMA
Ab
ASCRS
ATP
BSA
CK
D
DAB
ddH20
Dp
ECM
EGF
EM
FACIT
FasL
d
FITC
GAG
Gly
H&E
HGF
hrs
I
IF
IgA
IgG
IL
IVCM
KGF
Original Term
a-Smooth Muscle Actin 
Antibody 
American Society of Cataract and 
Refractive Surgery 
Adenosine Triphosphate 
Bovine Serum Albumin 
Cytokeratin 
Collagen periodicity 
Deaminobenzidine 
Double distilled Water 
Diopter 
Extracellular matrix 
Epidermal Growth Factor 
Electron Microscopy 
Fibril Associated Collagens with 
Interrupted Triple helices 
Fas Ligandx 
Collagen fibril diameter 
Fluorescein Isothiocyanate 
Glycosaminoglycan 
Glycine 
Haematoxylin and Eosin 
Hepatocyte Growth Factor 
Hours 
X-ray scatter intensity 
Intermediate Filament 
Immunoglobulin A 
Immunoglobulin 
Interleukin 
In vitro Confocal Microscopy 
Keratocyte Growth Factor
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kV Kilovolt
LASEK Laser Epithelial Keratomileusis
LASIK Laser in situ Keratomileusis
MD Molecular Dynamics
mg Milligram
min Minutes
MM Molecular Mechanics
MMP Matrix Metalloproteinase
N Newton
NBF Neutral Buffer Formalin
nm Nanometre
0/N Overnight
°C Degrees centigrade
PBS Phosphate Buffer Saline
PDGF Platelet-Derived Growth Factor
PFA Paraformaldehyde
PG Proteoglycan
PGF Prostaglandin F
PMN Polymorphonuclear
PRK
R
Photoreffactive Keratectomy 
Radial position/distance from the centre 
of an x-ray scattempattem
RK Radial Keratotomy
RMSD Root Mean Square Deviation
RT Room Temperature
SAXS Small Angle X-ray Scattering
SLRP Small Leucine Rich Proteins
TAC Transient Amplified Cell
TDC Terminally Differentiated Cell
TEM Transmission Electron Microscopy
TGF Transforming Growth Factor
Ua Uranil Acetate
WAXS Wide Angle X-ray Scattering
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X-Ray Diffraction 
Microliter 
Micrometer
Appendix 2- List of materials
Material Supplier
0.2 pm filters Fisher
Acetone BDH
Alexa Fluor® 488 Goat anti-mouse IgG 
(H+L) 2° Ab 
Anti a-smooth muscle actin
Molecular Probes 
Sigma
Anti-Cytokeratin 3 ICN
Anti-PAN Cytokeratin DAKO
Anti-Vimentin Sigma
Betadine AAH
Bovine Serum Albumin Sigma
Calcium Chloride BDH
Chloroform BDH
DAB Sigma
Disodium Hydrogen Orthophosphate Gibco
Eagle’s Minimal Essential Medium Gibco
Eosin BDH
Ethanol BDH
Forceps Fisher
Formaldehyde BDH
Formalin BDH
Fungizone Gibco
Goat anti-mouse IgG Biotinylated 2° Ab DAKO
Goat Serum Sigma
Haematoxylin BDH
HC1 Sigma
Human recombinant FasL R&D Systems
Human recombinant TGF-pl R&D Systems
Human recombinant IL-la R&D Systems
Human recombinant TNF-a R&D Systems
Hydrogen Peroxide Sigma
Hydromount BDH
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Methanol BDH
Microtome Disposable Blade Lamb
Paraffin Wax Lamb
Potassium Chloride BDH
Potassium Orthophosphate BDH
Proteinase K Qiagen
Resin Kit Agar
Scalpel blades Fisher
Sodium Chloride BDH
SuperFrost Plus Slides BDH
Tissue-Tek OCT compound Agar
Triton X-100 Sigma
Trypsin Sigma
Xylene BDH
Appendix 3 - Solution preparation 
Solutions for the organ culture 
Agar/Gelatin
2 g Agar 
2 g Gelatin 
200 ml ddH20  
Autoclave
Place agar, gelatine and ddH20  quantities into a 300ml bottle and autoclave at 120°C 
for 20mins.
Agar/Gelatin Support
200 ml Agar/Gelatin 
20 ml lOxMEM
10 ml 7.4% sodium bicarbonate 
2 ml Antibiotics 
1 ml Fungazone
Heat agar/gelatin mixture using the microwave in low power. Filter (0.2 pm) the rest 
of the solutions into the agar gelatin solution and mix.
Trowells T8 Medium
500 ml Trowels T8 
5 ml Antibiotics 
5 ml Fungizone
Filter (0.2 pm) the antibiotics and the fungizone into the Trowells T8 bottle.
7.4% Sodium Bicarbonate
22.2 g Sodium Bicarbonate 
300 ml ddH20
Mix until dissolved at RT.
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25% (v/v) Betadine Solution
100 ml Betadine 
400 ml ddH20
Mix and shake well before use.
Buffers and Solutions for Immunohistochemistrv 
PBS (IX)
40 g NaCl 
l gKCl
5.75 g Na2HP04 
1 g KH2P04 
5 1 distilled H20
10% NBF
60 ml Na2HP04 
40 ml KH2P04 
900 ml dd H20
Take 900 ml of the above mixture and add 100 ml formaldehyde.
9 g NaCl 
Adjust pH to 6.8
Trypsin Buffer (0.1 mg/ ml)
0.675 g TRIS
80 ml ddH20
0.1 g CaCl2.2H20
Adjust Ph to 7.8 with IN HC1
Bring up to volume (100ml) with ddH20
10 mg of Trypsin
0.6% H20 2
0.4 ml 30% H20 2 
19.6 ml Methanol
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3% H20 2
2 ml 30% H20 2
18 ml ddH20
Buffers and solutions for cytokine treated corneas
PBS, 0.1% BSA
0.05g BSA
50ml PBS
Mix and filter through a 45 pm filter
4mM HCL, 0.1% BSA
0.05g BSA
50ml 4mM HC1
Mix and filter through a 45 pm filter
Human recombinant TNF-a
100pg/ml-> lOOpg of protein in 1ml PBS, 0.1% BSA stock solution 1 
100ng/ml-> lpl of stock solution 1 in 1ml PBS, 0.1%BSA solution A 
50ng/ml-> 500pl solution A in 500|nl PBS, 0.1%BSA 
10ng/ml-> lOpl solution A in 90pl PBS, 0.1%BSA 
0.1ng/ml-> lpl solution A in 1ml PBS, 0.1%BSA
Human recombinant IL-la
2pg/ml-> 2pg of protein in 1ml PBS, 0.1% BSA stock solution 2 
100ng/ml-> 5 pi of stock solution 2 in 95 pi PBS, 0.1%BSA solution B 
50ng/ml-> 30pl solution B in 30pl PBS, 0.1%BSA 
10ng/ml-> lOpl solution B in 90pl PBS, 0.1%BSA 
0.1ng/ml-> lpl solution B in 1ml PBS, 0.1%BSA
Human recombinant FasL
10pg/ml-> 5 pg of protein in 500pl PBS, 0.1% BSA stock solution 3 
100ng/ml-> lOpl of stock solution 3 in 1ml PBS, 0.1%BSA solution C 
50ng/ml-> lOOpl solution B in lOOpl PBS, 0.1%BSA 
10ng/ml-> lOpl solution B in 90pl PBS, 0.1%BSA 
0.1ng/ml-> lp l solution B in 1ml PBS, 0.1%BSA
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Human recombinant TGF-pi
ljig/ml-> 1 pg of protein in 1ml HC1, 0.1% BSA stock solution 4 
100ng/ml-> lOOpl of stock solution 4 in 900pl HC1, 0.1%BSA solution D 
50ng/mI-> lOOpl solution B in lOOpl HC1, 0.1%BSA 
10ng/ml-> lOpl solution B in 90pl HC1, 0.1%BSA 
0.1ng/ml-> lpl solution B in 1ml HC1, 0.1%BSA
Buffers and solutions for TEM 
4% PFA
8 gPFA
100 ml IX PBS
Stir and heat for 1 hr
Add NaOH drop wise until the solution becomes clear.
Filter through a 0.5 pm filter.
Adjust pH to 7.4
Freeze aliquots for further use.
Before use, defrost aliquot and dilute it with equal volume of IX PBS.
Cuprolinic Blue stain
1.05 g MgCb in 20 ml ddH20
0.1025 g Sodium Acetate in 20 ml ddH20
Mix the above solutions
3 ml Glutamine
7 ml ddH20
Take 20 ml of the above buffer and add 0.01 g Cuprolinic Blue.
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Appendix 4: Raw data and statistics for stromal cells and myofibroblast cell 
counts
Stromal cells
Cornea
Number
Number of keratocytes in 
control cornea
Cornea
Number
Number of keratocytes in control 
cornea
0 hrs
Limbus
(1)
Equidistant
(2)
Mid
Cornea
(3) 2 weeks
Limbus
(1)
Equidistant
(2)
Mid
Cornea
_ (3)
1 12 21 23 1 13 21 23
2 17 21 18 2 17 21 18
3 16 15 16 3 16 15 16
24 hrs 3 weeks
1 15 15 19 1 15 15 19
2 24 17 16 2 24 17 16
3 9 12 16 3 9 12 16
72 hrs 4 weeks
1 22 16 16 1 22 16 16
2 15 15 20 2 15 15 20
3 20 13 17 3 20 13 17
7 days
1 13 8 11
2 10 7 8
3 18 14 11
Table 1: Raw data for stromal cell counts in control corneas
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Cornea Incision Site (1) Equidistant (2) Flap Edge (3)
Ohrs Above Below Above Below Above Below
1 6 22 7 6 8 18
2 13 10 12 11 12 18
3 12 10 17 12 16 13
p value 1 0.155 0.827 0.1 17
p value2 0.155 0.827 1.117 0.027 0.088 0.374
24hrs Above Below Above Below Above Below
1 34 38 26 20 13 9
2 19 16 22 14 26 26
3 14 14 20 29 21 14
p value 1 0.027 O.C188 0.3 74
p value2 0.442 0.240 0.703 0.198 0.486 0.903
72hrs Above Below Above Below Above Below
1 20 15 14 16 21 21
2 17 11 11 13 16 16
3 6 17 9 14 8 14
p value 1 0.5 O.C147 0.211
p value2 0.380 0.162 0.121 0.802 0.539 0.795
lweek Above Below Above Below Above Below
1 8 11 8 13 9 10
2 12 14 12 11 17 18
3 16 20 11 11 11 14
p value 1 0.4^12 0.41-93 O.C)25
p value2 0.638 0.725 0.025 0.431 0.421 0.187
2 weeks Above Below Above Below Above Below
1 22 18 11 13 16 13
2 13 17 6 8 11 6
3 12 11 15 12 11 16
p value 1 0.45 0.43 0.3
00
p value2 1.00 0.927 0.064 0.034 0.076 0.113
3 weeks Above Below Above Below Above Below
1 12 12 10 12 11 10
2 10 8 11 11 8 8
3 13 14 12 11 9 11
p value 1 0.371 0.371 0.371
p value2 0.385 0.377 0.079 0.089 0.05 0.05
4 weeks Above Below Above Below Above Below
1 13 26 8 8 8 8
2 15 22 6 9 7 6
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3 11 | 28 7 I 8 6 1 9
p value 1 0.026 0.135 0.317
p value2 0.065 | 0.081 0.003 | 0.002 0.001 | 0.003
Table 2: Raw data and student’s t-test results comparing the number of cells at
specific sites in the stroma above and below the incision in LASIK-like wounded 
corneas, p value 1 comparison between cell numbers above and above the incision
in the same cornea, p value2-> against controls
Days in 
culture
Incision site 
No of cells No of cells 
above/mm2 below/mm2
Corneal periphery control 
(No of cells /mm2)
0 500.00 700.00 750.00
1 1100.00 1150.00 800.00
3 700.00 700.00 950.00
7 600.00 750.00 700.00
14 800.00 750.00 750.00
21 600.00 550.00 800.00
28 650.00 1250.00 950.00
Days in 
culture
Equidistance 
No of cells No of cells Equidistance control (No of cells/mm2)above/mm below/mm
0 600.00 500.00 950.00
1 1150.00 1050.00 750.00
3 550.00 700.00 750.00
7 500.00 600.00 500.00
14 550.00 550.00 950.00
21 550.00 550.00 750.00
28 350.00 400.00 750.00
Days in Flap edge Mid Cornea control (No ofculture No of cells No of cells cells/mm2)above/mm2 below/mm2
0 600.00 800.00 950.00
1 1000.00 800.00 850.00
3 750.00 850.00 900.00
7 600.00 700.00 500.00
14 650.00 600.00 950.00
21 450.00 500.00 850.00
28 350.00 400.00 900.00
Table 3: Total cell counts/mm for stromal cells from different areas along the
LASIK-like flap.
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Myofibroblasts
Timepoint (weeks)
aSMA positive 
cells
Total cells %of positive cells
0 0.00 0.00 0.00
0 0.00 0.00 0.00
0 0.00 0.00 0.00
1 8.00 33.00 24.24
1 10.00 36.00 27.78
1 9.00 38.00 23.68
2 14.00 43.00 32.56
2 15.00 45.00 33.33
2 13.00 42.00 30.95
3 28.00 43.00 65.12
3 27.00 48.00 56.25
3 30.00 45.00 66.67
4 24.00 47.00 51.06
4 34.00 50.00 68.00
4 40.00 58.00 68.97
Table 4: Raw data for myofibroblast cell counts
Test Statistics?’6
PERCENT
Chi-Square
df
Asymp. Sig.
9.462
3
.024
Test Statistics?
PERCENT
N 12
Median 42.1986
Chi-Square 12.000®
df 3
Asymp. Sig. .007
a. Kruskal Wallis Test
b. Grouping Variable: TIMEPOIN
Figure 1: Results for Kruskal 
Wallis test for myofibroblast cell 
counts
a- 8 cells (100.0%) have expected frequencies less 
than 5. The minimum expected cell frequency is 1.5.
b. Grouping Variable: TIMEPOIN
Figure 2: Results for median test for 
myofibroblast cell counts
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Appendix §: Raw data and statistics for the effect of growth factors in LASIK- 
like injured corneas 
Mechanical strength
Control samples
Time in 
culture 
(weeks)
Force
(10_1N)
0 0.35
0 0.60
0 0.40
1 0.37
1 0.42
1 0.33
2 0.39
2 0.50
2 0.44
3 0.41
3 0.55
3 0.57
4 0.49
4 0.61
4 0.55
Table 5: Raw data for force required to detach the flap in a control/non cytokine
treated LASIK-like corneas.
Test Statistics^
Test Statistic^’1*
LSK
Chi-Square 5.952
df 4
Asymp. Sig. .203
LSK
N 15
Median .4400
Chi-Square 6.964a
df 4
Asymp. Sig. .138
a - Kruskal Wallis Test a. 10 cells (100.0%) have expected frequencies less
b. Grouping Variable: TIME ,han * 'The minimum expected cell frequency is 1.4
b- Grouping Variable: TIME
Figure 3: Kruskal Wallis statistical test Figure 4: Median statistical test results
results
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TNF-a treated corneas
Force (10'*N)
Time in 
Culture weeks
0.1ng/ml lOng/ml 50ng/ml lOOng/ml
0 0.35 0.35 0.35 0.35
0 0.60 0.60 0.60 0.60
0 0.51 0.51 0.51 0.51
1 0.65 0.85 0.91 0.75
1 0.70 0.90 0.95 0.81
1 0.72 0.88 0.97 0.86
2 0.78 0.92 0.98 0.80
2 0.73 0.95 0.93 0.86
2 0.76 0.96 0.99 0.88
3 0.77 0.91 0.97 0.93
3 0.85 0.99 0.98 0.95
3 0.89 1.00 0.99 0.96
4 0.62 0.99 1.01 0.91
4 0.83 0.97 1.13 0.99
4 0.71 1.04 1.20 1.12
Table 6: Raw data for force required to detach the flap in a TNF-a treated LASIK-
like corneas.
Test Statistic^’1*
C0.1 C10 C50 C100
Chi-Square 10.900 11.930 11.972 12.380
df 4 4 4 4
Asymp. Sig. .028 .018 .018 .015
a Kruskal Wallis Test
b. Grouping Variable: TIME
Fiaiirp! Si K niskal W allis  statistical test results
Test Statistic^
C0.1 C10 C50 C100
N 15 15 15 15
Median .7200 .9200 .9700 .8600
Chi-Square 12.3218 9.643a 9.643a 12.321a
df 4 4 4 4
Asymp. Sig. .015 .047 .047 .015
a- 10 cells (100.0%) have expected frequencies less than 5. The minimum 
expected cell frequency is 1.4.
b. Grouping Variable: TIME
Figure 6: Kruskal Wallis statistical test results
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IL-la treated corneas
Force (10‘N)
Time in 
Culture weeks
0.1ng/ml lOng/ml 50ng/ml lOOng/ml
0 0.35 0.35 0.35 0.35
0 0.60 0.60 0.60 0.60
0 0.51 0.51 0.51 0.51
1 0.61 0.61 0.81 0.66
1 0.75 0.95 0.88 1.00
1 0.66 0.64 0.86 0.80
2 0.66 0.75 0.90 1.01
2 0.78 0.70 0.90 0.99
2 0.72 0.77 0.92 1.03
3 0.70 0.82 0.78 1.07
3 0.85 0.90 1.05 1.10
3 0.80 0.88 0.93 1.05
4 0.90 0.78 1.15 1.15
4 0.75 1.01 0.99 1.00
4 0.97 0.92 1.06 1.00
Table 7: Raw data for force required to detach the flap in an IL-la treated LASIK-
like corneas. 
Test Statistics?’1*
C0.1 C10 C50 C100
Chi-Square 10.429 9.733 11.253 11.012
df 4 4 4 4
Asymp. Sig. .034 .045 .024 .026
a. Kruskal Wallis Test
b- Grouping Variable: TIME 
Figure 3: Kruskal Wallis statistical test results
Test Statistics c
C0.1 C10 C50 C100
N 15 15 15 15
Median .7200 .7700 .9000 1.0000
Chi-Square 6.964a 12.321s 9.444b 9.444b
df 4 4 4 4
Asymp. Sig. .138 .015 .051 .051
a. 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.4.
b. 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.2.
Figure 8: Median statistical test results
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FasL treated corneas
Force (10'N)
Time in 
Culture weeks
O.lng/ml 10ng/ml 50ng/ml lOOng/ml
0 0.35 0.35 0.35 0.35
0 0.60 0.60 0.60 0.60
0 0.51 0.51 0.51 0.51
1 0.66 0.67 0.90 0.63
1 0.78 0.77 0.79 0.76
1 0.70 0.75 0.83 0.80
2 0.67 0.76 0.95 0.80
2 0.76 0.62 0.99 0.71
2 0.71 0.68 1.00 0.75
3 0.80 0.80 0.98 0.90
3 0.61 0.61 1.06 0.99
3 0.61 0.75 1.02 1.00
4 0.70 0.75 1.00 1.05
4 0.81 0.66 0.99 0.90
4 0.83 0.78 1.07 1.10
Table 8: Raw cata for force required to detach the flap in a FasL treated LASIK-like
corneas. 
Test Statistics8’6
C0.1 C10 C50 C100
Chi-Square 8.113 7.084 11.474 12.327
df 4 4 4 4
Asymp. Sig. .088 .132 .022 .015
a Kruskal Wallis Test
b. Grouping Variable: TIME
Figure 9: Kruskal Wallis statistical test results
Test Statistics?
C0.1 C10 C50 C100
N 14 15 15 15
Median .7000 .6800 .9800 .8000
Chi-Square 3.792* 4.286b 9.643b 15.000c
df 4 4 4 4
Asymp. Sig. .435 .369 .047 .005
a- 10 cells (100.0%) have expected frequencies less than 5. The minimum 
expected cell frequency is .9.
b. 10 cells (100.0%) have expected frequencies less than 5. The minimum 
expected cell frequency is 1.4.
c. 10 cells (100.0%) have expected frequencies less than 5. The minimum 
expected cell frequency is 1.2.
d. Grouping Variable: TIME
Figure 10: Median statistical test results
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TGF-Bi treated corneas
Force (10 'N)
Time in 
Culture weeks
0.1ng/ml lOng/ml 50ng/ml lOOng/ml
0 0.35 0.35 0.35 N/A
0 0.60 0.60 0.60 N/A
0 0.51 0.51 0.51 N/A
1 0.77 0.69 1.42 N/A
1 0.66 0.80 1.17 N/A
1 0.70 0.75 1.55 N/A
2 0.76 0.89 1.38 N/A
2 0.61 0.91 1.21 N/A
2 0.65 0.90 1.60 N/A
3 0.80 1.20 N/A N/A
3 0.77 1.21 N/A N/A
3 0.75 1.25 N/A N/A
4 0.71 1.29 N/A N/A
4 0.90 1.35 N/A N/A
4 0.91 1.50 N/A N/A
Table 9: Raw data for force required to detach the flap in a TGF-pi treated LASIK-
like corneas.
Test Statistics8,5
C0.1 C10 C50
Chi-Square 10.160 13.500 5.422
df 4 4 2
Asymp. Sig. .038 .009 .066
a- Kruskal Wallis Test
b. Grouping Variable: TIME 
Figure 11: Kruskal Wallis statistical test results
Test Statistics c
C0.1 C10 C50
N 15 15 9
Median .7100 .9000 1.2100
Chi-Square 6.964a 12.321s 3.600b
df 4 4 2
Asymp. Sig. .138 .015 .165
3- 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.4.
b. 6 cells (.0%) have expected frequencies less than 5. The 
minimum expected cell frequency is 1.3.
c. Grouping Variable: TIME
Figure 12: Median statistical test results
Cell counts
Control samples
-> Please refer to Appendix 4-Myofibroblast cell counts
TNF-a treated corneas
Myofibroblast population
Time in 
Culture 
weeks
O.lng/ml lOng/ml 50ng/ml lOOng/ml
+ T % + T % + T % + T %
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
1 28 73 38 30 77 39 41 80 51 25 78 32
1 40 74 54 38 76 50 50 83 60 35 81 43
1 30 71 42 39 80 49 36 65 55 27 75 36
2 45 80 56 42 81 52 43 83 52 43 82 52
2 40 77 52 46 83 55 29 72 40 49 90 54
2 43 82 52 36 82 44 50 73 68 49 96 51
3 50 88 57 38 79 48 53 91 58 56 98 57
3 56 93 60 55 86 64 56 93 60 58 99 59
3 53 95 56 42 73 58 52 89 58 53 94 56
4 60 93 65 45 70 64 60 110 55 75 120 63
4 66 93 71 39 89 44 54 106 51 79 118 67
4 69 98 70 48 75 64 59 99 60 77 120 64
Table 0: Raw data for c langes in myofibroblast population in TNF-a treatec
LASIK-like corneas (+-> positivevely stained cells for aSMA, T t o t a l  cell counts, 
% -> % of myofibroblasts put of total cell population).
Test Statistics?’13
C0.1 C10 C50 C100
Chi-Square 12.791 8.494 7.621 13.597
df 4 4 4 4
Asymp. Sig. .012 .075 .106 .009
a. Kruskal Wallis Test
b. Grouping Variable: TIMEPOIN
Figure 13: Kruskal Wallis statistical test results
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Test Statistics^
C0.1 C10 C50 C100
N 15 15 15 15
Median 54.0541 48.7500 54.5455 52.4390
Chi-Square 12.321® 4.286® 6.964® 12.321®
df 4 4 4 4
Asymp. Sig. .015 .369 .138 .015
a- 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.4.
b. Grouping Variable: TIMEPOIN
Figure 14: Median statistical test results 
IL-la treated corneas
Myofibroblast population
Time in 
Culture 
weeks
O.lng/ml lOng/ml 50ng/ml lOOng/ml
+ T % + T % + T % + T %
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
1 21 50 42 21 82 26 42 55 76 54 92 59
1 15 24 63 25 69 36 35 45 78 61 102 60
1 25 38 66 11 45 24 48 50 96 42 86 49
2 29 58 50 32 65 49 50 75 67 66 110 60
2 35 56 63 36 70 51 51 80 64 68 115 59
2 36 60 60 35 69 51 59 87 68 75 109 69
3 40 75 53 50 80 63 65 90 72 80 116 69
3 45 77 58 55 83 66 70 93 75 76 106 72
3 52 76 68 57 81 70 69 89 78 90 118 76
4 60 80 75 78 90 87 80 110 73 89 123 72
4 63 75 84 66 96 69 92 109 84 96 125 77
4 72 90 80 85 100 85 78 96 81 85 130 65
Table 11: Raw data for changes in myofibroblast population in TNF-a treated 
LASIK-like corneas (+-> positivevely stained cells for aSMA, T->total cell counts, 
% -> % of myofibroblasts put of total cell population).
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Test Statistics?’15
C0.1 C10 C50 C100
Chi-Square 10.956 13.329 11.818 12.187
df 4 4 4 4
Asymp. Sig. .027 .010 .019 .016
a. Kruskal Wallis Test
b. Grouping Variable: TIMEPOIN
Figure 15: Kruskal Wallis statistical test results
Test Statistics^
C0.1 C10 C50 C100
N 15 15 15 15
Median 60.0000 50.7246 72.7273 60.0000
Chi-Square 6.964a 12.3213 9.643a 12.3213
df 4 4 4 4
Asymp. Sig. .138 .015 .047 .015
a- 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.4.
b. Grouping Variable: TIMEPOIN
Figure 16: Median statistical test results
FasL treated corneas
Myofibroblast population
Time in 
Culture 
weeks
O.lng/ml lOng/ml 50ng/ml lOOng/ml
+ T % + T % + T % + T %
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
1 9 27 33 11 32 34 15 35 43 20 40 50
1 8 30 27 13 38 34 16 33 48 18 41 44
1 11 29 38 16 35 46 18 31 58 27 42 64
2 12 35 34 15 35 43 21 42 50 25 52 48
2 15 40 38 13 39 33 29 38 76 27 53 51
2 11 38 29 18 40 45 25 36 69 28 59 47
3 14 45 31 20 38 53 30 50 60 29 75 39
3 15 48 31 23 42 55 32 55 58 26 63 41
3 12 45 27 19 41 46 34 58 59 30 69 43
4 16 53 30 18 46 39 39 65 60 50 80 63
4 18 60 30 20 55 36 40 69 58 55 81 68
4 20 58 34 25 53 47 45 71 63 61 79 77
Table 12: Raw data for changes in myofibroblast population in TNF-a treatec 
LASIK-like corneas (+-> positivevely stained cells for aSMA, T->total cell counts, 
% -> % of myofibroblasts put of total cell population).
Test Statistics?'b
C0.1 C10 C50 C100
Chi-Square 7.509 10.643 9.964 12.523
df 4 4 4 4
Asymp. Sig. .111 .031 .041 .014
a- Kruskal Wallis Test 
b. Grouping Variable: TIMEPOIN
Figure 17: Kruskal Wallis statistical test results
147
Test Statistics^
C0.1 C10 C50 C100
N 15 15 15 15
Median 30.1887 39.1304 58.0645 47.4576
Chi-Square 4.286a 6.964a 9.643a 9.643a
df 4 4 4 4
Asymp. Sig. .369 .138 .047 .047
a. 10 cells (100.0%) have expected frequencies less than 
5. The minimum expected cell frequency is 1.4.
b. Grouping Variable: TIMEPOIN 
Figure 18: Median statistical test results
Appendix 6: Raw data and statistics for x-ray diffraction experiments
Trephine wounded corneas 
Controls
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
F Sig. t df Sig. (2-tailed)
Mean
Difference
Std. Error 
Difference
95% Confidence 
Interval of the 
Difference
Lower Upper
C2WKSIFS Equal variances 
assumed 
Equal variances 
not assumed
16.000 .016 -1.000
-1.000
4
2.000
.374
.423
-.3333
-.3333
.33333
.33333
-1.25882
-1.76755
.59215
1.10088
A
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
C1WKIFS Equal variances 
assumed 16.000 .016 1.000 4 .374 .0600 .06000 -.10659 .22659
Equal variances 
not assumed 1.000 2.000 .423 .0600 .06000 -.19816 .31816
B
Figure 19: Independent sample t-test comparing IFS in control corneas. Ohrs and
1 weeks (A) and Ohrs and 2weeks (B)
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Ohrs
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
-9.00 36.98 36.22 67.58 67.59
-9.00 34.82 36.10 67.59 67.43
-9.00 36.88 35.27 67.56 67.52
-8.00 35.50 36.10 67.42 67.10
-8.00 35.27 35.98 67.20 67.65
-8.00 35.98 35.50 67.30 67.42
-7.00 35.98 36.22 67.43 67.01
-7.00 35.98 35.98 66.87 67.56
-7.00 36.22 35.98 66.44 67.47
-6.00 36.10 36.22 66.22 67.00
-6.00 35.62 35.74 66.70 67.76
-6.00 36.46 36.10 67.00 67.15
-5.00 35.74 35.74 66.75 67.00
-5.00 35.62 35.50 66.60 66.99
-5.00 36.59 36.10 66.21 66.72
-4.00 35.74 36.10 66.97 66.74
-4.00 35.34 35.74 67.04 67.25
-4.00 36.46 36.22 66.01 66.57
-3.00 35.98 35.98 65.67 67.24
-3.00 35.74 35.27 66.52 67.36
-3.00 36.22 35.98 65.65 65.65
-2.00 35.74 35.74 65.82 65.51
-2.00 35.50 35.50 65.59 65.59
-2.00 36.34 36.10 65.22 65.80
-1.00 35.39 35.74 65.65 65.31
-1.00 35.74 35.39 65.81 65.72
-1.00 36.59 35.74 65.02 65.60
0.00 35.86 35.86 65.61 65.30
0.00 35.50 35.16 65.53 65.42
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0.00 36.46 35.86 65.02 65.59
1.00 35.98 35.74 65.66 65.72
1.00 35.74 35.86 65.32 65.59
1.00 36.71 35.62 65.42 65.42
2.00 35.62 38.18 65.89 66.76
2.00 35.50 35.62 66.76 66.05
2.00 36.84 35.62 66.56 66.56
3.00 35.74 35.74 66.55 67.00
3.00 35.74 36.10 66.53 67.10
3.00 36.84 35.50 66.93 66.93
4.00 35.98 35.50 66.88 67.01
4.00 35.74 35.98 66.65 67.05
4.00 36.96 35.74 66.93 66.93
5.00 35.74 35.74 67.10 67.20
5.00 35.50 35.74 66.59 67.26
5.00 36.84 35.86 66.67 66.67
6.00 35.98 35.74 66.78 66.98
6.00 35.86 36.46 66.40 67.21
6.00 36.71 35.98 66.72 66.72
7.00 35.86 35.87 67.10 67.20
7.00 35.50 35.86 66.64 66.78
7.00 36.46 38.18 66.37 66.37
8.00 36.22 35.62 67.10 67.25
8.00 35.39 36.22 67.25 67.54
8.00 36.84 36.62 67.46 67.46
9.00 34.74 35.74 67.15 67.50
9.00 34.70 35.98 67.16 67.87
9.00 36.22 38.20 67.32 67.32
Table 13: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
trephine wounded corneas and their corresponding controls at Ohrs.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 3.070 18 .171 .454 .963
Within Groups 14.281 38 .376
Total 17.351 56
TWOHRS Between Groups 5.293 18 .294 .752 .738
Within Groups 14.867 38 .391
Total 20.160 56
Figure 20: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 23.822 18 1.323 12.302 .000
Within Groups 4.088 38 .108
Total 27.909 56
TREPHINE Between Groups 26.839 18 1.491 13.568 .000
Within Groups 4.176 38 .110
Total 31.015 56
Figure 21: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of trie 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAd&S Equal variances 
assumed 1.329 .252 .024 112 .981 .0026 .10840 -.21216 .21742
Equal variances 
not assumed .024 111.375 .981 .0026 .10840 -.21217 .21743
Figure 22: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Eaualitv of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS Equal variances 
assumed .175 .676 -1.754 112 .082 -.2382 .13587 -.50745 .03096
Equal variances 
not assumed -1.754 111.690 .082 -.2382 .13587 -.50746 .03097
Figure 23: Independent sample T-test comparing interfibrillar spacing
according to type (i.e. wounded/unwounded)
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lweek
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
-9.00 36.65 36.16 67.96 80.00
-9.00 35.47 36.68 67.59 77.38
-9.00 36.14 36.22 67.56 79.23
-8.00 35.98 35.78 67.55 80.00
-8.00 36.89 36.22 67.22 78.83
-8.00 35.65 36.46 67.30 78.94
-7.00 36.90 36.38 66.93 78.00
-7.00 35.45 36.22 67.02 76.66
-7.00 35.98 35.98 66.44 77.38
-6.00 36.64 35.74 67.50 79.00
-6.00 35.62 35.98 67.06 78.92
-6.00 36.14 35.62 67.00 78.67
-5.00 36.46 35.74 67.01 76.76
-5.00 35.98 35.50 66.06 76.10
-5.00 35.74 35.74 66.21 76.24
-4.00 36.22 35.74 66.58 75.75
-4.00 36.22 35.97 67.04 75.05
-4.00 35.14 36.22 67.50 75.00
-3.00 36.59 40.86 66.23 76.67
-3.00 35.74 40.22 66.56 76.65
-3.00 35.27 38.88 66.88 73.49
-2.00 36.22 40.34 65.98 74.24
-2.00 35.50 40.71 66.04 75.54
-2.00 35.16 39.88 66.02 73.49
-1.00 35.50 40.00 65.98 72.19
-1.00 36.00 40.16 66.21 74.23
-1.00 35.27 38.87 66.45 72.19
0.00 35.22 39.00 66.00 74.42
0.00 35.12 37.27 66.67 75.54
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0.00 35.50 38.74 65.20 73.17
1.00 36.39 40.86 66.45 76.01
1.00 35.74 40.22 65.55 75.77
1.00 36.42 39.49 65.35 75.06
2.00 37.00 39.71 65.99 74.22
2.00 35.50 40.44 66.28 74.02
2.00 36.71 39.87 66.21 75.67
3.00 36.14 38.82 67.68 76.56
3.00 36.48 37.74 66.23 75.02
3.00 36.96 40.00 67.03 75.62
4.00 36.46 35.98 66.68 76.77
4.00 35.97 35.74 66.67 75.54
4.00 36.84 35.84 66.24 76.63
5.00 35.98 35.74 66.48 77.75
5.00 35.74 35.68 67.05 78.31
5.00 36.59 35.59 66.98 77.96
6.00 36.16 35.62 66.95 77.00
6.00 35.62 36.46 66.78 77.22
6.00 36.46 35.85 66.73 77.66
7.00 35.85 35.62 67.10 79.00
7.00 35.62 35.97 67.28 79.29
7.00 35.98 36.14 67.20 79.75
8.00 36.46 35.62 68.45 79.34
8.00 35.62 36.22 67.42 80.14
8.00 36.22 36.40 67.53 78.28
9.00 35.85 35.50 66.82 79.36
9.00 35.50 36.10 67.27 72.98
9.00 36.10 36.37 67.93 74.26
Table 14: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
trephine wounded corneas and their corresponding controls at lweek.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 5.035 18 .280 1.101 .388
Within Groups 9.656 38 .254
Total 14.692 56
TREPHINE Between Groups 188.741 18 10.486 36.567 .000
Within Groups 10.897 38 .287
Total 199.637 56
Figure 24: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 18.567 18 1.031 6.254 .000
Within Groups 6.267 38 .165
Total 24.834 56
TREPHI_A Between Groups 204.434 18 11.357 8.656 .000
Within Groups 49.861 38 1.312
Total 254.295 56
Figure 25: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAGGS Equal variances 
assumed 134.747 .000 -5.020 112 .000 -1.3009 .25912 -1.81430 -.78746
Equal variances 
not assumed -5.020 64.198 .000 -1.3009 .25912 -1.81851 -.78325
Figure 26: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS Equal variances 
assumed 55.764 .000 -33.155 112 .000 -9.8043 .29571 -10.39023 -9.21840
Equal variances 
not assumed -33.155 66.834 .000 -9.8043 .29571 -10.39459 -9.21404
Figure 27: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
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2weeks
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
-9.00 36.22 36.34 67.46 82.00
-9.00 36.10 36.77 67.29 80.95
-9.00 36.03 36.48 67.57 79.67
-8.00 35.55 35.50 67.26 81.02
-8.00 36.10 36.42 67.33 80.00
-8.00 36.28 35.98 67.43 79.66
-7.00 36.28 35.74 67.15 78.96
-7.00 35.75 35.50 67.10 79.00
-7.00 36.22 35.39 67.04 79.86
-6.00 35.66 35.39 67.05 78.28
-6.00 35.62 35.49 67.12 78.34
-6.00 36.10 36.01 67.09 79.86
-5.00 35.75 35.50 67.01 79.24
-5.00 35.49 35.39 67.01 79.66
-5.00 36.22 36.01 66.71 79.86
-4.00 36.10 35.62 67.05 78.26
-4.00 35.78 35.49 67.40 78.39
-4.00 35.98 35.79 67.03 77.96
-3.00 35.84 35.39 67.00 77.24
-3.00 35.68 35.68 67.02 78.03
-3.00 35.74 36.14 67.00 77.96
-2.00 35.86 39.84 66.50 78.29
-2.00 35.50 42.00 66.74 76.25
-2.00 35.86 43.88 67.00 75.27
-1.00 35.49 42.24 66.94 78.24
-1.00 35.86 42.79 67.21 78.00
-1.00 35.98 41.98 66.65 77.96
0.00 35.74 38.29 66.73 78.06
0.00 35.49 38.64 66.57 76.24
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0.00 35.50 40.02 67.00 77.96
1.00 35.74 41.24 66.45 77.96
1.00 35.62 41.35 66.45 77.88
1.00 35.86 42.00 66.85 79.43
2.00 35.49 42.00 67.07 77.96
2.00 35.74 42.42 66.53 78.00
2.00 35.78 42.74 66.91 78.24
3.00 35.86 42.42 66.91 79.42
3.00 35.62 42.71 67.00 78.98
3.00 36.10 41.52 67.01 79.58
4.00 35.98 42.28 66.98 79.27
4.00 35.78 35.04 66.78 77.86
4.00 35.96 34.37 66.78 78.07
5.00 35.86 34.15 67.00 79.86
5.00 35.78 34.59 67.05 79.64
5.00 36.10 35.27 67.03 79.24
6.00 36.00 35.50 66.98 79.00
6.00 35.98 35.38 66.76 78.95
6.00 35.86 35.50 67.01 79.86
7.00 35.78 35.39 67.10 79.96
7.00 35.27 35.27 67.46 79.00
7.00 36.00 35.78 67.55 80.01
8.00 36.01 35.27 67.68 81.86
8.00 35.98 35.42 67.34 79.35
8.00 36.18 35.78 67.45 79.35
9.00 36.20 35.74 67:34 82.00
9.00 36.18 36.14 67;00 79.98
9.00 36.10 36.48 67.00 81.03
Table 15: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
trephine wounded corneas and their corresponding controls at 2weeks.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 1.435 18 .080 1.675 .089
Within Groups 1.808 38 .048
Total 3.243 56
TREPHINE Between Groups 450.410 18 25.023 18.075 .000
Within Groups 52.606 38 1.384
Total 503.016 56
Figure 28: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 3.249 18 .181 5.870 .000
Within Groups 1.169 38 .031
Total 4.418 56
TREPHI_A Between Groups 74.152 18 4.120 6.538 .000
Within Groups 23.943 38 .630
Total 98.094 56
Figure 29: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAGGS Equal variances 
assumed 189.240 .000 -4.342 112 .000 -1.7277 .39787 -2.51605 -.93939
Equal variances 
not assumed -4.342 56.940 .000 -1.7277 .39787 -2.52446 -.93098
Figure 30: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Eaualitv of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS Equal variances 
assumed 51.842 .000 -66.695 112 .000 -11.9523 .17921 -12.30736 -11.59720
Equal variances 
not assumed -66.695 61.034 .000 -11.9523 .17921 -12.31062 -11.59394
Figure 31: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
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LASIK-like injured corneas
Controls
Independent Samples Test
Levene's Test for
Equality of Variances t-test for Eaualitv of Means
95% Confidence
Interval of the
Mean Std. Error Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
C1WKIFS Equal variances 
assumed 4.119 .112 .391 4 .716 .1667 .42592 -1.01589 1.34922
Equal variances 
not assumed .391 2.196 .730 .1667 .42592 -1.51803 1.85136
C2WKSIFS Equal variances 
assumed 244 .648 .513 4 .635 .1667 .32462 -.73462 1.06795
Equal variances 
not assumed .513 3.513 .638 .1667 .32462 -.78607 1.11940
A
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
C1WKIFS Equal variances 
assumed 4.119 .112 .391 4 .716 .1667 .42592 -1.01589 1.34922
Equal variances 
not assumed .391 2.196 .730 .1667 .42592 -1.51803 1.85136
C3WKSIFS Equal variances 
assumed 3.479 .136 -.030 4 .977 -.0067 .22010 -.61776 .60443
Equal variances 
not assumed -.030 2.878 .978 -.0067 .22010 -.72420 .71087
B
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
C1WKIFS Equal variances 
assumed 4.119 .112 .391 4 .716 .1667 .42592 -1.01589 1.34922
Equal variances 
not assumed .391 2.196 .730 .1667 .42592 -1.51803 1.85136
C4WKSIFS Equal variances 
assumed 1.247 .327 -.242 4 .821 -.0633 .26202 -.79082 .66416
Equal variances 
not assumed -.242 3.447 .823 -.0633 .26202 -.83925 .71258
c
Figure 32: Independent sample t-test comparing IFS in control corneas. 1 weeks and 
2weeks (A), lweek and 2weeks (B), lweek and 3 weeks (C)
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lweek
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
11.00 36.66 36.66 67.97 74.00
11.00 35.48 36.34 67.88 73.89
11.00 36.00 36.57 67.66 73.96
10.00 36.29 35.92 67.55 73.75
10.00 36.54 35.57 67.22 73.89
10.00 35.65 36.16 67.32 73.65
9.00 36.24 36.48 66.93 73.05
9.00 36.33 36.23 66.75 73.25
9.00 35.74 36.00 66.24 73.68
8.00 36.00 35.74 67.50 73.00
8.00 35.57 35.93 67.66 72.92
8.00 36.01 35.57 67.00 73.67
7.00 35.69 35.74 67.01 73.74
7.00 35.98 35.57 66.96 73.01
7.00 35.57 35.74 66.81 73.24
6.00 35.93 35.57 66.75 72.95
6.00 36.00 35.93 67.04 72.24
6.00 35.69 35.34 67.30 72.00
5.00 35.88 35.36 66.23 72.15
5.00 35.69 35.00 66.96 72.24
5.00 35.27 35.88 66.81 72.67
4.00 35.98 35.74 66.00 72.24
4.00 35.93 35.93 66.04 72.55
4.00 35.74 35.74 66.23 72.15
3.00 35.50 35.57 66.00 72.19
3.00 35.74 35.26 66.04 72.24
3.00 35.27 35.00 66.23 72.19
2.00 35.22 35.74 66.00 72.55
2.00 35.23 35.93 66.75 72.24
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2.00 35.57 36.00 66.23 72.19
1.00 35.69 37.69 66.23 72.95
1.00 35.74 37.27 66.75 73.00
1.00 35.98 37.28 66.35 72.88
.00 36.34 37.69 66.00 76.35
.00 35.50 37.72 66.23 75.25
.00 35.21 37.00 66.21 74.61
-1.00 35.24 35.57 66.00 72.15
-1.00 35.57 36.00 66.23 72.02
-1.00 35.93 36.23 67.03 72.55
-2.00 35.74 35.98 66.68 72.19
-2.00 35.97 35.74 66.67 72.24
-2.00 35.83 35.86 66.23 72.74
-3.00 35.93 35.57 66.48 72.74
-3.00 35.74 35.68 66.00 72.24
-3.00 35.65 35.57 66.98 72.95
-4.00 35.24 35.67 66.95 72.68
-4.00 35.57 35.74 66.78 72.94
-4.00 35.69 35.93 66.75 72.64
-5.00 35.85 35.64 67.10 73.00
-5.00 35.64 35.93 67.03 73.65
-5.00 35.93 36.00 66.98 73.25
-6.00 36.00 35.64 68.45 73.68
-6.00 35.98 36.03 67.03 73.89
-6.00 36.04 35.74 67.53 73.96
2.00 35.23 35.93 66.75 72.24
2.00 35.57 36.00 66.23 72.19
1.00 35.69 37.69 66.23 72.95
Table 16: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
LASIK-like injured corneas and their corresponding controls at lweek.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 2.488 17 .146 1.643 .103
Within Groups 3.206 36 .089
Total 5.694 53
LSK Between Groups 18.054 17 1.062 18.030 .000
Within Groups 2.121 36 .059
Total 20.175 53
Figure 33: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 14.258 17 .839 7.795 .000
Within Groups 3.873 36 .108
Total 18.131 53
LSKIFS Between Groups 35.319 17 2.078 18.090 .000
Within Groups 4.135 36 .115
Total 39.454 53
Figure 34: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAGGS Equal variances 
assumed 6.779 .011 -2.141 106 .035 -.2035 .09507 -.39201 -.01503
Equal variances 
not assumed -2.141 80.709 .035 -.2035 .09507 -.39269 -.01435
Figure 35: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS Equal variances 
assumed 4.457 .037 -44.166 106 .000 -6.2649 .14185 -6.54610 -5.98365
Equal variances 
not assumed -44.166 93.218 .000 -6.2649 .14185 -6.54654 -5.98320
Figure 36: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
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2weeks
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
11.00 36.26 36.36 67.98 76.23
11.00 35.37 36.24 67.56 75.89
11.00 36.05 35.92 67.05 76.98
10.00 36.18 36.00 67.35 75.74
10.00 36.43 35.57 67.55 75.89
10.00 35.65 36.06 67.00 76.36
9.00 36.23 35.93 67.23 76.05
9.00 36.33 36.26 67.33 76.23
9.00 35.74 36.00 67.00 75.89
8.00 36.00 35.57 67.00 75.00
8.00 35.57 35.74 67.56 75.95
8.00 36.05 35.45 67.00 75.74
7.00 35.65 36.04 67.00 75.74
7.00 36.05 35.74 66.96 75.01
7.00 35.65 35.57 67.03 75.74
6.00 36.00 35.57 66.75 75.95
6.00 36.00 36.00 67.04 75.24
6.00 35.65 35.93 67.35 75.00
5.00 35.74 35.69 67.23 75.24
5.00 35.65 36.04 67.00 75.24
5.00 35.37 35.74 67.01 75.74
4.00 36.00 35.57 67.00 75.24
4.00 36.00 35.69 67.04 75.78
4.00 35.54 35.45 67.23 75.01
3.00 35.57 35.69 67.00 75.24
3.00 35.74 35.54 67.04 75.89
3.00 35.16 35.57 67.23 75.18
2.00 35.24 35.93 67.00 75.68
2.00 35.37 36.00 66.96 75.24
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2.00 35.67 36.04 67.23 75.18
1.00 35.69 37.00 67.23 75.95
1.00 35.74 37.33 66.75 75.00
1.00 36.00 37.25 67.00 75.89
.00 36.00 37.15 67.00 68.40
.00 35.57 37.25 67.23 69.85
.00 35.24 37.00 67.35 69.12
-1.00 35.24 35.57 67.00 75.47
-1.00 35.57 36.01 67.23 75.68
-1.00 36.00 36.23 67.03 75.89
-2.00 35.74 36.00 66.96 75.24
-2.00 36.00 35.69 66.75 75.89
-2.00 35.74 35.77 67.23 75.24
-3.00 36.00 35.57 67.45 75.78
-3.00 35.74 35.69 67.00 75.24
-3.00 35.74 35.57 66.96 75.95
-4.00 35.24 35.34 66.95 75.68
-4.00 35.57 35.77 66.78 75.89
-4.00 35.57 36.00 67.00 75.68
-5.00 35.74 35.69 67.10 75.00
-5.00 35.57 35.93 67.03 75.64
-5.00 36.00 36.00 67.00 76.00
-6.00 36.00 36.29 67.56 75.68
-6.00 36.05 36.00 67.00 75.89
-6.00 35.74 35.57 67.53 76.00
2.00 36.26 36.36 67.98 76.23
2.00 35.37 36.24 67.56 75.89
1.00 36.05 35.92 67:05 76.98
Table 17: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
LASIK-like injured corneas and their corresponding controls at 2weeks.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 2.007 17 .118 1.565 .127
Within Groups 2.716 36 .075
Total 4.723 53
LSK Between Groups 10.985 17 .646 14.482 .000
Within Groups 1.606 36 .045
Total 12.591 53
Figure 37: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 1.162 17 .068 1.310 .241
Within Groups 1.878 36 .052
Total 3.041 53
LSKIFS Between Groups 124.496 17 7.323 43.704 .000
Within Groups 6.032 36 .168
Total 130.528 53
Figure 38: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAddS Equal variances 
assumed 3.502 .064 -2.659 106 .009 -.2069 .07778 -.36106 -.05265
Equal variances 
not assumed -2.659 87.855 .009 -.2069 .07778 -.36143 -.05228
Figure 39: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS q^ual variances 
assumed 9.669 .002 -37.760 106 .000 -8.1574 .21603 -8.58574 -7.72913
Equal variances 
not assumed -37.760 55.468 .000 -8.1574 .21603 -8.59029 -7.72458
Figure 40: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
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3weeks
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
11.00 36.33 36.23 67.56 77.22
11.00 35.57 36.98 67.29 77.02
11.00 36.05 35.88 67.26 77.33
10.00 36.28 35.57 67.57 77.00
10.00 36.33 35.69 67.03 76.98
10.00 35.57 36.00 67.33 76.56
9.00 36.33 36.16 67.05 76.05
9.00 36.33 35.93 67.35 76.23
9.00 35.74 35.74 67.00 76.79
8.00 36.00 36.00 67.05 76.17
8.00 35.57 35.57 67.22 75.95
8.00 36.00 35.74 67.00 76.78
7.00 35.57 36.00 67.05 76.77
7.00 36.00 35.57 67.25 76.00
7.00 35.75 35.69 67.35 76.74
6.00 36.00 35.57 67.05 76.68
6.00 36.06 36.00 67.35 76.24
6.00 35.57 35.93 67.57 76.00
5.00 35.74 35.69 67.00 76.24
5.00 35.65 36.00 67.05 76.74
5.00 35.57 35.75 67.22 76.77
4.00 36.00 35.57 66.74 76.24
4.00 36.05 35.69 66.67 76.78
4.00 35.57 35.48 67.00 76.00
3.00 35.75 35.74 67.00 76.24
3.00 35.74 35.57 67.22 76.89
3.00 35.26 35.69 66.67 76.28
2.00 35.24 35.93 66.73 76.78
2.00 35.57 36.05 66.67 76.24
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2.00 35.75 36.10 67.00 76.78
1.00 35.75 36.98 66.35 76.00
1.00 35.69 37.00 66.45 76.05
1.00 36.00 37.88 66.67 76.29
.00 36.00 37.00 67.00 71.36
.00 35.57 37.35 66.53 69.11
.00 35.29 37.01 67.00 71.37
-1.00 35.26 36.00 67.00 76.47
-1.00 35.57 35.57 67.05 76.69
-1.00 36.00 36.33 67.01 76.89
-2.00 35.75 35.78 67.00 76.89
-2.00 36.00 36.00 67.05 76.24
-2.00 35.75 35.74 66.78 76.33
-3.00 36.00 35.69 67.00 76.24
-3.00 35.75 35.57 67.05 76.74
-3.00 35.57 35.74 67.03 75.95
-4.00 35.29 35.27 66.98 75.68
-4.00 35.57 35.74 66.76 76.89
-4.00 35.93 35.69 67.05 76.00
-5.00 35.74 36.01 67.15 76.30
-5.00 35.57 35.93 67.58 76.64
-5.00 36.00 36.01 67.23 76.00
-6.00 36.05 36.17 67.58 77.00
-6.00 36.23 35.74 66.98 77.24
-6.00 35.75 36.00 67.57 77.35
2.00 36.33 36.23 67.56 77.22
2.00 35.57 36.98 67.29 77.02
1.00 36.05 35.88 67.26 77.33
Table 17: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
LASIK-like injured corneas and their corresponding controls at 3weeks.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 1.593 17 .094 1.192 .319
Within Groups 2.831 36 .079
Total 4.424 53
LSK Between Groups 11.690 17 .688 10.281 .000
Within Groups 2.408 36 .067
Total 14.099 53
Figure 41: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 2.926 17 .172 4.377 .000
Within Groups 1.416 36 .039
Total 4.342 53
LSKIFS Between Groups 103.458 17 6.086 28.963 .000
Within Groups 7.564 36 .210
Total 111.022 53
Figure 42: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
DBRAGGS Equal variances 
assumed 3.803 .054 -2.461 106 .015 -.1980 .08045 -.35746 -.03847
Equal variances 
not assumed -2.461 83.280 * .016 -.1980 .08045 -.35796 -.03796
Figure 43: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IFS Equal variances 
assumed 8.388 .005 -45.478 106 .000 -9.1307 .20077 -9.52879 -8.73269
Equal variances 
not assumed -45.478 57.139 .000 -9.1307 .20077 -9.53276 -8.72873
Figure 44: Independent sample T-test comparing fibril interfibrillar spacing to type
(i.e. wounded/unwounded)
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4weeks
Position of 
scan
Control
Fd
Trephine 
wounded Fd
Control
IFS
Trephine 
wounded Fd
11.00 36.28 36.33 67.66 78.17
11.00 36.00 36.76 67.24 77.89
11.00 35.57 35.93 67.22 78.00
10.00 36.28 35.69 67.57 77.94
10.00 36.23 35.57 67.03 77.89
10.00 35.57 36.01 67.34 77.76
9.00 35.74 35.93 67.05 77.05
9.00 36.23 36.00 67.35 77.24
9.00 36.06 35.77 67.00 77.68
8.00 35.57 35.77 67.05 77.24
8.00 36.00 36.00 67.22 77.89
8.00 36.06 35.57 67.00 77.76
7.00 35.75 35.69 67.05 77.05
7.00 35.57 35.74 67.25 77.24
7.00 36.00 35.93 67.35 77.68
6.00 35.57 35.57 67.05 77.24
6.00 36.06 36.00 67.35 77.55
6.00 35.75 35.93 67.57 77.05
5.00 35.69 35.69 67.00 77.24
5.00 35.57 36.05 67.05 77.76
5.00 35.74 35.74 67.22 77.68
4.00 36.05 35.57 66.74 77.24
4.00 35.57 35.69 66.67 77.00
4.00 36.00 35.74 67.00 77.68
3.00 35.74 35.57 67.00 77.25
3.00 35.69 35.93 67.22 77.89
3.00 35.16 35.69 66.67 77.24
2.00 35.06 35.93 66.73 77.00
2.00 35.74 36.04 66.67 77.68
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2.00 35.57 36.19 67.00 77.07
1.00 35.69 37.00 66.35 77.00
1.00 35.57 37.76 66.45 77.15
1.00 36.05 38.00 66.67 77.28
.00 35.57 37.66 67.00 68.40
.00 36.00 37.76 66.53 71.36
.00 35.16 38.00 67.00 69.85
-1.00 35.16 37.00 67.00 77.48
-1.00 36.00 37.05 67.05 77.68
-1.00 35.75 36.98 67.01 77.76
-2.00 35.57 36.77 67.00 77.68
-2.00 36.05 36.00 67.05 77.34
-2.00 35.57 36.30 66.78 77.24
-3.00 35.69 35.69 67.01 77.74
-3.00 35.74 35.77 67.15 77.69
-3.00 35.57 35.57 67.03 77.93
-4.00 35.16 35.77 67.00 77.89
-4.00 35.69 35.69 66.76 77.68
-4.00 35.74 35.57 67.05 77.34
-5.00 35.57 36.00 67.49 77.00
-5.00 36.04 35.98 67.58 77.74
-5.00 35.93 36.00 67.23 77.05
-6.00 36.05 36.33 67.69 77.00
-6.00 36.29 36.00 67.00 77.24
-6.00 35.93 36.05 67.62 77.35
2.00 36.28 36.33 67.66 78.17
2.00 36.00 36.76 67.24 77.89
1.00 35.57 35.93 67.22 78.00
Table 18: Raw data for fibril diameter (Fd) and interfibrillar spacing (IFS) for
LASIK-like injured corneas and their corresponding controls at 4weeks.
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ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROL Between Groups 1.734 17 .102 1.193 .318
Within Groups 3.078 36 .085
Total 4.812 53
LSK Between Groups 21.624 17 1.272 23.929 .000
Within Groups 1.914 36 .053
Total 23.538 53
Figure 45: One-way ANOVA statistical test results comparing fibril diameter
according to the position of scan
ANOVA
Sum of 
Squares df Mean Square F Sig.
CONTROLI Between Groups 3.263 17 .192 4.572 .000
Within Groups 1.511 36 .042
Total 4.774 53
LSKIFS Between Groups 167.076 17 9.828 50.817 .000
Within Groups 6.962 36 .193
Total 174.039 53
Figure 46: One-way ANOVA statistical test results comparing interfibrillar spacing
according to the position of scan
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Eaualitv of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Siq. t df Siq. (2^ tailed) Difference Difference Lower Upper
DBRAGGS Equal variances 
assumed 16.220 .000 -3.965 106 .000 -.3946 .09953 -.59195 -.19731
Equal variances 
not assumed -3.965 73.800 .000 -.3946 .09953 -.59295 -.19631
Figure 47: Independent sample T-test comparing fibril diameter according to type
(i.e. wounded/unwounded)
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Sig. (2-tailed) Difference Difference Lower Upper
IPS Equal variances 
assumed 7.017 .009 -39.940 106 .000 -9.9832 .24996 -10.47877 -9.48764
Equal variances 
not assumed -39.940 55.906 .000 -9.9832 .24996 -10.48395 -9.48246
Figure 48: Independent sample T-test comparing interfibrillar spacing according to
type (i.e. wounded/unwounded)
171
Differential Regulation o f Key Stages in  Early Corneal 
Wound Healing by TGF-0 Isoform s and Their Inhibitors
Louise M. Carrington,12 Julie A lbon,12 Ian Anderson ,3 Christina K am m a,12 an d  
Mike Boulton1,2
Purpose. Inhibition of TGF-0 reduces myofibroblast differenti­
ation and fibrosis in the cornea. Determining the actions of 
distinct TGF-0 isoforms and their inhibitors during early cor­
neal wound healing is an essential step in guiding therapeutic 
intervention.
Methods. Bovine serum-free comeal cell and wounded organ 
cultures were challenged with a range of concentrations of 
TGF-0,, -02, and -03; IL-10; and neutralizing human monoclonal 
antibodies (mAbs) against TGF-0, (CAT-192) or -02, (CAT-152). 
Cultures were assessed for re-epithelialization, proliferation 
(cell counts and cresyl violet assay), morphology (histologic 
examination), repopulation of the area under the wound, and 
myofibroblast transformation (a-smooth muscle actin) be­
tween 0 and 5 days.
Results. TGF-01 delayed re-epithelialization, increased repopu­
lation of the stroma, increased keratocyte proliferation and was 
the only isoform to promote myofibroblast differentiation. The 
anti-TGF-01 mAb, CAT-192 promoted re-epithelialization and 
reduced repopulation of the stroma. Exogenous TGF-03 had 
little effect on re-epithelialization but reduced repopulation of 
the stroma. IL-10 promoted comeal re-epithelialization at low  
doses but inhibited this response at high doses. Stromal re­
population was prevented by all doses of IL-10. TGF-02 or the 
anti-TGF-02 mAb, CAT-152 had little effect on any repair pa­
rameter.
Conclusions. The results confirm TGF-0, as the principal iso­
form in comeal wound healing and suggest that inhibition of 
the action of TGF-0, can promote comeal wound healing. 
Treatment with the anti-TGF-0, mAb CAT-192 accelerates cor­
neal re-epithelialization but reduces cell repopulation of the 
stroma. The cytokines TGF-03 and IL-10 have opposing actions 
to that of TGF-01. (Invest Ophthalmol Vis Sci. 2006;47: 
1886 -1894) DOI: 10.1 l67/iovs.05-0635
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TGF-0 has been established as a major regulator of wound healing in most species and tissues, including the cor­
nea.1-3 To date, TGF-0, and -02 have been localized to both the 
comeal epithelium and stroma, and both are constituents of 
the tear fluid (Vesaluoma M, et al. IOVS 1996;37:ARVO Abstract 
3912).4-9 Although mRNA of the 03 isoform has been isolated 
from whole rat corneas at very low levels, its tissue location is 
unclear, and the protein has yet to be detected in the non- 
pathologic cornea.6,10
The TGF0 receptors RI and RII are located in epithelial, 
stromal, and endothelial layers of the cornea.11-13 RI and RII 
are present predominantly in the basal layer of comeal epithe­
lial cells, with receptor density increasing proximal to the 
limbus in many species, including humans. The nonsignaling 
TGF0-RIII (0-glycan receptor) has been located on both the 
epithelium and endothelium in vivo, but appears to be absent 
in keratocytes in vivo.11
As with many other growth factor signaling systems the 
levels and spatial location of each component in the TGF-0 
system alters dramatically after a comeal wound. All three 
isoforms are present in the comeal epithelium,414"16 and cor­
neal epithelial cells in culture release TGF-0, and -02.17,18 
TGF-02 is reported to be more strongly expressed than the 
other two isoforms4 and throughout wound healing after PRK 
and TGF-0,, -02, and -03 are present in the comeal epitheli­
um.19 In stromal cells TGF-0 is upregulated,15 but isoforms 
cannot be detected immunohistochemically until 2 days after 
PRK, when rounded cells in the ablated area express all three 
isoforms. TGF-0,, -02, and -03 expression is delayed in spindle 
shaped fibroblasts until 10 days after PRK. Expression of all 
three isoforms returns to normal after 30 days. In addition, 
levels o f TGF-0, in the tear film increase dramatically (Vesa­
luoma M, et al. IOVS 1996;37:ARVO Abstract 3912). Of partic­
ular interest is the finding that topical administration of 1 D ll,  
a TGF-0,-, -02-, and -03-neutralizing antibody, to rabbit corneas 
after PRK and lamellar keratectomy wounds, results in a reduc­
tion in the appearance of myofibroblasts, and substantially 
decreases the incidence of haze in rabbits.2'3 Taken together, 
this indicates a pivotal role for the TGF-0 system in comeal 
maintenance and wound repair.
The TGF-0 superfamily is a structurally related group of 
bioactive ubiquitous proteins with diverse and pleiotropic ac­
tivities. TGF-01 and -02 share 80% sequence homology but can 
have opposite actions on biological processes such as prolifer­
ation, migration, and differentiation.1 The role of the various 
isoforms of TGF-0 in comeal wound healing is not fully under­
stood, and therefore optimal treatment may rely on selective 
inhibition of one or more TGF-0 isoforms. To manipulate the 
cytokine environment of the healing cornea after either trauma 
or elective surgery, it is necessary to understand the actions of 
each TGF-0 isoform. It appears increasingly likely that the 
events occurring within the earliest stages of comeal wound 
healing alter prognosis.2 3 Herein, we describe the very differ­
ent actions of the three TGF-0 isoforms in early comeal wound- 
healing events and their inhibition by human isoform-specific 
neutralizing antibodies. The action of the cytokine IL-10, a 
potential antagonist of TGF-0, was also evaluated. The results
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of the study have been reported in part in abstract form 
(Carrington LM, et al. IOVS 2001;42:ARVO Abstract 5018).
M e t h o d s  
Cell Culture
Nonactivated bovine keratocytes were cultured based on established 
methods.3 20 In brief, the epithelial and endothelial layers were scraped 
from the stroma which was incubated in 2 mg/mL collagenase (wt/vol 
RPMI at 37°C; Invitrogen-Gibco, Paisley, Scotland, UK) overnight at 
37°C. Isolated cells were plated at 1 x  104 cells/well (24-well plate) in 
1 mL of serum-free RPMI containing nonessential amino acids (Invitro­
gen-Gibco), glutamine, antibiotics, amphotericin B. Cultures were 
maintained in medium at 37°C in a standard 5% C 0 2-95% air atmo­
sphere for 48 hours, to allow attachment. Medium was replaced with 
fresh medium containing 0.1, 1, or lOng/mL TGF/31, -{52, or -/3, or IL-10 
(R&D, Abingdon, UK). Diluents were used as the control: 10 pL of 
phosphate buffered saline (PBS) containing 0.1% BSA and 0.01 M HC1 
(TGF-/3 isoform diluent) or 10 pL of PBS containing 0.1% BSA (IL-10 
diluent). All treatments were applied in triplicate for up to 5 days in 
culture, and experiments were performed at least three times.
Organ Culture
Bovine corneas were centrally wounded with a 5-mm trephine, as 
previously described,21 and the disc of epithelial-stromal tissue within 
the wound was excised. Sterile, serum-free DMEM containing 1% agar
and 1% gelatin (BDH, Poole, UK) was used as a support, and serum-free 
Trowell’s T8 medium (Invitrogen-Gibco) containing antibiotics, am­
photericin B, and glutamine was added to the dish to a level just below 
the limbal region. Twice daily, 100 pL of fresh serum-free T8 medium 
was pipetted onto the surface of the cornea containing 1, 10, or 100 
ng/mL TGF/3,, -/32, or -/33 or IL-10 (R&D Systems); or neutralizing mAb 
against either active hTGF/3, (CAT-192; 0.1 nM-10 pM human IgG4; 
Cambridge Antibody Technology, Cambridge, UK); or hTGFj32 (CAT- 
152; 10 pM human IgG4; Cambridge Antibody Technology); or 10 p i  
of PBS containing 0.1% BSA (IL-10 and neutralizing antibody diluent) or 
10 pL of PBS containing 0.1% BSA, and 0.01 M HC1 (TGF-/3 isoform 
diluent). Cultures were maintained in serum-free T8 medium for up to 
5 days (n = 6, per time, per treatment).
Re-epithelialization
Re-epithelialization was assessed as previously described,20,21 by using 
captured macroimages of the wound area, where both the original 
wound cut and the leading edge of the epithelium could be seen. 
Re-epithelialization was expressed as the percentage of the original 
wound area that was re-covered.
M orphologic Assessm ent o f Epithelium
Wounded and unwounded corneas were fixed overnight in 10% neu­
tral buffered formalin (NBF), processed into wax. Seven-micrometer 
sections were stained with Harris hematoxylin and eosin.
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Figure 1. Percentage re-epithelialization of bovine comeal trephine wounds treated with 100 pL of serum-free medium twice daily, containing 
1% growth factor diluent (PBS+0.1% BSA+HCL) or 1, 10, or 100 ng/mL (a) TGF-/3, and 10 pM neutralizing mAb against hTGF-j3,, (b) TGF-/32 and 
10 pM neutralizing mAb against hTGF-02, (c) TGF-/3,, or (d) IL-10. Each point represents the average of at least six corneas ± SEM. Significant 
differences were determined by Student’s f-test *P <  0.05, **P < 0.01.
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Assessm ent o f Proliferation in  Cell Culture Using 
the Cresyl Violet Assay
Briefly, cells were fixed in 70% ethanol for 10 minutes at room tem­
perature and incubated with a 0.5% solution of cresyl violet (BDH) for 
1 minute at room temperature. After washing with PBS, acetic acid 
(33%, vol/vol ddH20 )  was added to the wells to elute the dye. The 
absorbance of the wells was read at 540 nm, with an ELISA reader, and 
wells containing 33% acetic acid were used as a blank.
Stromal Cell Density beneath the W ound
Corneas were fixed in 10% NBF overnight and processed into wax. 
Seven-micrometer sections were floated and incubated in 1 /xg/mL 
bisbenzimide solution (Sigma-Aldrich, Poole, UK) for 10 minutes. Im­
ages of stained sections were captured, and the number of nuclei in the 
area 100 pun below the wound surface was analyzed (ImagePro Plus 
software; Media Cybernetics, Silver Spring, MD).
complete cover was established at 48 hours, corresponding to 
a re-epithelialization rate of 2.11% ± 0.1% h-1 (P <  0.05 
compared with the rate observed in vehicle-treated controls, 
1.56% ± 0.07% h-1 , Fig. lb). In a separate experiment the 
concentration-response for CAT-192 was evaluated at a single 
time point. CAT-192 (10 ng/mL-100 pig/mL) applied to 
wounded corneas resulted in a concentration-related enhance­
ment of comeal re-epithelialization measured at 40 hours, with 
a calculated EC5Q of 0.51 ptg/mL (0.23-1.10, 95% confidence 
limits; n =  12, Fig. 2). Neither CAT-152 or a null control IgG4 
had a significant effect on the rate of re-epithelialization (Figs. 
lb, 2)
IL-10 exhibited a pleiotropic effect on re-epithelialization 
(Fig. Id): 1 ng/mL had no effect, 10 ng/mL increased re- 
epithelialization, and 100 ng/mL decreased re-epithelialization 
(without apparent cytotoxicity using the trypan blue assay, 
data not shown).
Identification o f M yofibroblasts
Cultured cells were fixed at 0, 1, 2, 3, 4, and 5 days after treatment in 
1% paraformaldehyde for 5 minutes. Comeal organ cultures were snap 
frozen in liquid nitrogen at 0, 1, 2, 3, and 5 days after treatment; 
embedded in optimal cutting temperature compound (OCT); and sec­
tioned at 5-fun intervals. Cultures and sections were pretreated with
0.1% Triton-X-100 for 20 minutes, incubated with a monoclonal anti-a 
smooth muscle actin antibody (Sigma-Aldrich) for 2 hours followed by 
an Alexafluor 488<onjugated goat anti-mouse IgG (Invitrogen, Eugene, 
OR) for 1 hour. Counterstaining of nuclei was obtained using bis­
benzimide solution incubation for 10 minutes. Cell cultures were also 
costained with TRITC-conjugated phalloidin (5 /xg/mL in PBS; Sigma- 
Aldrich) for 2 hours, to identify F-actin.
Statistical Analysis
Cell counts beneath the wound were compared by using the nonpara- 
metric Mann-Whitney test. Proliferation was compared with unpaired, 
two-way Wests (Prism 3.0; GraphPad Software, San Diego, CA) Comeal 
re-epithelialization was compared at each time point using either the 
Kruskal-Wallis test (nonparametric ANOVA) with Dunn’s post test or 
Mann-Whitney test, as appropriate. The rate of re-epithelialization was 
assessed with a least-squares regression function of data between 24 
and 48 hours and was expressed as the percentage of the wound area 
re-epithelialized in 1 hour. The calculated ECso for CAT-192 in the 
re-epithelialization assay is indicated as the geometric mean with asso­
ciated 95% confidence limits.
R e sults
Epithelial Wound Healing
Re-epithelialization followed a pattern similar to that previ­
ously described for this organ culture model.20,21 Epithelial 
migration commenced within 12 hours after wounding, and, 
by 72-hours, wounds had completely re-epithelialized for cor­
neas treated with medium alone or medium containing diluent 
(Fig. 1). The rate of re-epithelialization was calculated to be 
1.56% ± 0.07% h_1.
Comeal reepithelialization was differentially sensitive to 
the three TGF-/3 isoforms tested. TGF-/3, was the most potent 
inhibitor of reepithelialization, inhibition was greatest at 100 
ng/mL and halved the rate of reepithelialization compared 
with the control (0.71% ± 0.3% h-1 ; P  <  0.05). The rate of 
reepithelialization for corneas treated with TGF-/32 or -03 was 
similar to that for the control (P >  0.05), except that TGF-/32 at 
100 ng/mL caused a small delay in reepithelialization at 72 
hours (Figs. lb, lc).
Administration of CAT-192 (100 /xg/mL) resulted in an ac­
celerated rate of regrowth of the comeal epithelium such that
Epithelial M orphology
Epithelial morphology during reepithelialization in control 
corneas and those receiving diluent was similar to that previ­
ously described for this model20,21 and as depicted in Figure 3- 
Initial rounding off and retraction of the epithelium from the 
wound site at 4 hours was followed by migration onto the 
denuded stroma at 12 hours with the leading edge of the 
epithelium one cell deep, with no obvious stratification. Migra­
tion continued across the wound, with the leading edge of 
epithelium increased to 3 to 4 cells and slight hypercellularity 
at the original wound edge evident. By 72 hours, wound 
closure had occurred with the epithelium at the closure site 
thinner and less differentiated than the distal epithelium. After 
5 days in culture the entire epithelium within the wound site
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Figure 2. Dose response to CAT-192 during comeal re-epithelializa­
tion after an excisional trephine wound. The EC50 for CAT 192 was 0.51 
mg/mL (95% Cl, 0.23-1.10; n = 12). Data are expressed as the per­
centage change in re-epithelialization of the vehicle-treated control 
group. Dotted lines: SEM of the vehicle control group data. A null IgG4 
antibody control group (CAT-001, n = 6) was included. Each point 
represents the mean; vertical bars, SEM. The effect of the different 
doses of CAT-192 was compared with control treatment using the 
Kruskal-Wallis and Dunn tests. *P <  0.01.
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Figure 3- Epithelial morphology of 
wounded corneas at various stages of 
re-epithelialization. Unwounded bo­
vine corneas (a) contained 8 to 10 
layers of cells within the epithelium 
and 1 to 2 layers of desquamating, 
flattened superficial epithelial cells 
(black arrow). Corneas that had un­
dergone wounding with a trephine, 
showed clean, sharply cut edges (b) 
through the epithelium immediately 
after wounding (black arrow), stro­
mal cutting was less defined (grey 
arrow). Four hours after wounding
(c), the epithelium had retracted 
from the cut edge of the stroma 
0black arrow). As the epithelium mi­
grated across the denuded stroma
(d), the epithelium over the comer 
of the original cut (black arrow) had 
thinned to one to three layers deep, 
whereas hypercellularity was often 
observed within the wound’s edge 
(white arrow), (e) The leading edge 
of the epithelium had lost stratifica­
tion and become one to two cells 
deep (black arrow). By 120 hours 
(f), stratification of the healed epithe­
lium was evident with a slight thick­
ening compared with unwounded 
corneas. Scale bar, 100 pun.
exhibited good stratification, although slight th ickening o f  the  
epithelium  within the w ound area w as com m on.
M orphologic differences w ere observed in corneas treated 
with TGF-jS, (Fig. 4). This included considerable thinning o f  
the epithelium  in the w ound site at all tim e poin ts and was 
more pronounced in the corneas receiving 100 ng/m L TGF-/3, 
(Fig. 4b). Stratification o f  the epithelium  m igrating into the  
w ound w as always evident, although the layers w ere  thinner 
than those in control corneas. By 120 hours, re-epithelialization  
was com plete, confirm ing the results o f  m acroscopic im age 
analysis. Corneas treated w ith  the anti-TGF /3, antibody CAT- 
192 w ere similar to the control, although the epithelium  ap­
peared slightly thinner (Figs. 4c , 4d).
Corneas receiving 1 ng/mL TGF-/32 sh o w ed  a retraction o f  
the w ound edge that w as not observed at higher concentra­
tions (Fig. 4e). Thinning o f  the epithelium  w as particularly 
obvious at 100 ng/mL, especially at the interface betw een  
w ounded and unw ounded stroma. By 4 8  hours in culture, 
hypercellularity was evident at all TGF-/32 concentrations, w ith  
sparse populations o f  cell nuclei in the superficial layers and 
loss o f stratification correlated w ith  increasing d oses o f  TGF-/32, 
and at 100 ng/mL no obvious basal cells or superficial ep ithe­
lium w ere observed. Patches o f  acellularity w ere  observed  
within the epithelium  (Fig. 40- By 120 hours in culture all 
w ounds had closed, stratification o f  the epithelium  w as poor in 
corneas treated w ith higher d oses o f  TGF-/3,. Corneas receiving  
a neutralizing antibody against TGF-/32, CAT-152, sh ow ed  mor­
phologic features similar to those observed in the control 
corneas (Fig. 4g, 4h).
TGF-/33, at all doses, show ed considerable epithelial retrac­
tion from the w ou nd edge at 4 hours and som e cellular debris 
(Fig. 4i). M orphology o f the epithelium  w as reasonably normal 
w ith som e thinning toward the epithelial edge in corneas 
treated w ith higher doses. By 24 hours, migration into the 
w ound had begun but w as less advanced than in the control. 
Hypercellularity and extrem e thinning o f  the epithelium  was 
evident at the w ound edge and stratification, as indicated by 
lack o f  colum nar cells in Fig 4j, becam e less evident with  
increasing TGF-/33 concentrations. By 120 hours in culture, the 
epithelium  had an increased thickness throughout the wound, 
com pared w ith the control (Fig. 4j).
IL-10 produced contrasting results, depending on dose. At 4 
hours after w ounding 1 ng/mL IL-10 show ed neither retraction 
nor migration, but the epithelium  was thinned to three to four 
cell layers, 10 ng/mL resulted in extrem e thinning o f  the 
leading edge o f the epithelium  and som e retraction, whereas 
100 ng/mL prom pted migration o f a very thin leading edge into 
the w ound area (Fig. 4k). At 24 and 48 hours, apart from 
degree o f  migration, epithelial m orphology was similar for all 
three doses o f IL-10. Stratification w as not evident at the lead­
ing edge and hypercellularity was evident at the original 
w ound margin. By 72 hours, differentiation o f  cells was evident 
but not confined to obvious layers, and basal cells w ere diffi­
cult to distinguish; 1-ng/mL-treated corneas demonstrated an
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stratification w as seen in corneas treated w ith all three doses 
(Fig. 41).4 hours 120 hours
F i g u r e  4 .  Epithelial morphology after trephine wounding 4 ( a ,  c ,  e ,  
g ,  i, k )  and 120 ( b ,  d ,  f , h ,  j ,  1) hours after treatment with 100 ng/mL 
TGF-0, ( a ,  b )  or anti-TGF-0, ( c ,  d ) ;  TGF-02 ( e ,  10 ng/mL; f ,  1 ng/mL; 
white arrow, an area apparently devoid of nuclei) or anti-TGF-0, (g, 
h ) ;  100 ng/mL TGF-0, ( i ,  j ;  black arrow: cellular debris and retraction 
of epithelium from the wound edge, white arrow) ; or IL-10 ( k ,  100 
ng/mL; 1, 10 ng/mL). Scale bar, 100 p,M.
even epithelium  within the w ound area w ith  som e disruption  
o f the layering, whereas both 10 and 100 ng/m L produced  
hypercellularity at the w ound edges and a thinning o f  the  
epithelium  at the site o f  w ound closure. At 120 hours, good
Keratocyte Proliferation
K era to cy te  C ell C ulture. Bovine keratocytes in serum-free 
cell culture retained a stellate m orphology similar to that seen  
in vivo, forming a m onolayer w ith interconnecting processes. 
The initial seeding density o f 1 X 104 cells per w ell, resulted in 
a preconfluent culture; how ever, after 2 days in culture the  
num ber o f  cells had increased to approxim ately 4 X 104 cells 
per w ell and the keratocytes had extended long processes 
toward each other, forming a network. The culture conditions 
allow ed low-level proliferation o f keratocytes throughout the 5 
days o f experim entation (Fig. 5). Twenty-four hours after the 
m edium  w as changed, the number o f keratocytes had in­
creased to 7.3 ±  0.1 X 104 cells and continued to increase, 
reaching 1.8 ±  0.2 X 10s cells at 120 hours. Diluents had no  
effect on  keratocyte proliferation.
TGF-0, had no significant effect on keratocyte numbers at 
either 1 or 10 ng/mL. However, at 0.1 ng/mL, TGF-0, more 
than doubled the num ber o f  keratocytes at 120 hours o f cul­
ture com pared w ith  the control (P  <  0.001; Fig. 5a). Other 
isoform s had no effect on  keratocyte proliferation at the con­
centrations tested (Fig. 5b, 5c).
All three concentrations o f IL-10 stimulated keratocyte pro­
liferation in cell culture, w ith  the cell num ber doubling com ­
pared w ith  the control (P <  0.011; Fig. 5d). The proliferative 
response appeared to be initiated earlier in cultures treated 
w ith  10 ng/mL IL-10.
T rep h in e -W o u n d e d  C o rn ea s. The num ber o f keratocytes 
decreased to 56% ±  2% com pared w ith  unwounded control 
corneas im m ediately after wounding, and a maximum reduc­
tion to  33% ±  15% w as measured 4 hours after wounding. 
Thereafter, the num ber o f keratocytes gradually increased in 
the w ound area, and, by 120 hours, the number o f  cells be­
neath the w ound had increased to 60% ±  7.5% o f that in 
unw ounded corneas (Fig. 6).
The TGF-0 isoform s prom pted very different repopulation 
behavior. In agreem ent w ith the results from keratocyte cell 
culture, the increase in cells under the w ound w as evident only 
in corneas treated w ith the low est concentration o f TGF-0, (1 
ng/mL), w here, by 4 and 120 hours, the repopulation o f cells 
under the w ound had increased from 33% ±  1.5% to 83% ±  
4.0%, respectively, o f  the unwounded control (Fig. 6a). In 
contrast, the TGF-0, neutralizing mAb CAT-192 dramatically 
decreased keratocyte numbers at all tim e points, compared  
w ith the control (Fig. 6a). TGF-03 significantly decreased the 
cell density under the w ound at all concentrations tested (Fig. 
6c). Similarly, addition o f IL-10 decreased the number o f cells 
beneath the w ound (Fig. 6d). Neither TGF-0, nor CAT-152 had 
a significant effect on this response (Fig. 6b).
Myofibroblast Differentiation
Keratocytes cultures maintained in m edium alone or plus di­
luent retained a stellate m orphology and w ere a-sm ooth mus­
cle  actin negative. 0-Actin was located perinuclearly and 
throughout the cytoplasm with no obvious stress fiber bundles 
(Fig. 7a). O f all the factors tested in cell culture, only high-dose 
TGF-0, prom pted the differentiation o f  keratocytes into myo­
fibroblasts. Prominent stress fibers w ere obvious w hen cells 
w ere stained w ith phalloidin, the cells lost their stellate shape 
and elongated into spindles (Fig. 7b). More than half o f  the 
cells staining positive for a sm ooth m uscle actin w hich ap­
peared to be organized in bundles similar to the 0-actin fila­
ments.
Only very occasional cells, if any, w ere a-sm ooth muscle 
actin positive in control cornea organ cultures (Figs. 7e) with
IOVS, May 2006, Vol. 47, No. 5 TGF-0 Isoform s and Inhibitors in  Corneal Healing 1891
control
0.1 ng/ml TGF-01 
1 ng/ml TGF-01 
10ng/ml TGF-01
0 24 48 72 96 120
time in culture (hr)
—O— control 
— 0.1ng/ml TCF-03 
■■♦— 1ng/ml TGF-0J 
10ng/ml TGF-03
0 24 48 72 96 120
control
0.1 ng/ml TGF-0J 
1ng/ml TGF-02 
10ng/ml TGF-0,
e
I
0 24 48 72 96 120
i
E
time in culture (hr)
d  7.5*10*-
time in culture (hr)
5.0x10*-
?  2.5x10“-
O.OxiO-*-
control
0.1ng/ml L-10 
1 ng/ml L-10 
10ng/ml IL-10
—-r- 
24
—r- 
48
T -
72
“i—
96
—r 
120
time in culture (hr)
F ig u r e  5. The effect of (a) TGF-/3,, (b) TGF-02, ( c )  TGF-03, and (d) IL-10 on the number of keratocytes in serum-free cell culture assessed using 
the cresyl violet assay. Each point is the average of three experiments of triplicate wells. Error bars, SEM. Data were analyzed using the Students 
/-test. *P < 0.05; **P < 0.01.
the ex cep tion  o f  cells surrounding the lum en o f  b lo o d  v esse ls  
in the com eal lim bus (Figs. 7c , 7d). Very occasionally , isolated  
cells w ere  evident in the area under the w o u n d  after re- 
epithelialization had occurred. M yofibroblasts becam e evident 
in the stroma o f  corneas treated w ith  100 ng/m L  o f  TGF-/3, 
(Figs. If). These w ere located  in the area directly  under the  
w ound, w ith in  the upper 150 /im  o f  th e  strom a at th e  ed g e  o f  
the w ou nd  face, w ith  isolated cells (<1%  o f  strom al cells)  
appearing at 72 hours after w ounding. At 120 hours, the  
num ber o f  a-sm ooth m uscle  a ctin -p ositive  cells  had signifi­
cantly increased to  65.97%  ±  13-57%, com pared  w ith  control 
corneas at the sam e tim e point (P <  0 .0 0 1 ). T he strom al cells  
o f  corneas treated w ith  CAT-192 (anti-TGF-0,), TGF-/33 or IL-10 
had no obvious a-sm ooth m uscle  actin p ositive  ce lls  at any  
tim e point.
D iscussion
W e present ev idence that TGF-0 isoform s differentially regu­
late several key events in early c o m ea l w o u n d  healing. TGF-0, 
appeared to be the m ost active c o m ea l isoform  and w a s  able to  
delay re-epithelialization, increase proliferation o f  keratocytes, 
enhance repopulation o f  th e  per iw ou n d  area, and p rom ote  
myofibroblast transformation. M oreover, neutralization o f  en ­
dogenously produced TGF-0, after treatm ent w ith  the anti- 
TGF-0, mAb, CAT-192, m ediated an e ffec t o p p o site  the re­
sponse to  exogen ously  added TG F-0,. In contrast to  th e  TGF-0, 
isoform, TGF-03 reduced th e  keratocyte repopulation  o f  the  
periw ound area. TGF-02 or neutralization o f  TGF-02 w ith  the  
selective antibody CAT-152 had little e ffect o n  c o m ea l w ou n d  
healing.
T he effects o f  TGF-0, reported in this study concur w ith  the  
findings o f  other investigators in various species. First, TGF-0, 
w as the on ly  factor capable o f  inducing a-sm ooth m uscle actin 
exp ression  in stromal cells in cell and organ culture, a well- 
docu m en ted  p h en om en on .3,22 Second, TGF-0, increased the  
num ber o f  cells under the w ou n d  in w ou nd ed , organ-cultured 
corneas, a finding in com m on w ith  reports in the literature 
involving rabbits.3 Third, a neutralizing antibody against the  
active form o f  TGF-0,, inhibits the s lo w  repopulation o f  stro­
mal cells  under the w ou n d  as previously sh ow n  after laser 
keratectom y.23 Although not exam ined in this study, it is likely 
that th ese  even ts are, at least in part, m ediated via connective  
tissue grow th  factor.24
TGF-03 inhibited not only the repopulation o f  the stroma 
observed  in the control but also decreased the num ber o f  cells 
b e lo w  that seen  at any tim e poin t in untreated corneas. O f 
note, neutralizing TGF-03 had no effect, either on  the num ber 
o f  cells beneath the w ou n d  or the expression  o f  laminin and 
fibronectin in the cornea,23 and thus may act by inhibiting the  
action o f  endogenou s TGF-0, as occurs during w ou nd  healing 
in the skin.25 TGF-03 knockout m ice dem onstrate scarring in 
the fetal stage that does not occur after w ounding in the  
wild-type equivalent,26 and it appears that the ratio o f  TGF-0, 
to  -03 is critical in determ ining the ex ten t o f  fibrosis. Thus, 
TGF-03 may be a candidate for therapeutic interventions, es­
pecially  because it had no detrimental e ffect on  com eal re­
epithelialization in this study.
M oller-Pedersen et al. 2 have reported that a pan neutraliz­
ing antibody (1 D 1 1) able to  block all isoform s o f  TGF0 reduced  
keratocyte activation and transformation and inhibited stromal 
fibrosis in a rabbit m odel o f  PRK. H ow ever, in this rabbit
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F ig u r e  6 .  The effect of (a) TGF-0, and anti-TGF-0,, (b) TGF-/32 and anti-TGF-02, ( c )  TGF-03, and (d) IL-10 on the number o f keratocytes beneath 
a trephine wound in organ-cultured corneas between 0 and 120 hours after wounding. Points represent the average number of cells under the 
wound as a percentage of the number at a comparable depth in that unwounded control. Each point is the average of six corneas per treatment 
and error bars, SEM. Data were analyzed using the Kruskal-Wallis test (*P <  0.05; **P <  0.01). Significance symbols for 4-hour time points are not 
shown due to lack of space.
m odel, the regrowth o f  the strom a w as un affected  by pan  
isoform  neutralization w ith  1D11. Our results su ggest that 
w h ile  neutralizing TGF-0, may b e  im portant in p reven tin g  
fibrosis, the neutralization o f  TGF-03 may w e ll b e  agonistic  to  
TGF-0! action. O ne may postulate that the b est o u tco m e  (o f  a 
single agent) w ou ld  be selective  neutralization o f  TG F-0,, and  
this could  be achieved w ith  the hum an m on oclon a l antibody  
CAT-192. This approach may reduce fibrosis, keratocyte trans­
formation (and hence  light-reflective keratocytes), as w e ll as 
repopulation o f  the stroma. Rapid re-epithelialization w o u ld  
also limit additional stromal trauma. This approach w o u ld  be  
w orthy o f  study in a m odel system  su ch  as experim en ta l PRK.
IL-10 is classically regarded as a p o ten t anti-inflammatory 
cytokine and m ost studies into its fun ction  and e ffec t have  
centered on this prem ise. This study is th e  first to  report th e  
effect o f  IL-10 on co m ea l w o u n d  healing. IL-10 w a s seen  to  
have a pleiotropic effect o n  the ep ithelium , increasing re­
epithelialization at 10 ng/mL, but suppressing w o u n d  coverage  
at 100 ng/mL.
Sources for I H 0  include TH2 c e lls27 and m o n o cy tes ,28 b oth  
o f  w h ich  should have no  access  to  th e  corn ea  in non path olog ic  
situations. IL-10 mRNA has b een  isolated  from  the corneas o f  
m ice both before and after alkali b u m s29 and in hum ans during 
com eal transplant surgery.30 C om eal epithelia l cells  are a likely  
candidate, as the epithelia o f  o th er  organs includ ing skin pro­
duce IL-10.31-33 Previous studies have sh o w n  that IL-10 treat­
m ent can reduce the m igration o f  T-cells and neutrophils into 
H SV-l-infected m ouse corneas,34 reduce HLA-DR expression  
o n  co m ea l cells  and infiltrating leukocytes o f  hum an herpetic  
strom al keratitis sp ec im en s,35 and decrease com ea l opacifica­
tion  in H SV-l-infected BALB/c m ice .34,36 All o f  these  in vivo 
experim en ts w ere  perform ed in the presen ce  o f  a functioning  
im m une system  and w ere  characterized by im m une cell infil­
tration o f  the cornea, w h ich  could  have m ediated the effects o f  
IL-10 o n  th e  co m ea l cells. The current study is therefore the  
first to  sh o w  that co m ea l cells, in the absence o f  lym phocytes, 
can respond to  IL-10 treatm ent and as such  provides com pel­
ling ev id en ce  that the cornea contains the IL-10 receptor. 
Indeed, the upregulation o f  IL-10 Rc mRNA expression has 
b een  identified in corneas after excim er laser injury.37
Little is k n ow n about the m echanism  by w h ich  IL-10 regu­
lates epithelial cells and fibroblasts. IL-10 has been  sh ow n to  
have antagonistic effects to  the actions o f  TGF-0,38 although  
h o w  this is achieved is unclear. IL-10 has been  show n to 
m odulate extracellular matrix com ponents by downregulating  
type I collagen  expression  and upregulating collagenase and 
stom elysin mRNA in hum an skin fibroblasts39; reducing con­
stitutive and transforming grow th factor-0-stimulated, type I 
collagen mRNA expression  in hum an lung fibroblast cells40; 
and dow nregulating the biosynthesis o f  fibrinogen in sm ooth  
m uscle cells ,41 all o f  w h ich  may contribute to modulation o f  
fibrosis.
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F i g u r e  7 .  a-Smooth muscle actin 
staining in myofibroblasts. In serum- 
free cell culture, untreated kerato­
cytes did not express a-smooth mus­
cle actin (not shown); however, 
serum-treated cultures ( a )  developed 
a-smooth actin expression appar­
ently within stress fibers in groups of 
cells after 5 days, commonly these 
cells were overlying the initial mono­
layer. In cultures treated with 10 
ng/mL TGF-/3,, ~50% of cells ex­
pressed a-smooth muscle actin after 
5 days ( b ) .  Untreated wounded bo­
vine corneas, except for the limbal 
vasculature (arrow  denotes blood 
vessel), which acted as an internal 
positive control (c), shown at higher 
magnification in ( d ) ,  were negative 
for a-smooth muscle actin (e). Cor­
neas treated with 100 ng/mL TGF-P, 
for 5 days contained cells within the 
stroma, immediately beneath the 
wound site, that expressed a-smooth 
muscle actin ( f ) ,  indicating the pres­
ence of myofibroblasts (arrowy  
Scale bar: ( a ,  b )  50 p.m; (c) 100 /zm; 
( d )  20 /zm; (e) 40 /zm.
Our study confirms the primary role o f  the /3, isoform  o f  
TGF during com eal w ound healing. Furthermore, it identifies 
I H 0  and TGF-P, as potential therapeutic regulators o f  com ea l  
repair and the prevention o f  fibrosis. It is also likely that early 
application o f treatment w ill be essential to  m inim ize adverse  
healing and optim ize repair. A postoperative indication such as 
com eal refractive surgery could be benefited  by this type o f  
biological therapy.
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